Computational Integrative Models for Cellular Conversion: Application to Cellular Reprogramming and Disease Modeling by Jung Geb. Zickenrott, Sascha
 
 
PhD-FSTC-2018-16 
The Faculty of Sciences, Technology and Communication 
 
DISSERTATION 
 
Defence held on 09/02/2018 in Luxembourg  
 
to obtain the degree of 
  
 
DOCTEUR DE L’UNIVERSITÉ DU LUXEMBOURG 
 
EN BIOLOGIE 
 
by 
 
Sascha JUNG GEB. ZICKENROTT 
Born on 12 May 1988 in Göttingen, (Germany) 
 
COMPUTATIONAL INTEGRATIVE MODELS FOR 
CELLULAR CONVERSION: APPLICATION TO 
CELLULAR REPROGRAMMING AND DISEASE 
MODELING 
 
 
Dissertation defence committee 
Dr Antonio del Sol, dissertation supervisor 
Professor, Université du Luxembourg 
 
Dr Lasse Sinkkonen 
Research Scientist, Université du Luxembourg 
 
Dr Jorge Goncalves, Chairman 
Professor, Université du Luxembourg 
 
Dr Miguel Andrade 
Professor, Johannes Gutenberg University Mainz 
Institute of Molecular Biology GmbH 
 
Dr Noel J. Buckley, Vice Chairman 
Professor, University of Oxford

Affidavit 	I	 hereby	 confirm	 that	 the	 PhD	 thesis	 entitled	 “Computational	 Integrative	Models	 For	Cellular	Conversion:	Application	To	Cellular	Reprogramming	and	Disease	Modeling”	has	been	written	independently	and	without	any	other	sources	than	cited.				 Sascha	Jung	Luxemburg	January	9,	2018		 	
	2	
Acknowledgements 	 	During	 the	 course	 of	 my	 PhD,	 I	 met	 a	 number	 of	 people	 who	 supported	 my	personal	 and	 academic	 developments	 and	 would	 like	 to	 use	 this	 opportunity	 for	expressing	my	gratitude	to	them.		 First	 and	 foremost,	 I	 would	 like	 to	 express	 my	 sincere	 gratitude	 to	 my	supervisor,	Prof.	Dr.	Antonio	del	Sol,	for	the	continuous	support	of	my	research	and	the	encouragement	 to	 aim	 for	bigger	 achievements	and	 ideas.	He	 created	a	 truly	 amazing	environment	of	critical	scientific	discussions	that	greatly	helped	in	focusing	my	research	and	provided	invaluable	feedback	to	my	work.	His	door	was	always	open	to	discuss	new	ideas,	so	that	my	productivity	was	only	limited	by	my	own	working	capacity	and	ability	to	develop	in	new	directions.		 I	would	also	like	to	thank	the	members	my	evaluation	committee,	Prof.	Dr.	Jorge	Goncalves	 and	 Prof.	 Dr.	 Noel	 J.	 Buckley.	 Their	 critical	 assessment	 of	my	 research	 and	suggestions	of	new	research	directions	were	invaluable	in	defining	the	topics	addressed	during	my	study	and,	ultimately,	my	PhD	thesis.	During	the	course	of	my	PhD	studies,	I	collaborated	with	several	people,	which	greatly	contributed	to	 the	research	projects	reflected	 in	 this	 thesis.	Therefore,	 I	would	like	to	thank	Prof.	Dr.	Miguel	Andrade,	Dr.	Lasse	Sinkkonen,	Bimal	Babu	Upadhyaya	and	Julia	Becker.	I	would	 also	 like	 to	 thank	 the	 LCSB	 for	 hosting	me	 and	 providing	 an	 amazing	environment	 that	 stimulates	 collaborative,	 interdisciplinary	 research.	 It	 has	 been	 a	privilege	to	work	with	the	people	here	and	I	will	never	forget	this	experience.	Especially	my	 colleagues	 in	 the	 Computational	 Biology	 group	 provided	 invaluable	 personal	 and	academic	 support	 whenever	 I	 needed	 it.	 Dr.	 Srikanth	 Ravichandran,	 Dr.	 Andras	Hartmann,	Dr.	Vladimir	Espinosa	Angarica,	Gaia	Zaffaroni	and	Muhammad	Ali	provided	great	feedback	when	I	was	stuck	with	a	problem	and	stimulated	the	investigation	of	new	possibility,	whenever	I	needed	it.	Finally,	 I	would	 like	to	 thank	my	parents	 for	their	continuous	support.	 I	would	also	particularly	like	to	thank	my	wife,	Patrizia,	for	her	unconditional	love	and	support	in	each	and	every	situation	and	my	kids,	Anna	and	Felix,	for	showing	me	that	distraction	sometimes	helps	to	get	a	clear	view	when	being	stuck	with	a	problem.				 	
	 3	
Affidavit .................................................................................................................... 1	
Acknowledgements .................................................................................................. 2	
Figures & Tables ....................................................................................................... 5	
Summary .................................................................................................................. 7	
CHAPTER 1	 Introduction & Literature Review ...................................................... 9	1.1	 Modulation	of	Cell	Types	through	Gene	Regulation	...........................................................	11	
1.1.1	Condition	Specific	Transcriptional	Regulation	.........................................................................13	
1.1.2	Condition	Specific	Epigenetic	Landscapes	Govern	Transcription	....................................14	
1.1.3	Viewing	Diseases	as	Cellular	Conversions	...................................................................................19	1.2	Gene	Regulatory	Network	Inference	from	Condition	Specific	Transcriptomics	Data	22	1.3	Systematic	Identification	of	Instructive	Factors	for	Cellular	Conversions	......................	28	1.4	Summary	............................................................................................................................................................	31	
CHAPTER 2	  Scope & Aims of Thesis ................................................................... 33	2.1	Thesis	Aims	.......................................................................................................................................................	33	2.2	Originality	..........................................................................................................................................................	34	
CHAPTER 3	 Methods .......................................................................................... 36	3.1	Boolean	Networks	as	Models	of	Gene	Regulation	........................................................................	37	3.2	Reconstruction	of	cell-type	specific	gene	regulatory	network	models	.............................	41	
3.2.1	Prior	knowledge	network....................................................................................................................41	
3.2.2	Genetic	Algorithm	for	Boolean	network	reconstruction	......................................................42	3.3	Inference	of	candidate	instructive	factors	for	cellular	conversions	....................................	45	
3.3.1.	Ranking	of	small	compounds	for	inducing	cellular	conversions	......................................46	3.4	Prediction	of	binary	accessibility	measures	....................................................................................	47	
3.4.1	Dataset	for	model	training	.................................................................................................................48	
3.4.2	Stacked	classification	tree	model	....................................................................................................50	3.5	Reference-based	binarization	of	gene	expression	........................................................................	52	
3.5.1	Smoothing	of	empirical	gene	expression	distributions	.........................................................54	
3.2.2	Parameter	Distribution	Approximation	.......................................................................................57	
3.2.3	Derivation	of	Thresholds	.....................................................................................................................58	
3.5.4.	Statistical	Significance	Computation	...........................................................................................61	
3.5.5.	Statistical	assessment	of	the	reference-library	size	...............................................................62	
CHAPTER 4	 Results ............................................................................................. 65	4.1	Differential	Network	Reconstruction	for	Establishing	Disease-Gene-Drug	Relationships	...........................................................................................................................................................	66	
4.1.1	Network	Reconstruction	and	Validation	.....................................................................................66	
4.1.2	Inference	and	Validation	of	Disease-Gene-Drug	Relationships	.........................................68	
4.1.3.	Prediction	of	Candidate	Compounds	for	Treating	Autoimmune	Diseases	..................72	4.2	Prediction	of	Chromatin	Accessibility	in	Gene-Regulatory	Regions	from	Transcriptomics	Data	..........................................................................................................................................	74	
4.2.1	Machine-Learning	Model	Construction	and	Cross-Validation	...........................................75	
4.2.2	Comparison	of	predicted	gene-level	chromatin	accessibility	with	traditional	peak	
calling	algorithms	..............................................................................................................................................79	
4.2.3	Optimizing	peak	calling	parameters	with	model	predictions............................................83	4.3	Integrating	Epigenetics,	Transcriptomics	and	Prior	Knowledge	Networks	for	Predicting	Candidate	Instructive	Factors	in	Adipocyte	to	Osteoblast	Conversion	.............	85	
4.3.1	Differential	Network	Reconstruction	and	Identification	of	Candidate	Instructive	
Factors	.....................................................................................................................................................................86	
4.3.2	Prediction	of	Instructive	Factors	for	Adipocyte	to	Osteoblast	conversion	...................87	
4.3.3	Experimental	Validation	of	Predicted	Instructive	Factors	..................................................89	
	4	
4.4	Reference-based	Discretization	of	Gene	Expression	Data........................................................	90	
4.4.1	Qualitative	analysis	of	discretized	neuroepithelial	differentiation	measurements	.92	
4.4.2	Quantitative	Assessment	of	Discretization	with	RefBool	.....................................................96	4.4	Chapter	Summary	..........................................................................................................................................	99	
CHAPTER 5	 Discussion ...................................................................................... 101	5.1	Cell-type	specific	network	reconstruction	and	differential	network	analysis	............	102	
5.1.1	Advantages	of	this	approach	..........................................................................................................	104	
5.1.2	Limitations	..............................................................................................................................................	106	5.2	Prediction	of	gene-level	chromatin	accessibility........................................................................	107	
5.2.1	Advantages	of	the	chromatin	accessibility	prediction........................................................	108	
5.2.2	Limitations	..............................................................................................................................................	109	5.3	Reference-based	discretization	of	transcriptomics	data	.......................................................	110	
5.3.1	Advantages	of	RefBool	.......................................................................................................................	111	
5.3.2	Limitations	..............................................................................................................................................	112	5.4	Future	Work/Outlook...............................................................................................................................	113	
Logic	Rules..........................................................................................................................................................	113	
Data	Integration	..............................................................................................................................................	114	
Proteomics	..........................................................................................................................................................	115	5.5	Conclusion	......................................................................................................................................................	116	
References ............................................................................................................ 119	
Appendix .............................................................................................................. 132	Supplementary	Tables	.....................................................................................................................................	132	Published	Papers	................................................................................................................................................	141		 	
	 5	
Figures & Tables 	
Figures	
Figure	1.1	 Waddington	landscape	
Figure	1.2	 Shaping	of	the	epigenetic	landscape	through	gene	regulation	
Figure	1.3	 Cellular	conversions	as	displacements	in	the	Waddington	
landscape	
Figure	1.4	 Transcriptional	mediation	through	proximal	and	distal	
regulatory	regions	
Figure	1.5	 Interacting	factors	of	histone	modifications	
Figure	1.6	 Comparison	of	available	network	reconstruction	methods	
Figure	3.1	 Boolean	Network	Example	
Figure	3.2	 Workflow	of	the	genetic	algorithm	
Figure	3.3	 Illustration	of	stacked	classification	tree	model	
Figure	3.4	 Workflow	for	discretizing	gene	expression	data	
Figure	3.5	 Idealized	representation	of	threshold	computation	
Figure	3.6	 Threshold	distribution	used	for	classification	
Figure	3.7	 Minimal	reference	distribution	sizes	
Figure	4.1	 Drug	enrichment	in	six	validation	examples	
Figure	4.2	 Core	network	of	untreated	cells	in	case	of	cobalt	chloride	
Figure	4.3	 Drug	prioritization	results	for	Systemic	Lupus	and	Rheumatoid	
Arthritis	
Figure	4.4	 Correlation	analysis	of	cross-validated	and	full	model	
predictions	
Figure	4.5	 Comparison	of	stacked	classification	tree	model	with	peak	
calling	methods	
Figure	4.6	 Assessment	of	potential	sources	of	bias	in	the	prediction	of	
gene-level	accessibility	
Figure	4.7	 Validated	predicted	accessible	regions	not	detected	by	peak	
callers	
Figure	4.8	 Dependence	between	Recall-measure	and	F-score		
Figure	4.9		 Workflow	for	predicting	instructive	factors	of	adipocyte	to	
osteoblast	conversion	
Figure	4.10	 Predicted	pareto-optimal	combinations	for	inducing	adipocyte	
to	osteoblast	conversion	
Figure	4.11	 Hierarchical	clustering	of	raw	expression		
Figure	4.12	 Hierarchical	clustering	of	discretized	data	
	
Figure	4.13	
	
Correlation	differences	between	continuous	and	discretized	
values	of	successive	time	points	
	6	
Figure	4.14	 Comparison	of	RefBool	and	TascA	on	known	marker	genes	
Figure	4.15	 Quantitative	comparison	of	RefBool	against	other	methods	in	
clustering	RNA-seq	data	
Figure	4.16	 Clustering	consistency	assessment	on	microarray	data	
	
	
Tables	
Table	1.1	 Validated	pioneer	factors	
Table	1.2	 Current	methods	for	identifying	instructive	factors	
Table	3.1	 Training	dataset	for	predicting	gene-level	accessibility	
Table	3.2	 Candidate	distributions	fitted	to	empirical	distributions	
Table	4.1	 ChIP-seq	validated	interactions	of	condition	specific	network	
reconstruction	algorithm	
Table	4.2	 Regulatory	interaction	statistics	of	reconstructed	networks	
Table	4.3	 Comparison	of	simulated	drugs	in	validation	examples	
Table	4.4	 Comparison	of	drug	enrichments	for	Systemic	Lupus	and	
Rheumatoid	Arthritis	
Table	4.5	 False	Discovery	Rate	thresholds	for	peak	calling	methods	
Table	4.6	 Methods	for	comparison	against	RefBool	
Table	4.7	 Rules	for	determining	best	clustering	
Table	S1	 Gene	expression	datasets	for	network	inference	validation	
Table	S2	 ENCODE	filenames	of	transcription	factor	ChIP-seq	data	for	
defining	accessible	chromatin	regions	
Table	S3	 Utilized	datasets	for	reference-based	discretization	of	gene	
expression			 		  
	 7	
Summary 	 The	groundbreaking	identification	of	only	four	transcription	factors	that	are	able	to	induce	pluripotency	in	any	somatic	cell	upon	perturbation	stimulated	the	discovery	of	copious	 amounts	 of	 instructive	 factors	 triggering	 different	 cellular	 conversions.	 Such	conversions	 are	 highly	 significant	 to	 regenerative	 medicine	 with	 its	 ultimate	 goal	 of	replacing	 or	 regenerating	 damaged	 and	 lost	 cells.	 Precise	 directed	 conversion	 of	damaged	 cells	 into	 healthy	 cells	 offers	 the	 tantalizing	 prospect	 of	 promoting	regeneration	in	situ.		In	 the	 advent	 of	 high-throughput	 sequencing	 technologies,	 the	 distinct	transcriptional	 and	 accessible	 chromatin	 landscapes	 of	 several	 cell	 types	 have	 been	characterized.	 This	 characterization	 provided	 clear	 evidences	 for	 the	 existence	 of	 cell	type	 specific	 gene	 regulatory	 networks	 determined	 by	 their	 distinct	 epigenetic	landscapes	 that	 control	 cellular	 phenotypes.	 Further,	 these	 networks	 are	 known	 to	dynamically	 change	 during	 the	 ectopic	 expression	 of	 genes	 initiating	 cellular	conversions	and	stabilize	again	to	represent	the	desired	phenotype.	Over	 the	 years,	 several	 computational	 approaches	 have	 been	 developed	 to	leverage	 the	 large	amounts	of	 high-throughput	datasets	 for	 a	 systematic	prediction	of	instructive	factors	that	can	potentially	induce	desired	cellular	conversions.	To	date,	the	most	promising	approaches	rely	on	the	reconstruction	of	gene	regulatory	networks	for	a	panel	 of	 well-studied	 cell	 types	 relying	 predominantly	 on	 transcriptional	 data	 alone.	Though	useful,	 these	methods	are	not	designed	 for	newly	 identified	cell	types	as	their	frameworks	are	restricted	only	to	the	panel	of	cell	types	originally	incorporated.	More	importantly,	these	approaches	rely	majorly	on	gene	expression	data	and	cannot	account	for	 the	 cell	 type	 specific	 regulations	modulated	by	 the	 interplay	of	 the	 transcriptional	and	epigenetic	landscape.		 In	this	thesis,	a	computational	method	for	reconstructing	cell	type	specific	gene	regulatory	networks	is	proposed	that	aims	at	addressing	the	aforementioned	limitations	of	current	approaches.	This	method	integrates	transcriptomics,	chromatin	accessibility	assays	and	available	prior	knowledge	about	gene	regulatory	interactions	for	predicting	instructive	 factors	 that	 can	 potentially	 induce	 desired	 cellular	 conversions.	 Its	application	 to	 the	 prioritization	 of	 drugs	 for	 reverting	 pathologic	 phenotypes	 and	 the	identification	 of	 instructive	 factors	 for	 inducing	 the	 cellular	 conversion	 of	 adipocytes	into	osteoblasts	underlines	the	potential	to	assist	in	the	discovery	of	novel	therapeutic	interventions.			 	
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CHAPTER 1 Introduction & Literature Review Regenerative	medicine,	with	its	ultimate	goal	to	replace	or	regenerate	damaged	and	 lost	human	cells,	 is	striving	 to	develop	efficient	protocols	 for	 (re)generating	cells,	tissues	 or	 organs	 impaired	 in	 existing	 pathologies	 (Mason	 and	 Dunnill,	 2008).	Historically,	the	term	was	first	coined	25	years	ago	(Kaiser,	1992)	and	comprises	a	wide	variety	of	 techniques.	There	 are	 two	major	 lines	of	 regenerative	medicine	 that	 can	be	distinguished.	The	first	approaches	involved	the	transplantation	from	donor	tissues	and	aimed	at	restoring	 the	normal	 function	of	 tissues	and	cells.	 In	the	 late	1960s,	 the	 first	successful	cell	transplantation	of	bone	marrow	was	performed	in	living	humans	(Starzl,	2000)	 and	 laid	 the	 groundwork	 for	 future	 clinical	 applications.	 One	 of	 the	 earliest	developments	 is	 the	use	of	 engineered	 tissue	 transplants	 in	human.	Pioneered	by	 the	engineering	and	transplantation	of	skin	in	1981	(Burke	et	al.,	1981),	additional	tissues,	like	artificial	bladders	(Atala	et	al.,	2006)	and	re-engineered	livers	(Uygun	et	al.,	2010),	were	successfully	transplanted	in	living	humans.		Complementary	 to	 tissue	 transplantation,	 the	 second	 line	 of	 research	 in	regenerative	medicine	can	be	described	as	cell-based	therapy	and	follows	the	strategy	of	injecting	novel	and	healthy	cells	 in	pathologic	 tissues	(Sampogna	et	al.,	2015).	Several	approaches	 currently	 exist	 for	 obtaining	 healthy	 cells	 for	 transplantation.	 First,	differentiated	 cells	 can	 be	 directly	 collected	 from	 the	 patient’s	 respective	 tissue,	expanded	 in	 vitro	 and	 implanted	 again,	 without	 alterations.	 However,	 expanding	 the	collected	cells	typically	bears	problems	due	 to	 the	change	 in	 the	microenvironment	of	the	 cells,	 i.e.	 the	 culturing	 conditions	 (Atala,	 2012).	 	 A	 more	 promising	 approach	constitutes	 the	 cellular	 conversion	 of	 donor	 cells	 into	 induced	 pluripotent	 stem	 cells	(iPSCs)	 and	 their	 subsequent	 differentiation	 or,	 more	 generally,	 their	 direct	 trans-differentiation	into	the	desired	cell	type.		 With	the	groundbreaking	finding	that	the	cellular	conversion	of	somatic	cells	to	pluripotent	stem	cells	 (iPSCs)	can	be	 induced	by	up-regulating	only	 four	 transcription	factors,	 OCT4,	 SOX2,	 KLF4	 and	 c-MYC	 (Takahashi	 and	 Yamanaka,	 2006),	 the	 directed	cellular	conversion	into	particular	cell	types	became	widely	applicable.	Many	protocols	have	been	discovered	for	various	cellular	conversion	such	as	the	differentiation	of	iPSCs	into,	for	example,	cortical	neurons	(Shi	et	al.,	2012),	astrocytes	(Shaltouki	et	al.,	2013),	skeletal	muscle	cells	(Maffioletti	et	al.,	2015)	or	cardiomyocytes	(Burridge	et	al.,	2014)	and	 the	 trans-differentiation	 of	 fibroblasts	 into	 cardiomyocytes	 (Ieda	 et	 al.,	 2010),	hematopoetic	 progenitors	 (Szabo	 et	 al.,	 2010)	 or	 motor	 neurons	 (Son	 et	 al.,	 2011).	However,	the	instructive	factors	of	desired	conversion	are	unknown	in	many	cases,	due	
	10	
to	 the	 limited	 understanding	 of	 the	 cellular	 gene	 regulatory	 networks	 modulating	cellular	identity.		 The	discovery	of	instructive	factors	for	cellular	conversions	has	been	previously	accomplished	 by	 experimental	 testing	 of	 conjectures	 derived	 from	 literature.	 In	 the	advent	of	high-throughput	sequencing	technologies,	computational	methods	attempted	the	 reconstruction	 of	 the	 complex	 gene	 regulatory	 networks	 underlying	 cellular	phenotypes	for	enabling	their	systematic	analysis	(Liu,	2015).	Based	on	these	network	models,	strategies	for	identifying	important	transcriptional	regulators	or	for	examining	the	 cellular	 responses	 to	 perturbations	 by	 model	 simulation	 have	 been	 proposed	 in	order	to	facilitate	the	prediction	of	instructive	factors	(Crespo	et	al.,	2013;	Cahan	et	al.,	2014;	 Rackham	 et	 al.,	 2016).	 However,	 there	 exist	 several	 significant	 limitations	 that	prevent	these	methods	from	being	generally	applicable.		 The	 remainder	 of	 this	 chapter	 reviews	 the	 current	 knowledge	 about	 cellular	gene	 regulatory	 networks	 and	 discusses	 the	 limitations	 of	 existing	 methods	 for	identifying	 instructive	 factors	 of	 cellular	 conversions.	 The	 organization	 is	 as	 follows:	Section	 1.1	 (Modulation	 of	 Cell	 Types	 through	 Gene	 Regulation)	 describes	 the	modulation	 and	 stabilization	 of	 cellular	 phenotypes	 through	 the	 interplay	 of	transcriptional	 and	 epigenetic	 regulation.	 Section	 1.2	 (Gene	 Regulatory	 Network	Inference	 from	Condition	Specific	Transcriptomics	Data)	provides	a	detailed	review	of	modeling	formalisms	for	representing	gene	regulatory	networks	with	various	levels	of	detail	 and	 the	 practical	 issues	 with	 their	 identification.	 Then,	 section	 1.3	 (Systematic	Identification	 of	 Instructive	 Factors	 for	 Cellular	 Conversions)	 reviews	 current	computational	methods	for	the	identification	of	instructive	factors	with	and	without	the	aid	 of	 computational	 network	models.	 Finally,	 section	 1.4	 concludes	with	 a	 summary	including	the	main	limitations	of	current	computational	methods.		 	
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1.1 Modulation of Cell Types through Gene Regulation 	In	 1957,	 Conrad	 Waddington	introduced	 the	 concept	 of	 an	“epigenetic	 landscape”	representing	 the	 developmental	process	 of	 cells	 (Figure	 1.1)	depicted	by	a	ball	rolling	down	a	valley	 (Waddington,	 1957).	 On	its	 path,	 a	 number	 of	 forks,	 or	decision	 points,	 occur	 that	separate	 different	 valleys	 and	represent	 the	 differentiation	towards	 a	 more	 mature	 cell	type.	 Each	 fork	 represents	 here	the	metastable	state	of	stem	and	progenitor	 cells,	 ultimately	giving	rise	to	 fully	differentiated	cells	when	no	fork	exists	anymore.	In	most	cases,	 forks	 represent	 a	 binary	 cell	fate	 specification	 that	 forces	 cells	 to	adopt	one	of	two	cell	states	(Hayward	
et	 al.,	 2008)	 and	 are	 mediated	 by	transcriptional	 changes.	 Thus,	 the	“epigenetic	 landscape”	 is	 shaped	 by	the	 coordinated	 expression	 of	 genes	(Figure	 1.2)	 requiring	 an	 interaction	of	 transcription	 factors	 (TFs)	 that	control	 the	 expression	 of	 genes	 and	histone	 modifiers/chromatin	remodelers	 for	 determining	 the	accessibility	 of	 other	 transcription	factors	 to	 the	DNA	 and	 their	 binding	stability	 (Moris	 et	 al.,	 2016).	Particularly,	 transcription	 factors	
Representation	 of	 development	 as	 a	 ball	 rolling	
down	 a	 landscape	 with	 several,	 alternative	 paths.	
Distinct	 fates	 are	 separated	 by	 hills	 and	 inhibit	 a	
natural	switch	of	committed	cells.	Similarly,	not	all	
fates	 are	 equally	 likely,	 as	 can	 be	 seen	 on	 the	
second	decision	of	the	left	part.	(Picture	taken	from	
(Waddington,	1957))	
Figure	1.1.	Waddington	landscape	
The	 developmental	 paths	 are	 modulated	 by	
the	 interplay	 of	 genes,	 depicted	 as	 bars.	
Combinatorial	 effects	 of	 gene	 expression	
shape	 the	 height	 of	 hills	 and	 wideness	 of	
valleys	 and	 as	 such	 determine	 cell	 fate	
decisions.	 (Picture	 taken	 from	 (Waddington,	
1957))	
Figure	1.2.	Shaping	of	the	epigenetic	landscape	
through	gene	regulation	
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have	 been	 shown	 to	 actively	 regulate	 and	 control	 cell	 fate	 specification	 during	development	 in	 a	 variety	 of	 cases,	 including	 the	 retinal	 ganglion	 (Wu	 et	 al.,	 2015),	myeloid	 cells	 (Rosmarin	 et	 al.,	 2005),	 cardiomyocytes	 (Bai	 et	 al.,	 2015)	 and	 neurons	(Zhang	et	al.,	2013).		 The	 “epigenetic	 landscape”	 proposed	 by	 Conrad	Waddington	 served	 for	many	years	as	an	intuitive	explanation	of	cellular	transitions.	However,	the	pioneering	work	of	Davis	 et	 al.	 in	 1987	proved	 the	 feasibility	 of	 direct	 cellular	 conversions	 of	 fibroblasts	into	myoblasts	upon	overexpression	of	a	single	transcription	factor,	MYOD	(Davis	et	al.,	1987),	 which	 significantly	 changed	 the	 perception	 of	 cellular	 conversion.	 Subsequent	studies	confirmed	the	phenomenon	of	transcription	factor	induced	cell	fate	conversions	in	 several	 blood	 cell	 types	 (Kulessa	et	al.,	 1995)	and	 the	pancreas	 (Shen	et	al.,	 2000),	which	 led	 to	 a	major	 conceptual	 change	of	 the	 epigenetic	 landscape.	The	 concept	was	further	 shattered	 with	 the	 groundbreaking	 identification	 that	 somatic	 cells	 could	 be	reprogrammed	to	a	pluripotent	state	by	ectopic	expression	of	only	four	TFs	(Takahashi	and	Yamanaka,	 2006;	Takahashi	et	al.,	 2007).	 Instead	of	 a	unidirectional	 landscape	of	cellular	 developmental	 processes,	 these	 findings	 underline	 the	 multidirectionality	 of	cellular	 conversions	 including	 trans-differentiation	 and	 rejuvenation	 (Figure	 1.3,	(Takahashi	and	Yamanaka,	2015)).		 Even	 though	 Waddington’s	 classic	 proposition	 of	 an	 “epigenetic	 landscape”	underwent	 conceptual	 revisions,	 the	 experimental	 evidence	 for	 cellular	 conversions	supports	 the	 existence	 of	 gene	 regulatory	 networks	 (GRNs)	modulating	 different	 cell	
Developmental	 paths	 of	 embryonic	 to	 somatic	 cells	 can	 be	 altered	 through	 the	
perturbation	 of	 the	 underlying	 gene	 regulatory	 network.	 Three	 types	 of	 cellular	
conversions	 can	 be	 distinguished.	 Classical	 reprogramming	 involves	 the	
dedifferentiation	 of	 cells	 towards	 a	 pluripotent	 state	 not	 necessarily	 following	 the	
developmental	path.	Trans-differentiation	constitutes	the	conversion	of	differentiated	
cells	 either	 by	 direct	 induction	 or	 indirectly	 by	 following	 developmental	 paths.	
(Picture	taken	from	(Takahashi	and	Yamanaka,	2015))	
Figure	1.3.	Cellular	conversions	as	displacements	in	
the	Waddington	landscape	
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types	that	are	sensitive	to	perturbations.	Understanding	the	composition	and	function	of	these	 cell	 type	 specific	 GRNs	 is	 therefore	 crucial	 to	 identify	 perturbations	 inducing	desired	cellular	conversion.	
1.1.1 Condition Specific Transcriptional Regulation Transcription	describes	 the	process	of	 generating	an	RNA	 copy	of	 a	particular	segment	of	DNA	and	is	orchestrated	through	the	binding	of	transcription	factors.	In	this	process,	TFs	act	alone	or	 in	conjunction	with	other	proteins	 to	promote	or	 inhibit	 the	initiation	of	transcription	by	recruitment	of	RNA	polymerases.	The	regulatory	elements	transcription	 factors	 bind	 to	 can	 be	 divided	 into	 three	 main	 classes,	 i.e.	 promoters,	enhancers	 and	 insulators	 (Figure	 1.4).	 Promoters	 are	 proximal	 regulatory	 regions	located	 close	 to	 the	 transcription	 start	 site	 (TSS)	 and	 are	 sufficient	 for	 attracting	 the	transcriptional	machinery.	However,	transcription	is	often	weak	in	the	absence	of	more	distal	 regulatory	 elements	 (Shlyueva	 et	 al.,	 2014).	 These	 distal	 elements,	 called	enhancers,	 are	 potentially	 located	 hundreds	 of	 thousand	 base	 pairs	 away	 from	 the	transcription	 start	 site	 (TSS)	 but	 remain	 spatially	 close	 through	 DNA	 looping	 in	 the	nucleus	 (Amano	 et	 al.,	 2009).	 Due	 to	 the	 three	 dimensional	 organization	 of	 DNA,	multiple	 enhancers	 might	 contribute	 concurrently	 to	 the	 expression	 of	 their	 target	
Figure	1.4.	Transcriptional	mediation	through	proximal	and	distal	regulatory	regions	
Gene	transcription	is	achieved	through	the	regulation	of	proximal	and	distal	
regulatory	elements.	DNA	bending	spatially	brings	together	enhancer	and	promoter	
regions	allowing	for	the	attraction	of	the	transcriptional	machinery	by	transcription	
factors.	(Picture	taken	from	https://archive.cnx.org/contents/53013107-747b-41b0-
ad43-f4e97bd69ef1@2/gene-expression-eukaryotic-transcriptional-regulation-gpc)	
	14	
genes	 in	 a	 mostly	 additive	 manner	 (Shlyueva	 et	 al.,	 2014).	 In	 contrast	 to	 the	 active	regulation	in	enhancer	and	promoter	regions,	insulators	are	passive	regulatory	regions	separating	enhancers	and	promoters	to	block	their	interactions	(Gaszner	and	Felsenfeld,	2006).		 The	presence	of	multiple	regulatory	elements	targeting	the	same	gene	supports	a	combinatorial	binding	of	transcription	factors	ultimately	allowing	cells	to	give	rise	to	multiple	 cell	 types	 and	 respond	 to	 environmental	 stimuli.	 Despite	 their	 individual	contributions	 to	 the	phenotype	of	 cells,	 transcription	 factors	 form	 regulatory	 cores	of	mutual	regulation	to	maintain	a	stable,	cell	type	specific	gene	expression	profile	(Neph	
et	al.,	2012).	In	particular,	regulatory	cores	are	typically	composed	of	only	a	few	factors	and	 possess	 a	 strong	 maintenance	 capacity	 while	 suppressing	 transcription	 factors	implicated	 in	 other	 lineages	 (Hikichi	 et	 al.,	 2013).	 In	 this	 regard,	 the	 most	 studied	example	to	date	is	certainly	the	regulatory	core	of	pluripotent	stem	cells,	composed	of	OCT4,	 SOX2	 and	 NANOG	 (Ng	 and	 Surani,	 2011;	 Young,	 2011),	 which	 maintains	pluripotency	and,	thus,	suppresses	the	differentiation	to	trophectoderm,	mesendoderm	or	neural	ectoderm	(Thomson	et	al.,	2011;	Niwa	et	al.,	2000).		 A	 deeper	 understanding	 of	 the	 transcriptional	 modules	 and	 regulatory	interactions	 responsible	 for	 cellular	 stability	 requires	 the	 genome-wide	 dissection	 of	transcription	 factor	 binding.	 In	 essence,	 binding	 of	 transcription	 factors	 to	 DNA	 is	facilitated	 through	 the	 sequence-specific	 recognition	 of	 cis-regulatory	 elements,	 i.e.	genomic	 sequences,	 ranging	 in	 size	 from	 4	 to	 30	 base	 pairs.	 For	 example,	 a	 widely	studied	 cis-regulatory	 element	 is	 the	 TATA-Box,	 a	 DNA-sequence	 located	 in	 the	 core	promoter	of	genes,	at	which	the	preinitiation	complex	forms	after	binding	of	the	general	transcription	 factor	 TFIID.	 The	 binding	 affinities	 of	 proteins,	 i.e.	 the	 strength	 of	 the	chemical	 bond	 established	 between	 proteins	 and	 DNA,	 vary	 greatly	 from	 site	 to	 site	depending	on	the	actual	sequence	and	the	three	dimensional	shape	of	the	DNA	(Stormo	and	 Zhao,	 2010;	 Rohs	 et	 al.,	 2009).	 In	 addition	 to	 these	 features,	 recent	 studies	underpinned	 the	 crucial	 role	 of	 epigenetic	 modifications	 in	 establishing	 competent	protein-DNA	interactions	(Liu	et	al.,	2015).		
1.1.2 Condition Specific Epigenetic Landscapes Govern Transcription The	 term	 “epigenetics”	 comprises	 various,	 partially	 heritable	 changes	 in	 gene	function	not	related	to	changes	in	the	DNA	sequence	(Dupont	et	al.,	2009).	Among	them,	especially	 covalent	 histone	modifications	 and	 chromatin	 accessibility	 are,	 to	 date,	 the	
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most	 widely	 studied,	 though	 not	 necessarily	 most	 important,	 forms	 of	 epigenetic	mechanisms	that	will	be	discussed	in	the	remainder	of	this	section.		 	Chromatin	 is	 typically	 packaged	 into	 nucleosomes	 consisting	 of	 histone	octamers	 wrapped	 by	 approximately	 147	 base	 pairs	 of	 DNA.	 Positioning	 of	 the	nucleosomes	plays	an	important	role	in	transcriptional	regulation	as	it	determines	the	availability	 of	 regulatory	 regions	 or	 genes	 to	 the	 transcriptional	machinery	 (Radman-Livaja	and	Rando,	2010;	A	P	Boyle	et	al.,	2008;	Song	et	al.,	2011;	Thurman	et	al.,	2012;	Mercer	 et	al.,	 2013;	 Neph	 et	al.,	 2012).	 The	 accessibility	 of	 regulatory	 regions	 in	 turn	allows	for	crosstalk	between	the	epigenetic	and	transcriptional	regulation	in	which	the	binding	 of	 specific	 TFs	 promotes	 dynamic	 alterations	 of	 the	 chromatin	 landscape	(McVicker	 et	 al.,	 2013;	 Kilpinen	 et	 al.,	 2013;	 Kasowski	 et	 al.,	 2013).	 Not	 surprisingly,	variations	 in	 the	 chromatin	 landscape	 are	 an	 essential	 part	 of	 many	 phenotypic	transitions	during	development	 or	 cellular	 conversions	 (Apostolou	 and	Hochedlinger,	2013;	 Lara-Astiaso	 et	 al.,	 2014;	 Gaspar-Maia	 et	 al.,	 2011).	 	 Due	 to	 the	 importance	 of	accessible	chromatin	regions,	great	efforts	have	been	devoted	to	develop	experimental	and	computational	assays	for	profiling	active	regulatory	regions	in	accessible	chromatin.	Particularly	 the	 identification	 of	 DNase	 hypersensitive	 sites	 by	 DNase-seq,	formaldehyde-assisted	 isolation	 of	 regulatory	 elements	 by	 FAIRE-seq	 and	 accessible	regulatory	regions	sensitive	to	transposon	integration	by	ATAC-seq	are	frequently	used	experimental	 techniques	(Song	et	al.,	2011;	Buenrostro	et	al.,	2013;	Hesselberth	et	al.,	2009),	which	identify	accessible	genomic	regions.	In	this	context,	DNase-seq	and	ATAC-seq	 are	 of	 particular	 interest	 due	 to	 their	 pronounced	 ability	 of	 pinpointing	 genomic	regions	 bound	 by	 proteins.	 However,	 covalent	 chromatin	modifications	 play	 a	 critical	role	for	mediating	which	transcription	factors	bind	these	regions	and	contribute	to	the	stabilization	of	the	gene	expression	profile.		The	four	histone	proteins	contained	in	nucleosomes	can	be	modified	by	at	least	80	covalent	chromatin	modification	that	define	the	so	called	“histone	code”	(Tsompana	and	 Buck,	 2014;	 Jenuwein	 and	 Allis,	 2001).	 These	 post-translational	 modifications	include	the	acetylation,	methylation,	phosphorylation,	ubiquitylation	and	sumoylation	of	numerous	occasions	on	 the	N-terminals	of	histones	(Bannister	and	Kouzarides,	2011).	While	 every	 histone	 mark	 serves	 its	 own,	 distinct	 function,	 two	 main	 classes	 of	mechanisms	 can	 be	 distinguished.	 Histone	 acetylation	 and	 phosphorylation	 induce	structural	 changes	 by	 reducing	 the	 positive	 charge	 of	 the	 histones	 and,	 as	 a	consequence,	 reducing	 the	 interaction	 between	 histones	 and	 the	 negatively	 charged	DNA	 leading	 to	 less	 compact	 chromatin	 structures	 (Bannister	 and	Kouzarides,	 2011).	Examples	 include	 the	 acetylation	 of	 lysines	 four,	 nine	 and	 27	 on	 histone	 3	 that	 are	
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enriched	 at	 active	 enhancer	 and	 promoter	 regions	 and	 facilitate	 transcriptional	regulation	(Wang	et	al.,	2008).	
Figure	1.5.	Interacting	factors	of	histone	modifications	
However,	 in	 general	 terms,	 acetylated	 lysines	 on	 histone	 tails	 are	 not	 necessary	 to	induce	 structural	 rearrangements	 and	 sometimes	 even	 prevent	 their	 induction	(Bannister	 and	Kouzarides,	 2011).	 Complementary	 to	 their	 role	 in	 inducing	 structural	changes,	 histone	 modifications	 mediate	 the	 binding	 of	 chromatin-modifying	 proteins	(Figure	 1.5).	 Proteins	 are	 able	 to	 interact	 with	 modified	 histones	 through	 different	structural	domains	to	dynamically	regulate	the	epigenetic	landscape	of	cells.	Acetylated	lysines	 are,	 for	 example,	 recognized	 by	 histone	 deacetyltransferases	 (HATs)	 through	their	 bromodomain,	 which	 enables	 chromatin	 remodeling.	 However,	 different	chromatin	remodeling	complexes	or	 their	co-factors	contain	 the	same	domains	and	as	such	 compete	 for	 the	 formation	 of	 accessible	 and	 inaccessible	 chromatin	 regions	(Mujtaba	et	al.,	2007;	Hassan	et	al.,	2002;	Bannister	and	Kouzarides,	2011).		 In	contrast	to	the	profiling	of	transcriptomics	data,	the	experimental	information	about	 the	 epigenetic	 landscape	 is	 typically	 highly	 incomplete,	 which	 hinders	 the	identification	of	causal	relationships	between	the	epigenome	and	the	transcriptome.	In	fact,	a	previous	study	that	jointly	profiled	chromatin	accessibility,	DNA	methylation	and	the	transcriptome	in	single	cells	and	identified	genes	whose	expression	is	not	correlated	
Proteins	interact	with	histone	modifications	through	distinct	domains	to	modify	the	
chromatin	structure	or	recruit	additional	factors.	For	example,	ING	proteins	bind	to	
methylated	H3K4	and	recruit	either	histone	acetyltransferases	or	deacetylation	
complexes.	On	the	other	hand,	HP1	recognizes	H3K9me	and	is	necessary	for	chromatin	
compaction.	(Picture	taken	from	(Bannister	and	Kouzarides,	2011))	
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with	 their	 methylation	 status	 (Clark	 et	 al.,	 2018).	 This	 supports	 the	 hypothesis	 that	multiple	 epigenetic	 states	 are	 associated	 to	 the	 same	 transcriptome.	 Conversely,	epigenetic	modifications	have	been	related	with	transcriptional	noise,	 i.e.	variability	in	gene	expression.	For	example,	promoter	regions	enriched	 in	H3K27me3,	H3K4me1	or	H3K9me3	are	associated	with	increased	noise	while	genes	whose	gene	body	is	enriched	in	H3K36me3,	H3K4me3	or	H3K9ac	are	consistently	associated	 to	low	noise	(Faure	et	
al.,	 2017).	 Thus,	 multiple	 transcriptional	 states	 can	 arise	 from	 the	 same	 epigenetic	landscape.	However,	these	effects	of	the	epigenome	on	the	transcriptional	state	are	not	unidirectional.	 Rather	 the	 interplay	 of	 epigenetic	 and	 transcriptional	 regulatory	elements	 regulates	maintenance	 and	differentiation	 of	 cells,	 as	 exemplified	 by	 P53	 in	mammalian	 stem	 cells	 (Levine	 and	 Berger,	 2017).	 In	 particular,	 in	 human	 embryonic	stem	 cells,	 deacetylating	 lysines	 at	 positions	 120	 and	 373	 of	 the	 P53	 protein	transcriptionally	inactivates	it.	These	reduced	acetylation	levels	are	maintained	by	the	deacetylase	 SIRT1	 whose	 transcription	 is	 activated	 by	 OCT4,	 a	 transcription	 factor	responsible	 for	 maintenance	 of	 pluripotency	 (Ng	 and	 Surani,	 2011;	 Young,	 2011).	Despite	 its	 ability	 to	 deacetylate	 lysines	 residues	 of	 P53,	 SIRT1	 is	 a	 known	 histone	deacetylase	 and	 leads	 to	 transcriptional	 repression	 (Zhang	 and	Kraus,	 2010).	 In	 case	P53	 becomes	 activated	 in	 embryonic	 stem	 cells,	 it	 activates	 transcription	 of	 two	microRNAs,	 MIR349	 and	 MIR145,	 which	 inhibit	 key	 transcription	 factors	 for	maintaining	pluripotency	and	induce	differentiation	(Levine	and	Berger,	2017).		 Apart	 from	 the	 ability	 of	 some	 proteins	 to	 sense	 and	 interact	 with	 modified	histone	 tails,	 another	 important	 class	of	proteins	was	discovered	 (Cirillo	et	al.,	 2002).	These	 proteins,	 or	 more	 precisely	 transcription	 factors,	 can	 directly	 bind	 to	 silent	chromatin	regions	that	are	not	marked	by	repressive	chromatin	modifications,	such	as	H3K27me3	 or	 H3K9me3	 (Soufi	 et	 al.,	 2012;	 van	 Oevelen	 et	 al.,	 2015),	 and	 create	 an	accessible	chromatin	conformation	independent	of	other	chromatin	remodelers	(Cirillo	
et	 al.,	 2002).	 Despite	 the	 experimental	 confirmation	 of	 several	 pioneer	 factors	 (Table	1.1,	(Iwafuchi-Doi	and	Zaret,	2014)),	a	common,	determining	structural	property	has	not	been	 identified,	 yet.	 FOXA1,	 for	 example,	 interacts	 with	 histones	 for	 opening	 the	chromatin	 (Cirillo	 et	al.,	 2002)	while	 OCT4,	 SOX2	and	KLF4	 recognize	 partial	 binding	motifs	 (Soufi	 et	al.,	 2015).	 The	 importance	 of	 pioneer	 factors	with	 respect	 to	 cellular	conversions	becomes	evident	when	regarding	the	validated	instances	of	induced	cellular	transitions	in	which	they	are	involved	(Table	1.1	and	(Morris,	2016)).	These	include	the	direct	conversion	 from	fibroblast	 to	cell	types	of	all	germ	 layers	such	as	macrophages	(Feng	 et	 al.,	 2008),	 hepatocytes	 (Huang	 et	 al.,	 2011)	 and	 motor	 neurons	 (Son	 et	 al.,	2011).	
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Table	1.1.	Validated	pioneer	factors	
Pioneer	factors	 Cellular	context	 Predicted/Validated	
pioneer	activity	
References	
FoxA	 Transdifferentiation	from	fibroblast	to	iHep	 Induce	transdifferentiation	Binding	to	silent	chromatin	 (Sekiya	and	Suzuki,	2011;	Huang	et	al.,	2011;	Gualdi	
et	al.,	1996)	
Class	V	Pou	(e.g.	
Oct3/4,	Pou5f3)	
Reprogramming	from	fibroblast	to	iPSCs	 Binding	to	DNase-insensitive	chromatin	with	absent	histone	modifications	
(Soufi	et	al.,	2012)	
Group	B1	Sox	(e.g.	
Sox2)	
Reprogramming	from	fibroblast	to	iPSCs	 Binding	to	DNase-insensitive	chromatin	with	absent	histone	modifications	
(Soufi	et	al.,	2012)	
Klf4	 Reprogramming	from	fibroblast	to	iPSCs	 Induce	reprogramming	 (Takahashi	and	Yamanaka,	2006)	
Ascl1	 Transdifferentiation	from	fibroblast	to	induced	neurons	
Induce	transdifferentiation	Binding	to	DNase-insensitive	chromatin	in	vivo	
(Vierbuchen	
et	al.,	2010;	Wapinski	et	
al.,	2013;	Son	
et	al.,	2011;	Caiazzo	et	al.,	2011)	
PU.1	 Transdifferentiation	from	fibroblast	to	macrophages	
Induce	transdifferentiation	Increase	accessibility	in	DNase-insensitive	chromatin	
(Barozzi	et	al.,	2014;	Heinz	et	
al.,	2010;	Ghisletti	et	al.,	2010;	Feng	et	
al.,	2008)	
GATA4	 Transdifferentiation	from	fibroblast	to	iHep	Liver	development	
Induce	transdifferentiation	Binding	to	silent	liver	enhancer	
(Bossard	and	Zaret,	1998;	Huang	et	al.,	2011)	
GATA1	 Mitotic	bookmarking	 Binding	to	mitotic	chromatin	 (Kadauke	et	
al.,	2012)	
Validated	 pioneer	 factors	 and	 their	 implication	 in	 cellular	 conversions	 (modified	 from	
(Iwafuchi-Doi	and	Zaret,	2014))	
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1.1.3 Viewing Diseases as Cellular Conversions The	 complex	 interconnection	 of	 transcriptional	 and	 epigenetic	 regulation	enables	cells	to	respond	to	environmental	cues,	such	as	temperature	change	or	chemical	exposure,	 for	preserving	 cellular	 functions.	These	 signals	 lead	 to	 changes	 in	RNA	and	protein	concentrations,	protein-protein	interactions	or	chromatin	conformation,	which	eventually	is	reflected	in	modifications	of	transcriptional	and	epigenetic	interactions.	In	addition	 to	 extrinsic	 fluctuations,	 inherent,	 internal	 fluctuations	 of	 transcription	 and	translation	 arise	 naturally	 due	 to	 the	 stochastic	 nature	 of	 TF-DNA	 binding	 and	transcriptional	initiation	by	the	formation	of	the	pre-initiation	complex.	If	cells	are	not	able	 to	restore	proper	 functioning,	 i.e.	 the	amount	of	RNA	and	proteins	as	well	as	 the	epigenetic	 configuration,	 changes	manifest	 in	modified	 cellular	 behavior,	 proliferative	ability	or	the	induction	of	differentiation	of	stem	and	progenitor	cells.	Since	intrinsic	and	extrinsic	fluctuations	are	an	essential	part	of	cellular	regulation	for	proper	functioning	and	 development,	 the	 gene	 regulatory	 network	 has	 evolved	 to	 a	 robust	 yet	 flexible	system	responding	only	to	specific	perturbations	(Macneil	and	Walhout,	2011).	Some	of	these	perturbations,	thus,	 lead	to	 the	stabilization	of	molecular	dysregulations	causing	the	loss	of	normal	cellular	function,	a	disease	state.	Similar	to	cellular	conversions,	this	conceptually	 results	 in	 the	 repositioning	 of	 cells	 on	 the	 Waddington	 landscape	 to	 a	disease-related	valley,	which	is	maintained	by	the	robust	design	of	gene	regulation	and	might	be	escaped	upon	cellular	perturbation.	Therefore,	 the	 formation	of	diseases	can	be	interpreted	as	the	induction	of	cellular	conversions.		Systemic	 Lupus	 Erythematosus	 (SLE),	 for	 instance,	 is	 a	 complex	 autoimmune	disease	 whose	 onset	 is	 caused	 by	 genetic	 and	 environmental	 factors.	 A	 key	pathophysiological	indication	of	SLE	is	the	production	of	auto-antibodies	of	the	immune	system	 that	 are	 deposited	 in	multiple	 organs	 and	 cause	 constant	 inflammation.	 As	 a	consequence,	 multiple	 symptoms	 could	 occur,	 such	 as	 arthritis,	 fever,	 neurologic	dysfunctions	 or	 butterfly	 rash,	 which	 hampers	 an	 appropriate	 diagnosis	 in	 the	 early	stages	of	the	disease	(Kaul	et	al.,	2016).	 In	addition	 to	the	difficulty	of	early	diagnosis,	the	development	of	drugs	for	treating	the	disease	pathology	is	significantly	impeded	by	the	 incomplete	 understanding	 of	 the	molecular	mechanisms.	 Notable,	 rare	mutations	have	been	identified	in	the	complement	system	proteins	C2,	C4	and	C1Q	and	other	genes	responsible	 for	 clearance	 of	 cellular	 debris,	 nucleic	 acid	 degeneration	 and	 increased	activation	 of	 the	 adaptive	 and	 innate	 immune	 system	 (Kaul	 et	 al.,	 2016).	 Besides	 the	occurrence	of	high-risk	mutations,	 large-scale	variations	of	the	epigenetic	landscape	in	T-cells	 have	 been	 observed	 that	 might	 be	 inducible	 by	 environmental	 exposure	 to	chemicals.	A	previous	study	identified	procainamide,	a	DNA	methyltransferase	inhibitor,	
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to	 induce	similar	methylation	patterns	of	disease-related	genomic	 loci	 in	CD4+	cells	of	SLE	 patients	 (Lu	 et	al.,	 2005).	 Due	 to	 the	 association	 of	 DNA	methylation	with	 stable	silencing	of	genes,	which	prevents	their	transcription,	global	hypomethylation	suggests	new	potential	 transcriptional	 regulatory	 interactions.	 In	addition,	 CD4+	 cells	 from	SLE	patients	 show	 global	 hypoacetylation	 of	 histones	 3	 and	 4,	 which	 correlates	 with	decreased	mRNA	levels	of	chromatin	modifying	genes	EP300,	CREBBP,	HDAC2,	HDAC7,	SUV39H2	 and	 EZH2,	 as	 well	 as	 global	 H3K9	 hypomethylation	 (Hu	 et	 al.,	 2008).	 In	contrast	 to	 DNA	 methylation,	 acetylation	 of	 histones	 is	 associated	 to	 less	 compact,	permissive	chromatin	structures	 that	enable	 transcription.	Thus,	 its	global	loss	can	be	presumed	 to	 prevent	 transcription	 of	 various	 genes.	 Altogether,	 even	 though	 the	concepts	of	cellular	conversions	and	disease	manifestation	seem	to	be	very	different,	the	genetic,	epigenetic	and	transcriptional	dysregulations	in	Systemic	Lupus	Erythematosus	together	 with	 its	 inducibility	 by	 compounds	 supports	 their	 perception	 as	 cellular	conversions.	Another	 notable	 example	 of	 diseases,	 which	 can	 be	 perceived	 as	 cellular	conversions,	 constitutes	 osteoporosis,	 a	 progressive	 bone	 pathology	 characterized	 by	elevated	bone	marrow	fat	accumulation	and	reduced	bone	formation	(Hu	et	al.,	2018).	In	 particular,	 bone	 marrow	 fat	 is	 accumulated	 by	 increased	 differentiation	 of	mesenchymal	 stem	 cells	 (MSCs)	 into	 fat	 cells,	 i.e.	 adipocytes,	 while	 differentiation	 of	MSCs	into	osteoblasts	is	decreased,	which	reduces	bone	formation	(Hu	et	al.,	2018).	This	dysregulation	 of	 the	 adipogenic	 and	 osteogenic	differentiation	potential	 can	 be	 partly	attributed	 to	 alterations	 in	 the	 transcriptional	 regulatory	 network.	 Besides	 other	transcription	 factors,	 RUNX2	 and	 SP7	 have	 been	 demonstrated	 to	 be	 an	 integral	component	of	osteogenic	differentiation.	In	particular,	MSCs	deficient	in	either	of	these	genes	 are	 unable	 to	 give	 rise	 to	 osteoblasts	 (Hu	 et	 al.,	 2018).	 On	 the	 other	 hand,	adipogenic	 differentiation	 is	 directed	 by	 PPARG,	 while	 transcription	 factors	 such	 as	GATA2,	FOXA1	and	HOXC8	inhibit	adipocyte	maturation	(Hu	et	al.,	2018).	These	factors	are	incorporated	into	a	bigger	gene	regulatory	network	including	(post-)transcriptional	regulation	by	microRNAs	and	signaling	pathways	that	are	susceptible	to	environmental	factors.	Therefore,	 osteoporosis	 can	be	 regarded	as	 the	 cellular	 conversion	of	 healthy	mesenchymal	 stem	 cells	 into	 a	 diseased	 state	 in	which	 the	 adipogenic	 differentiation	potential	 is	significantly	 increased.	However,	other	 interpretations	exist	at	 the	 level	of	differentiated	adipocytes	and	osteoblasts.	In	particular,	the	shift	of	healthy	to	pathologic	cellular	 populations	 could	 be	 regarded	 as	 a	 cellular	 conversion	 of	 osteoblasts	 into	adipocytes	resulting	in	a	pathologic	proportion.	
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When	viewing	diseases	as	cellular	conversions	and,	therefore,	as	displacements	of	cells	in	different	wells	of	the	Waddington	landscape,	an	important	medical	questions	is	 the	search	 for	suitable	external	stimuli	or	perturbations	reverting	 the	disease	state.	Classical	 pharmacology	 approaches	 relied	 on	 the	 identification	 of	 compounds	 able	 to	revert	 the	 disease	 phenotype	 (Takenaka,	 2001).	 Cells	 from	 human	 or	mouse	 disease	models	 were	 extracted	 and	 in	 vitro	 screened	 with	 multiple	 compounds	 that	 were	expected	 to	 have	 the	 desired	 effects	 based	 on	 functional	 activity	 in	 the	 disease.	 After	obtaining	 a	 suitable	 drug	 candidate,	 its	 targets	 were	 determined	 to	 understand	 the	molecular	mechanism	leading	to	the	phenotypic	reversion	and	facilitate	the	discovery	of	compounds	 for	 treating	other	disease	pathologies.	However,	 in	 the	era	of	profiling	 the	transcriptional	and	epigenetic	state	of	cells	and	the	ever-growing	knowledge	about	the	regulatory	 interactions	 stabilizing	 disease	 phenotypes,	 this	 classical	 approach	 has	become	too	inefficient.	Instead,	the	focus	has	moved	to	prior	bioinformatics	and	system	biology	analysis	to	preselect	proteins	that	are	effective	targets	(Wooller	et	al.,	2017;	Xia,	2017).	 Great	 efforts	 have	 been	 devoted	 to	 identify	 disease-related	 genes	 and	 their	interactions	among	each	other.	More	specifically,	protein-protein	 interaction	networks	have	been	analyzed	to	obtain	a	systems	level	understanding	of	molecular	mechanisms	implicated	in	disease	pathologies	(Schadt	et	al.,	2009).	From	a	network	perspective,	the	identified	 genes	 show	 a	 number	 of	 interesting	 properties.	 First,	 cancer	 related	 genes	have	an	increased	node	connectivity	compared	to	non-cancer	genes,	 i.e.	they	are	more	likely	 to	 be	 hub-genes	 (Jonsson	 and	 Bates,	 2006).	 The	 importance	 of	 these	 highly	connected	proteins	is	supported	by	experiments	in	S.	cerevisiae	showing	their	criticality	in	phenotypic	stabilization	and	organism	survival	(Jeong	et	al.,	2001)	together	with	their	ability	 to	 modulate	 toxicity	 (Said	 et	 al.,	 2004).	 Second,	 a	 reconstructed	 disease-gene	network	 revealed	 that	 genes	 of	 the	 same	 disorder	 class	 are	 organized	 in	 strongly	connected	 modules	 suggesting	 distinct	 pathological	 mechanisms	 (Goh	 et	 al.,	 2007).	Indeed,	 further	analysis	confirmed	that	genes	 involved	 in	 the	same	disorder	are	more	likely	to	interact	through	protein-protein	interactions,	show	increased	tissue	expression	homogeneity,	are	more	highly	correlated	and	are	predominantly	co-expressed	(Goh	et	
al.,	2007).	The	 information	 obtained	 from	 network	 analyses	 have	 been	 exploited	 for	proposing	 predictive	 methodologies	 inferring	 drugs	 and	 drug-targets	 as	 potential	therapeutics	of	disease	pathologies.	Franke	et	al.	integrated	gene	ontology	(Ashburner	et	
al.,	 2000),	 gene	 co-expression	 and	 protein-protein	 interactions	 in	 a	 single	 Bayesian	network	 for	 prioritizing	 disease-related	 genes.	 In	 particular,	 this	 study	 found	 that	
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disease	genes	should	be	close	to	each	other	in	the	network	due	to	their	related	biological	function	and	modularization	(Franke	et	al.,	2006).	Application	of	the	method	yielded,	for	example,	the	identification	of	important	breast	cancer	genes	like	BRCA1	and	TP53,	but	only	34%	of	known	disease	related	genes	were	recapitulated	in	the	top	10	predictions,	overall.	Other	approaches	follow	the	same	rationale	and	predict	candidate	proteins	that	are	 close	 to	 already	known	disease	 genes	with	 respect	 to	 random	walks	 and	 flows	 in	protein-protein	interaction	networks	(Vanunu	et	al.,	2010;	Köhler	et	al.,	2008).	Despite	 the	 amount	of	 research	 conducted	 for	detecting	disease-related	 genes,	there	 is	 a	 lack	of	methods	 for	 establishing	disease-gene-drug	 relationships.	 Currently,	information	about	chemical	perturbations	and	drug	response	is	organized	in	databases	and	 linked	to	diseases	based	on	gene	signatures	 (Hu	and	Agarwal,	2009;	Lamb,	2007;	Lamb	et	al.,	2006).	A	notable	example	of	these	databases	is	the	Connectivity	Map	(CMap)	(Lamb,	 2007),	 which	 has	 been	 successfully	 used	 for	 predicting	 effective	 drugs	 in	different	human	diseases	(Hieronymus	et	al.,	2006;	Wei	et	al.,	2006;	D’Arcy	et	al.,	2011).	However,	 these	 methods	 disregard	 the	 underlying	 gene	 regulatory	 network	 that	ultimately	 controls	 drug	 response.	 In	 view	 of	 diseases	 as	 cellular	 conversions,	 the	development	 of	 a	 network-based	 approach	 for	 predicting	 disease-gene-drug	relationships	is	a	tantalizing	prospect.	Overall,	 due	 to	 the	 complex	 interconnection	 of	 transcriptional	 and	 epigenetic	landscapes	 stabilizing	 condition	 specific	 phenotypes,	 it	 is	 essential	 to	 understand	 the	underlying	 gene	 regulatory	 network	 for	 the	 prediction	 of	 instructive	 factors	 inducing	cellular	 transitions	upon	perturbation.	Therefore,	 it	 is	 of	 utmost	 importance	 to	 gain	 a	systems	 level	 understanding	 of	 the	 underlying	 mechanisms	 provided	 by	 the	reconstruction	 of	 regulatory	 interaction	networks.	 The	 next	 section	 discusses	 current	approaches	for	inferring	gene	regulatory	networks	in	more	detail.		
1.2 Gene Regulatory Network Inference from Condition Specific 
Transcriptomics Data The	increasing	availability	of	condition	specific	gene	expression	profiles	has	offered	the	unique	opportunity	to	reconstruct	the	gene	regulatory	networks	stabilizing	phenotypic	identity	 of	 cell	 types	 or	 pathological	 conditions	 (Liu,	 2015).	 In	 general,	 there	 are	different	approaches	to	model	GRNs	at	different	levels	of	detail	(Liu,	2015).	For	instance,	the	following	are	the	commonly	employed	levels	of	detail	for	modeling	gene	regulatory	interactions:	
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• (Is	 there	 a	 regulatory	 interaction?)	 The	 minimal	 amount	 of	 information	required	 to	 reconstruct	 a	 gene	 regulatory	 network	 is	 whether	 there	 exists	 a	regulatory	 interaction	 between	 two	 genes.	 In	 practice,	 this	 notion	 is	 often	further	 simplified	 to	 identify	 co-expressed	 genes	 sharing	 a	 similar	 gene	expression	pattern	in	several	conditions,	cell	or	tissue	types.	
• (Who	 is	 the	 regulator?)	 The	 second	 level	 of	 information	 is	 considering	 the	directionality	 of	 the	 regulatory	 interactions.	 Here,	 the	 goal	 is	 to	 identify	 the	regulator	for	every	two	genes	exhibiting	an	interaction.	
• (What	 is	 the	mode	 of	 action?)	When	 the	directionality	 of	 the	 interactions	 is	known,	they	can	be	further	distinguished	by	their	mode	of	action.	In	the	context	of	transcriptional	regulation,	genes	can	act	as	activators	or	inhibitors	resulting	in	increased	or	decreased	transcription,	respectively.	
• (What	is	the	regulatory	strength?)	The	regulatory	strength	of	an	interaction	is	the	 most	 complex	 level	 of	 information	 due	 to	 the	 influence	 of	 various	mechanisms,	 like	 the	 binding	 affinity	 of	 the	 TF	 to	 DNA	 or	 the	 strength	 of	 the	protein-protein	interaction	with	the	transcriptional	machinery.	In	 the	remainder	of	 this	section,	current	methodologies,	which	model	gene	regulatory	networks	 of	 different	 detail,	 are	 discussed,	 including	 their	 particular	 advantages	 and	limitations.		 Gene	 co-expression	 networks	 offer	 a	 naïve,	 yet	 widely	 used	 view	 on	 the	coordinated	 control	 of	 genes	 in	 living	 organisms	 (Eisen	 et	 al.,	 1998;	 Ben-Dor	 et	 al.).	Based	 on	 the	 identification	 of	 patterns	 across	 different	 gene	 expression	 profiles,	relationships	 between	 genes	 are	 established	 representing	 their	 synchronized	 actions.		Thus,	 co-expression	 networks	 offer	 insights	 into	 coordinated	 expression	 indicating	which	genes	are	simultaneously	active	and	are	therefore	assumed	to	belong	to	the	same	biological	 process.	 The	 most	 recent	 advancement	 includes	 the	 introduction	 of	differential	 co-expression	 analysis	 that	 aims	 to	 identify	 genes	 significantly	 more	 co-expressed	in	one	condition	compared	to	another	(Fiannaca	et	al.,	2015;	Bhar	et	al.,	2013;	Amar	et	al.,	2013).	Several	earlier	studies	reported	differentially	co-expressed	TFs	to	be	involved	 in	 cancer	 (Kostka	 and	 Spang,	 2004;	 Lai	 et	 al.,	 2004;	 Amar	 et	 al.,	 2013)	 and	found	a	significant	decrease	in	co-expression	compared	to	healthy	samples	(Kostka	and	Spang,	2004)	highlighting	the	importance	of	differential	analysis	of	regulation.	However,	gene	 co-expression	 networks	 solely	 offer	 insights	 about	 correlations,	 i.e.	 coordinated	expression,	 rather	 than	 identifying	 causal	 regulatory	 relationships,	 which	 constitutes	the	 major	 drawback	 of	 these	 methods.	 In	 the	 presence	 of	 co-expression,	 it	 is	 not	determined	what	mechanism	or	set	of	genes	causes	the	observed	pattern	and	whether	
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the	same	process	regulates	all	strongly	correlated	genes	at	the	same	time.	Also,	from	a	methodological	point	of	view,	co-expression	analysis	assumes	the	observed	correlation	to	be	consistent	across	unobserved	datasets,	which	does	not	hold	in	most	of	the	cases.	Even	differential	co-expression	networks	cannot	fully	address	this	issue	as	they	impose	the	 correlation	 to	 be	 consistent	 in	 unobserved	 samples	 of	 the	 same	 condition.	 As	 an	example,	 cancer	 cell	 populations	 exhibit	 highly	 heterogeneous	 expression	 patterns,	which	invalidates	this	assumption	(Mentzen	et	al.,	2009).		 In	 order	 to	 address	 the	 existing	 limitations	 of	 undirected	 gene	 co-expression	networks,	 great	 efforts	 are	 being	 devoted	 to	 the	 reconstruction	 of	 directed	 gene	regulatory	 networks	 (Marbach	 et	 al.,	 2012).	 The	 developed	 methods	 are	 based	 on	 a	variety	of	mathematical	techniques	while	most	of	them	can	be	classified	into	three	main	categories,	 regression-based,	mutual	 information-based	and	Bayesian	networks.	All	 of	these	 methods	 share	 the	 goal	 of	 identifying	 networks	 that	 are	 directed	 but	 do	 not	contain	 information	 about	 the	 mode	 of	 action	 of	 individual	 interactions	 or	 their	strength.			 Most	available	methods	relying	on	regression	analysis	for	identifying	regulatory	interactions,	or	gene	regulatory	networks	 in	general,	perform	 least	absolute	shrinkage	and	 selection	 operator	 (LASSO)	 regression	 (Meinshausen	 and	 Bühlmann,	 2010;	 Yuan	and	Lin,	2006;	van	Someren	et	al.,	2006;	Lèbre	et	al.,	2010;	Haury	et	al.,	2012).	Since	its	introduction	 in	 1996,	 LASSO	 regression	 got	 increasing	 attention	 due	 to	 its	 ability	 to	perform	 feature	 selection	 and	 regularization	 at	 the	 same	 time.	 In	 the	 context	 of	 gene	regulatory	network	 inference,	other	regression	 techniques	would	retain	small	weights	for	every	possible	interaction	while	LASSO	is	able	to	efficiently	select	which	interactions	should	not	appear	at	all	and	pinpoint	most	influential	regulatory	mechanisms.		Methods	 based	 on	mutual	 information	 aim	 to	 identify	 the	 interdependence	 of	two	 genes.	 In	 particular,	 the	mutual	 information	 obtained	 from	 expression	 sample	 of	two	genes	across	several	conditions	is	a	measure	of	how	much	information	of	one	gene	can	 be	 obtained	 by	 the	 other.	 Since	 this	 measure	 is	 symmetric,	 it	 does	 not	 readily	provide	 information	 about	 the	 directionality	 of	 interactions	 justifying	 the	 need	 for	combining	 it	 with	 other	 formalisms.	 Available	 methods	 additionally	 use	 Bayesian	network	approaches	 for	 inferring	 the	causal	relationship	between	two	genes	(Faith	et	
al.,	2007;	Mani	and	Cooper,	2004).	The	goal	is	to	recover	a	network	structure	from	the	data	 representing	 the	 conditional	 dependencies	 between	 genes.	 However,	 these	methods	 typically	 result	 in	 dense	 regulatory	 networks,	 since	 they	 cannot	 faithfully	identify	 the	 absence	 of	 interactions	 between	 conditionally	 independent	 genes	 (Figure	1.6,	“Fan-in”	column).	
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A	 thorough	 comparison	 of	 available	 methods	 based	 on	 mutual	 information,	regression	 and	 Bayesian	 networks	 revealed	 the	 elevated	 importance	 of	 choosing	 the	appropriate	mathematical	framework	compared	to	the	actual	implementation	(Marbach	
et	al.,	 2012).	 The	 reconstructed	networks	 of	 all	methods	 are	more	 similar	 among	 the	same	mathematical	 framework	 than	among	others,	 each	having	particular	 advantages	and	 limitations	 for	 correctly	 predicting	 certain	 regulatory	 motifs	 (Figure	 1.6).	 While	mutual	 information	 based	 methods	 provide	 more	 confidence	 in	 the	 identification	 of	feed-forward	 loops,	 they	 are	 mostly	 disadvantageous	 in	 the	 prediction	 of	 regulatory	cascades.	Complementary,	 regression-based	and	Bayesian	network	 techniques	provide	more	confidence	in	the	predicted	cascades	compared	to	feed-forward	loops.	However,	it	is	important	to	note	that	all	methods	perform	similarly	in	identifying	the	directionality	of	 interactions	 even	 though	 mutual	 information	 approaches	 show	 slightly	 reduced	performance	overall,	which	hinders	 the	 recapitulation	of	 dynamic	 changes	 induces	by	transcription	factor	knockout	experiments.		
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Figure	1.6.	Comparison	of	available	network	reconstruction	methods		
	Regarding	 the	 accurate	modeling	 of	 cellular	 gene	 regulatory	 networks	 and	 its	subsequent	utilization	 for	 identifying	 instructive	 factors	 for	cellular	conversions,	 these	results	highlight	the	inability	of	level	two	network	models	to	provide	faithful	predictions	and,	 therefore,	 the	 need	 for	 more	 sophisticated	 formalisms.	 Continuous	 modeling	frameworks	 are	 the	most	desirable	 form	of	network	 representation	 as	 they	 allow	 the	precise	dissection	of	the	transient	network	behavior	through	the	interplay	of	regulatory	interactions	 with	 different	 strengths.	 In	 this	 setting,	 an	 interaction	 is	 typically	formulated	 in	 terms	 of	 hill	 functions	 extrapolated	 from	 experimental	 evidence	 in	 the	context	 of	 effector	 concentration	 on	 the	 synthesis	 rate	 of	 enzymes	 (Polynikis	 et	 al.,	2009;	 Yagil	 and	 Yagil,	 1971).	 Depending	 on	 the	 regulatory	 mode	 of	 action,	 these	functions	are	increasing	if	the	gene	is	an	activator	and	decreasing	if	it	is	an	inhibitor.	The	joint	 effect	 of	 multiple	 interactions	 on	 the	 same	 target	 gene	 is	 then	 modeled	 as	 an	ordinary	 differential	 equation	 combining	 individual	 interactions	 additively.	 This	
Comparison	of	network	reconstruction	methods	on	the	
basis	of	known	motifs.	Rows	represent	individual	
methods	and	the	color-coding	depicts	the	prediction	
confidence	in	comparison	to	other	methods	from	less	
(blue)	to	more	confident	(red).	Methods	from	the	same	
class	show	highly	similar	performance	biases	
indicating	that	the	choice	of	the	modeling	framework	is	
more	important	than	the	actual	implementation.	
Regression	and	Bayesian	network	based	methods	show	
stronger	performance	in	resembling	cascades	while	
mutual	Information	and	correlation	based	methods	are	
more	prompt	to	detect	feed-forward	loops.	Other	
methods	using	transcription	factor	knockout	
experiments	show	clear	advantages	over	all	other	
methods	in	reproducing	knockouts.	However,	they	lack	
the	ability	of	faithfully	reconstructing	network	motifs.	
(Modified	picture	from	(Marbach	et	al.,	2012)).	
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modeling	framework	has	got	considerable	attention	for	reconstructing	gene	regulatory	networks	of,	 for	 example,	 the	 cell	 cycle	 (Nachman	et	al.,	 2004),	 circadian	 system	 in	A.	
thaliana	 (Locke	 et	 al.,	 2005)	 or	 carbon	 starvation	 response	 in	 E.	 coli	 (Ropers	 et	 al.,	2006).	 Even	 though	 continuous	models	 of	 regulation	are	desirable	 for	modeling	gene	regulatory	networks,	due	 to	 their	 explicit	 inclusion	of	 underlying	 chemical	 properties,	considerable	 practical	 constraints	 limit	 their	 applicability.	 In	 particular,	 the	 kinetic	parameters	are	mostly	unknown	in	the	context	of	transcriptional	regulation	(Le	Novère,	2015)	and	are	therefore	subject	to	inference	based	on	transcriptional	(time-series)	data.	Albeit	 the	 dramatic	 increase	 of	 available	 experimental	 data	 in	 the	 advent	 of	 next	generation	 sequencing	 techniques	 (e.g.	 RNA-seq),	 the	 reconstructed	 networks	 are	typically	restricted	to	a	few	genes	whose	interactions	can	be	faithfully	determined	from	gene	 expression	 data.	 More	 importantly,	 continuous	 models	 utilize	 gene	 expression	measurements	as	a	proxy	for	protein	expression.	However,	there	exists	only	a	moderate	relationship	 between	 these	 two	 quantities	 (Maier	 et	 al.,	 2009).	 This	 significantly	impedes	 the	 reliability	 of	 the	 observed	 transient	 evolution	 of	 the	 system	 upon	perturbation,	which	 is	 an	 integral	 part	 in	 the	 determination	 of	 instructive	 factors	 for	cellular	 conversions.	 	 Finally,	 these	models	usually	 contain	many	parameters	 that	 are	subject	to	estimation	and	pose	substantial	computational	challenges	to	the	identification	of	medium	and	large	gene	regulatory	networks	(Vijesh	et	al.,	2013).	In	the	early	1970s,	Kauffman	introduced	Boolean	networks,	a	particular	class	of	logical	models,	as	mathematical	representations	of	gene	regulatory	networks	(Glass	and	Kauffman,	1973;	Kauffman,	1969).	 In	 contrast	 to	 the	models	discussed	before,	 a	 gene	can	only	take	on	two	values,	active	and	inactive,	and	gene	regulation	is	represented	by	Boolean	 logic	 functions	over	a	set	of	 regulators	determining	 the	state	of	 the	regulated	gene.	 Importantly,	 the	 Boolean	 representation	 of	 genes	 decreases	 the	 complexity	 of	network	 inference	 considerable	 while	 the	 superimposition	 of	 Boolean	 functions	connecting	the	regulatory	interactions	contribute	to	the	complexity.	In	this	context,	cell-types	 are	 represented	 by	 discretized	 gene	 expression	 profiles,	 i.e.	 genes	 are	 deemed	active	 or	 inactive	 based	 on	 their	 mRNA	 abundance,	 that	 are	 stable	 states	 of	 the	networks.	 A	 variety	 of	methods	were	 developed	 over	 the	 past	 years	 aiming	 for	more	accurate	network	inference	(Dorier	et	al.,	2016;	Terfve	et	al.,	2012;	Barman	and	Kwon,	2017;	 Crespo	 et	 al.,	 2013;	 Melas	 et	 al.,	 2013)	 and	 applied	 to	 study	 haematopoiesis	(Bonzanni	et	al.,	2013),	embryonic	stem	cells	 (Xu	et	al.,	2014)	or	cancer	(Grieco	et	al.,	2013;	 Wittmann	 et	 al.,	 2009;	 Calzone	 et	 al.,	 2010).	 Due	 to	 their	 reduced	 complexity,	Boolean	 networks	 address	 the	 main	 limitations	 of	 continuous	 models	 for	 gene	
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regulation.	 First,	 the	 parameter	 search	 space	 is	 significantly	 smaller	 as	 an	 interaction	can	be	only	present	or	absent	and	the	regulatory	strength	does	not	differ.	Therefore,	the	amount	 of	 data	 needed	 for	 faithfully	 reconstructing	 gene	 regulatory	 networks	 is	dramatically	 reduced.	 Second,	 even	 though	 gene	 expression	 is	 utilized	 as	 a	 proxy	 for	protein	 expression,	 like	 in	 continuous	 modeling	 frameworks,	 discretization	 by	differential	 expression	 analysis	 is	 assumed	 to	 yield	 higher	 correlations	 with	 protein	abundance	compared	to	raw	measurements	and,	as	such,	increases	the	reliability	of	the	model	(Kosti	et	al.,	2016).	Altogether,	these	advantages	allow	for	the	reconstruction	of	larger	networks	compared	to	continuous	modeling	frameworks,	which	provides	a	more	complete	 view	 on	 the	 regulatory	 mechanisms	 responsible	 for	 phenotypic	 stability.	Undoubtedly,	 Boolean	 networks	 also	 possess	 limitations.	 While,	 for	 example,	 the	discretization	 of	 gene	 expression	 by	 differential	 expression	 analysis	 increases	 the	correlation	 with	 protein	 abundance,	 quantitative	 differences	 influencing	 protein	concentrations,	 translating	 to	 the	 number	 of	 concurrent	 regulatory	 events,	 are	neglected.	 In	 addition,	 kinetic	 preferences	 of	 certain	 genes	 to	 proximal	 or	 distal	regulatory	 regions	 are	 assumed	 to	 play	 a	 minor	 role	 in	 gene	 regulation	 and	 every	regulator	 corresponds	 equally	 to	 the	 activation	 or	 inhibition	 of	 their	 target	 genes.	Finally,	 Boolean	 networks	 possess	 only	 a	 discrete	 time	 representation	 that	 does	 not	allow	for	modeling	slow	or	fast	processes.		The	different	mathematical	modeling	frameworks	reviewed	in	this	section	have	been	used	in	various	ways	to	uncover	regulatory	interactions	of	the	underlying	cellular	network.	 In	 this	regard,	several	methods	have	been	developed	 in	past	years	aiming	at	the	exploitation	of	these	models	for	predicting	instructive	factors	of	cellular	conversions	rather	than	solely	describing	static	gene	regulatory	networks.	
1.3 Systematic Identification of Instructive Factors for Cellular Conversions  	 Despite	 the	 interest	 in	 identifying	 cell	 type	 specific	 networks	 that	 closely	resemble	 the	 real,	 partially	 known	 gene	 regulatory	 networks,	 a	 model’s	 quality	 is	typically	 assessed	 in	 terms	 of	 its	 predictive	 rather	 than	 descriptive	 power.	 The	advantage	of	models	describing	the	regulation	of	particular	genes	in	the	context	of	other	genes	has	been	exploited	in	many	methods	for	identifying	instructive	factors	triggering	the	 transition	 from	 one	 condition	 or	 cell	 type	 to	 another.	 In	 this	 section,	 the	computational	models	 for	predicting	 these	 instructive	 factors	(see	Table	1.2,	modified	from	(Bian	and	Cahan,	2016))	are	comprehensively	reviewed.	Two	 of	 the	 presented	 methods	 are	 network-free	 relying	 solely	 on	 gene	expression	 or	 histone	 modification	 data.	 D’Alessio	 et	 al.	 (D’Alessio	 et	 al.,	 2015)	
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developed	a	method	for	identifying	the	expression	specificity	of	transcription	factors	in	a	set	of	233	cell	and	tissue	types.	For	each	sample,	a	set	of	ten	most	specific	core	TFs	has	been	computed	that	are	most	representative	of	the	given	cell	or	tissue	type.	These	core	TFs	 then	 serve	 as	 a	 starting	 point	 to	 induce	 cellular	 conversions	 and	 have	 been	demonstrated	in	the	conversion	from	fibroblasts	to	retinal	pigment	epithelial	cells.	One	important	 limitation	 of	 this	 approach	 constitutes	 the	 biasedness	 of	 core	 TF	identification	 towards	 high	 expression.	 Established	 collections	 of	 expression	 profiles	already	 revealed	 that	 genes	 are	 expressed	 on	 different	 scales	 and	 typically	 lowly	expressed	TFs	cannot	be		
	
Table	1.2.	Current	methods	for	identifying	instructive	factors	
Method	 Input	Data	 Species	 Cell/Tissue	Types	 Output	
CellNet	 Microarray	gene	expression	 Human,	mouse	 20	cell/tissue	types	 Similarity	to	known	cell/tissue	types	and	predicted	instructive	factors	
Mogrify	 Initial/Final	cell	type	 Human	 Gene	expression	of	300	cell	and	tissue	types	
Predicted	TFs	for	cellular	conversion	
D’Alesio	 Target	cell	type	 Human	 TF	expression	of	233	cell	and	tissue	types	
Predicted	TFs	for	cellular	conversion	
Crespo	 Gene	expression	profile/Prior	knowledge	GRN	
Human,	mouse	 Published	networks	of	various	cell	types	 Predicted	set	of	core	TFs	for	cellular	conversion	
Davis	 Gene	expression/Chromatin	profiles	
Human,	mouse	 65	datasets	 Predicted	TFs	for	cellular	conversion	
	captured	by	this	approach.	From	a	practical	point	of	view,	the	set	of	core	TFs	is	too	large	to	 be	 efficiently	 used	 in	 experiments,	 but	 could	 be	 further	 reduced	 by	 identifying	 the	underlying	regulatory	network	governing	the	initial	cell	type	to	be	conversed.	The	 other	method,	 presented	 by	Davis	and	Eddy	(Davis	 and	 Eddy,	 2013),	 uses	gene	 expression	 profiles	 and	 polycomb	 repressed	 genomic	 regions	 marked	 by	H3K27me3	 for	 identifying	 potential	 instructive	 factors.	 Based	 on	 the	 analysis	 of	 65	published	 sets	 of	 instructive	 factors,	 genes	 that	 are	 prompt	 to	 induce	 the	 trans-differentiation	 from	 an	 initial	 to	 a	 desired	 cell	 type	 are	 more	 likely	 to	 be	 polycomb	
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repressed	 than	 genes	 not	 associated	 to	 the	 induction	 of	 the	 conversion.	 Therefore,	 a	prioritization	 scheme	 is	 proposed	 based	 on	 the	 differential	 polycomb	 repression	 and	expression	of	genes	in	the	initial	and	final	cell	type.	Nevertheless,	the	practical	utility	of	this	 approach	 is	 significantly	 impeded	 by	 the	 absence	 of	 a	 threshold	 for	 selecting	potential	 candidate	 genes	 based	 on	 the	 proposed	 analysis.	 In	 case	 the	 threshold	 is	chosen	inappropriately,	the	number	of	identified	genes	is	intractably	high	or	too	small,	respectively.	It	further	neglects	the	causal	relationship	among	genes	and	their	ability	to	directly	 or	 indirectly	 modify	 the	 epigenetic	 landscape	 through	 the	 downstream	expression	of	TFs	and	their	co-factors.	The	 second	 class	 of	 methods	 relies	 on	 the	 identification	 of	 networks	 from	various	 data	 sources	 and,	 to	 date,	 constitute	 the	 most	 promising	 approaches	 for	systematically	 identifying	 the	 instructive	 factors	 for	 triggering	 desired	 cellular	conversions.	 CellNet	 aims	 to	 reconstruct	 directed	 (level	 2)	 networks	 from	 cell/tissue	specific	gene	expression	and	transcription	factor	binding	(ChIP-seq)	datasets	(Cahan	et	
al.,	2014).	For	the	initial	study,	every	cell	type	was	required	to	be	represented	by	at	least	60	 gene	 expression	 profiles	 including	 perturbation	 experiments	 for	 inferring	 a	 single	gene	 regulatory	 network	 from	 the	 complete	 dataset	 of	 all	 cell	 and	 tissue	 types.	Condition-specific	 GRNs	 are	 subsequently	 obtained	 by	 identifying	 densely	interconnected	sub-networks.	The	resulting	compendium	of	cell	and	tissue	type	specific	GRNs	 can	 be	 used	 for	 confirmatory	 and	 exploratory	 analysis.	 For	 that,	 CellNet	 first	estimates	 probabilities	 for	 a	 query	 expression	 sample	 to	 correspond	 to	 one	 of	 the	included	 cell	 types.	 Second,	 CellNet	 ranks	 transcription	 factors	 based	 on	 a	 postulated	‘Network	Influence	Score’	measuring	their	expression	in	comparison	to	other	cell	types.	This	 strategy	 has	 been	 applied	 to	 increase	 the	 fidelity	 of	 the	 B-cell	 to	 macrophage	conversion	by	 additionally	 knocking	down	 the	 expression	of	Pou2af1and	EBF1,	which	have	 been	 identified	 as	 essential	 B-cell	 genes	 (Morris	 et	 al.,	 2014).	 However,	 even	though	 CellNet	 proved	 its	 utility	 in	 certain	 cases,	 its	 predictive	 power	 is	 significantly	hampered	by	the	vast	amount	of	data	required	for	building	the	background	GRN.	More	specifically,	 the	 background	 network	 is	 assembled	 from	 publicly	 available	 ChIP-seq	datasets	 for	 determining	 potential	 regulatory	 interactions	 between	 transcription	factors.	For	introducing	new	cell	or	tissue	types	in	the	approach,	specific	transcription	factor	 binding	 site	 data	 must	 be	 collected.	 However,	 necessary	 amounts	 of	 data	 are	usually	solely	available	for	widely	studied	cell	types.		To	date,	CellNet	consists	of	only	16	human	 and	 20	mouse	 cell	 types	making	 it	 impractical	 as	 a	 general	 tool	 for	 studying	cellular	conversions.		
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Mogrify	 (Rackham	 et	 al.,	 2016)	 follows	 a	 network-based	 approach,	 as	 well.	 It	uses	publicly	 available	databases	of	 regulatory	 interactions	 to	 estimate	 the	 individual	effect	of	overexpressing	a	single	TF	in	the	starting	cell	type	and	subsequently	identifies	a	minimal	set	of	TFs	that	is	potentially	able	to	up-regulate	all	TFs	associated	to	the	target	cell	 type.	 Following	 this	 approach,	 novel	 instructive	 factors	 have	 been	 identified	 for	converting	 dermal	 fibroblasts	 to	 keratinocytes	 and	 keratinocytes	 to	 microvascular	endothelial	 cells.	 The	 inherent	 disadvantage	 of	 the	 transcription	 factor	 prioritization	performed	by	Mogrify	is	the	use	of	networks	composed	of	undirected	interactions	(level	1)	 from	 curated	 databases	 as	well	 as	 predictions.	 The	 absence	 of	 directionality	 does	therefore	 not	 guarantee	 the	 desired	 effect	 upon	 up-regulation	 of	 a	 TF	 while	 the	predicted	interactions	introduce	an	unquantifiable	level	of	noise	in	the	network.	Finally,	Crespo	et	al.	(Crespo	et	al.,	2013)	developed	a	method	that	reconstructs	Boolean	gene	regulatory	networks	given	a	prior	knowledge	network	and	a	differential	expression	profile	of	the	initial	and	final	cell	type.	The	reconstructed	network	allows	the	identification	of	higher-level	regulatory	motifs	(e.g.	positive	feedback	loops)	upon	which	a	minimal	 set	 of	 transcription	 factors	 is	 selected	 corresponding	 to	 the	 ones	with	 the	highest	impact	on	the	network	state.	Thus	far,	it	has	been	shown	to	reproduce	existing	trans-differentiation	and	reprogramming	protocols	like	the	conversion	from	myeloid	to	erythroid	 and	 fibroblasts	 to	 IPSCs.	 Nonetheless,	 the	 approach	 requires	 explaining	 the	gene	 expression	 programs	 of	 highly	 unrelated	 cell	 types	 within	 the	 same	 gene	regulatory	network	topology.	However,	as	described	in	section	1.1,	the	gene	regulatory	interactions	 are	modulated	 through	 epigenetic	 differences	 of	 the	 initial	 and	 final	 cell	types.	 Another	 limitation	 of	 Boolean	 network-based	 approaches,	 like	 the	 one	 from	
Crespo	et	al.,	 is	 the	 requirement	of	discretized	gene	 expression	profiles.	Typically,	 this	discretization	is	obtained	through	differential	expression	analysis	of	the	cell	types	under	study,	which	creates	an	isolated	view	of	the	two	conditions	under	study	(Hudson	et	al.,	2012).	This	makes	it	impossible	to	compare	the	condition	specific	networks	of	multiple	phenotypes.		
1.4 Summary 	 There	 is	 a	 continuous	 development	 of	 new	 methodologies	 for	 identifying	instructive	factors	of	cellular	conversions.	GRN	based	methodologies,	which	rely	on	the	analysis	 or	 reconstruction	 of	 gene	 regulatory	 networks	 representing	 the	 complex	regulatory	relationships	between	genes	and	transcription	 factors,	are	widely	used	and	have	shown	their	utility	in	predicting	instructive	factors	of	cellular	conversions.	Based	
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on	ever-growing	 information	about	the	gene	regulatory	 interactions,	every	cell	 type	 is	determined	 by	 its	 own	 gene	 regulatory	 network	 stabilizing	 the	 resulting	 phenotype	through	the	interplay	of	transcriptional	activators,	 inhibitors	and	epigenetic	modifiers.	These	 networks	 dynamically	 change	 during	 the	 ectopic	 expression	 of	 transcription	factors	 initiating	 cellular	 conversions	 and	 stabilize	 again	 to	 represent	 a	 desired	phenotype.		Existing	methods	 for	 predicting	 instructive	 factors	 suffer	 from	 at	 least	 one	 of	three	 major	 limitations.	 First,	 network-based	 methodologies	 do	 not	 account	 for	 the	differences	 in	 transcriptional	 regulation	 modulated	 by	 the	 epigenetic	 landscape	 of	covalent	 histone	 modifications	 and	 chromatin	 accessibility	 and	 model	 multiple	phenotypes	within	a	single	network	 topology.	Second,	 the	data	requirements	 limit	 the	general	 applicability	 of	 these	 methods	 to	 cell	 types	 or	 conditions	 not	 given	 broad	attention.	 Especially	 for	 studying	 disease	 pathologies	 where	 transcriptomics	 and	epigenetics	 datasets	 are	 typically	 highly	 limited,	 methodologies	 with	 low	 data	requirements	are	essential	for	the	identification	of	instructive	factors	inducing	disease	phenotype	reversion.	Finally,	some	of	the	approaches	only	offer	a	predefined	catalogue	of	different	cell	or	tissue	types	for	computing	instructive	factors	for	cellular	conversions	and	are	not	extendible	with	user-defined	input	data.	Similar	to	high	data	requirements,	the	lack	of	extendibility	of	the	computational	approaches	constitutes	a	severe	limitation	in	the	analysis	of	disease-related	phenotypes.	Addressing	 these	main	 limitations	 are	 the	 keynote	 aims	 of	 this	 thesis	 and	 the	developed	solutions	will	be	presented	in	the	remainder	of	this	thesis.		 	
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CHAPTER 2  Scope & Aims of Thesis 	 The	 complexity	of	 transcriptional	 regulation	presents	a	major	 challenge	 to	 the	systematic	identification	of	instructive	factors	inducing	desired	cellular	transitions	upon	perturbation.	While	next	generation	sequencing	methodologies	enabled	a	cost	efficient	and	accurate	screening	of	cellular	phenotypes,	chromatin	accessibility	and	transcription	factor	binding	sites,	the	understanding	of	the	interplay	of	transcriptional	and	epigenetic	regulation	 in	 the	 stabilization	 of	 cellular	 phenotypes	 is	 still	 limited.	 The	 virtual	infeasibility	 of	 compiling	 complete	 gene	 regulatory	networks	 for	 specific	 cell	 types	or	pathological	conditions	hinders	the	development	of	systematic	approaches	for	deducing	multitarget	 combinations	 of	 instructive	 factors	 that	 potentially	 induce	 cellular	conversions.	Nevertheless,	experimental	evidence	has	already	provided	an	 impression	of	the	complexity	and	specificity	of	gene	regulation	in	distinct	cell	types.		 Therefore,	 the	 major	 issue	 in	 developing	 a	 systematic	 approach	 for	 studying	cellular	 conversions	 is	 the	understanding	of	 the	 gene	 regulatory	 circuitry	maintaining	and	 destabilizing	 particular	 phenotypes.	 The	 analysis	 is	 further	 complicated	 by	 the	limited	amount	of	data	for	providing	a	window	into	the	accessible	chromatin	landscape	and	 the	 computational	 tools	 for	analyzing	 transcriptomics	and	 chromatin	accessibility	data	that	do	not	provide	reliable	information	in	the	context	of	network	reconstruction.		 Due	to	these	difficulties	a	wealth	of	methods	has	been	developed	for	identifying	instructive	 factors	 of	 desired	 cellular	 conversions.	 The	 most	 promising	 approaches	reconstruct	gene	regulatory	network	models	of	various	levels	of	detail,	as	described	in	the	 first	chapter	(see	section	1.2),	and	deduce	potential	combinations	of	 factors	based	on	 their	 analysis.	 All	 of	 these	 approaches	 have	 their	 own	 advantages	 and	 limitations	while	 all	 network-based	 methodologies	 share	 the	 inability	 to	 reconstruct	 condition	specific	regulatory	networks.		 This	thesis	proposes	to	approach	the	modeling	of	gene	regulatory	networks	by	reconstructing	 condition	 specific	 network	 models	 and	 exploiting	 their	 topological	characteristics	 combined	with	 in	 silico	 perturbations	 to	 predict	 and	 score	multitarget	combinations	of	instructive	factors	that	potentially	induce	desired	cellular	transitions.	
2.1 Thesis Aims Aim	1. Reconstruct	 condition	 specific	 networks	 by	 integrating	 available	 biological	information	on	 experimentally	 validated	 regulatory	 interactions	 in	diverse	 cell	types	with	 condition	 specific	 transcriptomics	and	 chromatin	 accessibility	data.	This	 involves	 the	selection	of	a	suitable	modeling	 framework	able	 to	represent	transcriptional	 regulation	 and	 the	 design	 of	 a	 strategy	 for	 reconstructing	
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networks.	Subsequently,	 the	approach	will	be	validated	with	condition	specific	gene	regulatory	interactions	identified	by	ChIP-seq	experiments.	Aim	2. Integrative	analysis	for	identification	of	candidate	instructive	factors	for	cellular	conversion	 by	 examining	 the	 topological	 features	 of	 the	 initial	 and	 final	condition	specific	networks	that	were	reconstructed	from	transcriptomics	data	and/or	available	chromatin	accessibility	information.	This	requires	the	choice	of	informative	 topological	 network	 motifs	 for	 obtaining	 dependable	 results.	Identified	 candidate	 genes	 and	 multitarget	 combinations	 are	 then	 validated	against	 previous	 studies	 implicating	 them	 in	 phenotypic	 stabilization	 and	applied	to	the	cellular	conversion	of	adipocytes	into	osteoblasts	as	well	as	to	the	prioritization	of	drugs	for	inducing	desired	cellular	transitions.	Aim	3. Overcome	 limitations	 of	 downstream	 computational	 tools	 for	 processing	transcriptomics	 and	 chromatin	 accessibility	 data	 in	 order	 to	 obtain	 reliable	datasets	 that	 can	 be	 readily	 used	 for	 reconstructing	 and	 analyzing	 gene	regulatory	 networks.	 First,	 a	 machine-learning	 framework	 is	 presented	 that	predicts	gene-level	accessibility	for	each	gene	in	order	to	overcome	the	limited	amount	 of	 available	 chromatin	 accessibility	data.	Validation	 of	 the	 predictions	will	 be	 performed	 against	 experimental	 chromatin	 accessibility	 assays	processed	with	 current	peak-calling	methodologies	on	 the	basis	 of	 a	 compiled	gold	 standard	 dataset.	 Second,	 a	 method	 for	 absolute	 discretization	 of	 gene	expression	data	is	developed	that	classifies	genes	into	active	and	inactive	states.	With	 it,	 the	consistent	comparison	of	multiple	cell	 types	and	conditions	within	the	same	network	reconstruction	methodology	will	be	feasible.	Validation	of	the	method	will	 consist	 of	 the	 qualitative	 and	 quantitative	 comparison	 to	 current	state-of-the-art	approaches.			
2.2 Originality 	 The	 integrative	 gene	 regulatory	 network	 reconstruction	 approach	 combines	multiple,	available	sources	of	biological	information	to	better	characterize	condition	or	cell	type	specific	regulatory	networks.	With	it,	the	chromatin	accessibility	landscape	can	be	 projected	 onto	 the	 transcriptional	 regulatory	 network	 and	 utilized	 for	 studying	differential	 regulatory	 mechanisms	 of	 cellular	 conditions.	 However,	 on	 one	 hand,	current	computational	tools	for	processing	experimental	chromatin	accessibility	assays	are	not	able	to	reliably	detect	accessible	genomic	regions.	On	the	other	hand,	despite	the	ever-growing	 amount	 of	 experimental	 data,	 chromatin	 accessibility	 assays	 are	 not	
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available	 for	many	cell	types	or	cellular	conditions.	The	proposed	approach	addresses	these	 limitations	by	predicting	whether	genes	are	 located	in	accessible	or	 inaccessible	chromatin	domains	in	a	condition	specific	manner.	This	way,	it	assists	in	overcoming	the	unavailability	of	experimental	data	and	can	be	further	utilized	to	optimize	current	tools	for	 interpreting	 experimental	 data.	 Overall,	 the	 combination	 of	 the	 developed	methodologies	for	gene	regulatory	network	reconstruction	and	chromatin	accessibility	prediction	 allows	 the	 identification	 of	 candidate	 instructive	 factors	 that	 potentially	induce	 desired	 cellular	 conversions.	 Previous	 approaches	 have	 used	 network	 based	inference	methods,	but	require	tremendous	amounts	of	data,	limiting	their	applicability	to	 other	 cell	 types	 or	 conditions,	 and	 do	 not	 take	 into	 account	 the	 distinct	 gene	regulatory	 interactions	 of	 different	 cell	 types.	 However,	 these	 distinct	 regulatory	programs,	which	are	mediated	by	transcriptional	and	epigenetic	landscapes,	have	been	demonstrated	by	 combined	 large	 scale	probing	of	 the	 gene	 expression	 and	 chromatin	profiles.	 That	 these	 changes	 impact	 the	 cellular	 response	 to	 gene	 perturbations	 is	undeniable	and	makes	them	valuable	to	model.		 This	 thesis	 aims	 to	 address	 the	main	 limitations	 of	 current	methodologies	 for	modeling	gene	regulatory	networks	and,	thus,	provides	a	systematic	analysis	approach	integrating	 available	 biological	 knowledge	 about	 transcriptional	 gene	 regulation,	transcriptomics	and	epigenetics	data	that	could	serve	as	a	general	strategy	for	selecting	suitable	combinations	of	genes	that	potentially	induce	desired	cellular	transitions	upon	perturbation.		 	
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CHAPTER 3 Methods The	prediction	of	instructive	factors	for	cellular	conversion,	i.e.	the	identification	of	genes	with	the	most	pronounced	effect	on	the	phenotype	upon	perturbation,	requires	an	understanding	of	the	transcriptional	regulatory	processes	occurring	in	the	cell	types	under	study.	Current	methodologies	impose	the	strong	assumption	that	the	underlying	gene	 regulatory	 networks	 do	 not	 change	 but	 only	 differ	 in	 the	 expression	 of	 their	constituent	genes.	This	 implies	 that	the	set	of	 regulated	genes	stays	 the	same	 for	each	transcription	factor,	regardless	of	the	cell	type,	and	only	the	influence	on	transcription	changes.	With	the	availability	of	the	latest	experimental	protocols	to	measure	accessible	genomic	regulatory	regions	(e.g.	DNase-seq,	FAIRE-seq,	ATAC-seq)	this	assumption	has	been	invalidated.	To	 increase	 the	 reliability	 of	 identified	 combinations	 of	 instructive	 factors	 for	cellular	 conversions	 a	 different	 strategy	 is	 needed	 that	 considers	 different	transcriptional	 regulatory	 programs	 in	 different	 cell	 types.	 This	 thesis	 proposes	 one	such	method,	which	reconstructs	condition	specific	transcriptional	regulatory	networks	that	are	subsequently	analyzed	to	identify	candidate	instructive	factors.	For	constructing	cell-type	specific	transcriptional	regulatory	networks	a	suitable	mathematical	 modeling	 formalism	 is	 needed.	 The	 Boolean	 network	 model	 has	 been	chosen	 to	 represent	 genes	 and	 their	 effects	 on	 the	 transcription	 of	 other	 factors.	 The	network	is	reconstructed	by	selecting	a	subset	of	experimentally	validated	interactions	between	genes	from	prior	knowledge	networks,	in	which	one	factor	activates	or	inhibits	the	 transcription	 of	 other	 factors	 such	 that	 the	model	 represents	 the	 phenotype	 of	 a	single	cell	type	or	condition.	Candidate	instructive	factors	are	obtained	by	analyzing	the	reconstructed	Boolean	network	models	and	scored	through	 in	silico	simulation	of	their	perturbation	effects	on	the	network.	The	 reconstruction	of	Boolean	gene	 regulatory	networks	 crucially	depends	on	an	accurate	classification	of	gene	expression	measures	(e.g.	from	RNA-seq	or	microarray	experiments)	into	active	or	inactive	states.	Traditionally,	a	variety	of	statistical	tests	are	carried	out	to	obtain	significantly	up-	and	down-regulated	genes	in	the	initial	and	final	cell	types,	which	serves	as	the	desired	binary	classification.	However,	in	the	presence	of	multiple	cellular	conditions	of	the	same	cell	type,	these	tests	are	either	not	applicable	or	have	 low	 statistical	 power.	 Therefore,	 the	 method	 for	 reconstructing	 regulatory	networks	 is	complemented	with	a	reference-based	approach	 for	accurately	classifying	gene	 expression	 data	 allowing	 for	 the	 eventual	 comparison	 of	 multiple	 cell	 types	 or	conditions	on	the	network	level.	
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Following	 the	 approach	 of	 classifying	 genes	 into	 active	 or	 inactive	 states	 is	necessary	 for	 reconstructing	 regulatory	 networks.	 However,	 cellular	 transcriptional	regulation	 is	 governed	 by	 the	 epigenetic	 landscape	 of	 the	 cells	 and,	 in	 particular,	accessible	chromatin	domains	allow	the	transcription	of	genes.	Conversely,	 if	a	gene	is	classified	 to	 be	 inactive	 or	 not	 expressed	 it	 can	 be	 either	 due	 to	 transcriptional	repression	or	its	location	in	inaccessible	chromatin	regions	preventing	transcription.	In	a	network	model,	genes	in	inaccessible	chromatin	regions	do	not	have	to	be	explained	by	 transcriptional	 repressors	 and	 should	 thus	be	disregarded.	However,	 experimental	accessibility	 measures	 are	 not	 available	 for	 all	 cell	 types	 and	 conditions	 making	 it	necessary	to	predict	the	genes	located	in	inaccessible	chromatin	domains.	This	 chapter	 provides	 the	 methodological	 background	 of	 the	 developed	approaches	 for	 addressing	 these	 issues.	 Section	 3.1	 provides	 a	 formal	 introduction	 of	Boolean	 networks	 and	 their	 analysis	with	 respect	 to	 their	 application	 as	 a	model	 for	gene	 regulatory	 networks.	 Section	 3.2	 gives	 a	 detailed	 overview	 of	 the	 method	 for	reconstructing	cell-type	specific	gene	regulatory	networks	and	section	3.3	describes	the	analysis	 of	 these	 networks	 and	 the	 strategy	 for	 selecting	 combinations	 of	 candidate	instructive	 factors	 of	 cellular	 conversions.	 Section	3.4	describes	 the	machine	 learning	approach	for	predicting	the	accessibility	of	genes	from	transcriptomics	data	and,	finally,	section	3.5	describes	 the	method	 for	 classifying	 gene	 expression	measures	 into	 active	and	 inactive	 states	 by	 statistical	 comparison	 against	 a	 reference	 distribution	 for	enabling	the	consistent	comparison	of	multiple	cellular	conditions.		
3.1 Boolean Networks as Models of Gene Regulation 	 A	Boolean	network	can	be	intuitively	envisioned	as	a	graph	consisting	of	nodes	that	are	connected	by	directed	edges.	Each	node	can	take	on	one	of	two	values	(0	or	1)	and	is	governed	by	a	logic	function	consisting	of	all	parent	nodes	in	the	graph.	Definition	1	formalizes	this	notion	of	a	Boolean	network.		
	
Definition	1	(Boolean	network).	A	Boolean	network	B	=	(V,E,F,s)	is	a	directed	graph	with	
nodes	 V	 :=	 [1,n]	 for	 some	 𝑛	 ∈ ℕ ,	 edges	 𝐸	 ⊆ 𝑉	𝑥	𝑉 ,	 a	 set	 of	 Boolean	 functions	𝐹 ∶=	{𝑓.: {0,1}4 → {0,1}|𝑖 ∈ 𝑉}	
and	sign-function	 𝑠 ∶ 𝐸	 → 	 {−1,1}	
that	assigns	interaction	types	to	the	edges	𝑒 ∈ 𝐸.	
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Let	𝑣 ∈ 𝑉	be	 a	node	of	 the	network.	Then	𝑉<(𝑣)and	𝑉B(𝑣)	denote	 the	 set	 of	 predecessors	
and	successors,	respectively.	A	predecessor	𝑣C ∈ 𝑉<(𝑣)	is	then	called	a	regulator	of	𝑣.		 In	the	context	of	gene	regulatory	networks,	the	nodes	describe	genes	and	edges	denote	the	transcriptional	regulatory	effect	of	a	gene	on	another	gene.	For	convenience,	the	terms	nodes	and	genes	as	well	as	edges	and	interactions,	respectively,	will	be	used	interchangeably	in	the	following.	In	this	setting,	genes	can	either	activate	or	inhibit	their	target	 genes,	 denoted	 by	 the	 sign-function	 that	 assigns	 1	 to	 activating	 and	 	 -1	 to	inhibiting	interactions.		The	set	of	Boolean	functions	defining	the	network	allows	the	specification	of	the	dynamic	behavior,	i.e.	the	transition	from	one	network	state	to	another.	In	this	context,	a	state	is	an	assignment	of	0	(inactive)	or	1	(active)	to	every	gene	and	the	transition	from	one	 state	 to	 another	 corresponds	 to	 the	 application	 of	 the	 Boolean	 functions	 to	 this	assignment.	The	 syntax	 and	 semantics	 considered	 for	Boolean	 functions	 in	 this	 thesis	are	defined	in	Definition	2	and	3.			
Definition	 2	 (Syntax	 of	 Boolean	 Functions).	 A	 Boolean	 function	 can	 be	 inductively	
defined,	using	the	Backus	Naur	form	(Knuth,	1964),	as		𝜑	 ∶= 	𝑡𝑟𝑢𝑒	|	𝑓𝑎𝑙𝑠𝑒	|	(𝜑	&	𝜑)	|	(𝜑	|	𝜑)	|	! 𝜙	|	𝑣	
where	𝑣 ∈ 𝑉	is	a	node.		
Definition	3	(Semantics	of	Boolean	Functions).	
• true	is	always	true	and	false	is	never	true.	
• (𝜑	&	𝜑C)	is	true,	if	𝜑	is	true	and	𝜑Cis	true.	
• (𝜑	|	𝜑′)	is	true,	if	𝜑	is	true	or	𝜑C	is	true	or	both	are	true.	
• ! 𝜑	is	true,	if	𝜑	is	false.	
• 𝑣	is	true,	if	𝑥M = 1	for	a	given	state	x			Informally,	 genes	 contribute	 to	 the	 regulation	 of	 their	 targets	 only	 if	 they	 are	active	(expressed),	which	is	encoded	as	true	in	the	definition	of	the	Boolean	syntax	and	semantics,	and	can	have	and	(&)	and	or	(|)	relationships.	And-relationships	require	that	all	 regulators	 are	 active,	 such	 as	 in	 the	 presence	 of	 protein	 complexes	 required	 for	regulation,	while	or-relationships	require	the	activity	of	a	single	factor.	Each	gene	in	the	network	 is	 represented	as	 a	 literal	𝜈	while	 its	discretized	 expression	 is	denoted	by	𝑥O .	Based	 on	 the	 previous	 definitions	 of	 Boolean	 functions,	 the	 one-step	dynamics	 of	 the	network	is	provided	in	Definition	4.	
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Definition	4	(One-step	dynamics	of	Boolean	networks).	Let	B	=	(V,E,F,s)	be	a	Boolean	
network	and	𝑥P ∈ {0,1}4	a	state	of	the	network	at	a	discrete	time	instance	t.	The	state	of	
node	i	at	time	t+1	can	be	defined	as:	 𝑥.PBQ = 	 𝑓.(𝑥P)	
Then,	the	state	of	the	entire	network	B	can	be	defined	as	𝑥PBQ = 	𝐹(𝑥P)	
where	the	i-th	function	in	F	determines	the	i-th	state	at	time	t+1.			 Boolean	networks	evolve	in	discrete	time-steps	and	the	state	of	each	node	of	the	network	in	the	next	step	is	solely	controlled	by	the	logic	function	for	this	state	and	the	expression	 of	 its	 regulators.	 A	 successive	 application	 of	 these	 functions	 is	 called	 a	
simulation	run	–	or	simply	simulation	–	of	the	network	(Definition	5).		
Definition	5	(k-Step	Simulation).	Let	B	=	(V,E,F,s)	be	a	Boolean	network	and	𝑥P ∈ {0,1}4	
a	state	of	the	network	at	time	t.	A	k-step	simulation	of	the	network	starting	from	x	is	a	path	𝑥P → 𝑥PBQ → 𝑥PBR → ⋯ → 𝑥PBT	
such	that	𝑥PB. = 𝐹(𝑥PB.<Q)	for	1 ≤ 𝑖 ≤ 𝑘.		 While	 the	 next	 state	 of	 each	 node	 in	 the	 network	 is	 determined	 by	 the	application	of	the	corresponding	logic	function,	there	exist	two	different	methods,	called	update	schemes,	 for	computing	the	network	state.	First,	 the	asynchronous	updating	 in	which	only	one	randomly	selected	node	is	updated	and,	second,	synchronous	updating	in	which	all	of	 the	nodes	 in	 the	network	are	updated	simultaneously	 to	constitute	 the	next	state.	Throughout	 this	 thesis,	 the	simulation	of	 the	Boolean	networks	 follows	 the	synchronous	updating	scheme	exclusively.			 Suppose	 to	 simulate	 a	 finite	 Boolean	network	 for	 an	 infinite	number	 of	 steps,	then	 –	 because	 of	 the	 finite	 state	 space	 –	 at	 least	 one	 network	 state	must	 be	 visited	multiple	 times.	All	the	states	having	this	property	of	being	visited	multiple	 times	 for	a	simulation	starting	from	any	state	are	called	attractors.	Two	distinct	types	of	attractors	can	be	distinguished,	fixed-point	and	cyclic	attractors.	Fixed-point	attractors,	sometimes	referred	to	as	steady	states,	are	states	whose	individual	node	states	do	not	change	upon	invocation	 of	 the	 Boolean	 functions	whereas	 cyclic	 attractors	 are	 a	 series	 of	 network	states	that	indefinitely	repeats	in	a	simulation.	Definition	6	defines	fixed-point	and	cyclic	attractors	more	precisely.		
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Definition	 6	 (Attractors).	 Let	 B	 =	 (V,E,F,s)	 be	 a	 Boolean	 network	 and	𝑥, 𝑥P ∈ {0,1}4	
network	states.	Then	
x	is	called	a	fixed-point	attractor	if	and	only	if	𝑥 = 𝐹(𝑥).	
A	 path	 is	 called	 a	 cyclic	 attractor	 if	 and	 only	 if	 the	 path	 is	 of	 the	 form	𝑥 → 𝑥P → ⋯ →𝑥PB. → 𝑥	such	that	𝑥 = 𝐹W𝑥PB.X, 𝑥P = 𝐹(𝑥)	and	𝑥PBY = 𝐹(𝑥PBY<Q)	
		 Figure	3.1	shows	an	example	network	with	its	corresponding	Boolean	functions	(logic	 rules)	 and	 state	 space	 diagram.	 It	 contains	 three	 genes	 that	 are	 activating	(arrows)	or	inhibiting	(dashes)	other	genes.	The	topology	of	the	network	in	conjunction	with	 the	 given	 logic	 rules	 entirely	 define	 the	 Boolean	 network.	 Here,	 inhibition	 is	formalized	as	the	requirement	of	the	gene	to	be	inactive	or,	more	precisely,	not	active.	The	state	space	diagram	contains	all	possible	network	states	and	subsumes	all	paths	of	a	simulation	with	edges	representing	the	one-step	dynamics	of	the	network.	Steady	states,	shown	 in	 blue,	 are	 characterized	 by	 self-loops	 in	 the	 diagram	 corresponding	 to	 their	definition	 of	 being	 a	 fixed-point	 of	 the	 Boolean	 functions	 whereas	 the	 only	 cyclic	attractor,	 shown	 in	 yellow,	 corresponds	 to	 an	 alternation	 of	 states	 ‘100’	 and	 ‘010’	 as	soon	as	one	of	these	states	is	reached.			
Figure	3.1.	Boolean	Network	Example	
Boolean	networks	are	defined	by	their	topology	(left)	and	corresponding	logic	rules	
(middle).	In	the	context	of	transcriptional	regulatory	networks,	genes	repressing	the	
transcription	 of	 their	 target	 are	 represented	 by	 dashed	 lines	 and	 activators	 as	
arrows.	The	logic	rules	define	which	network	configurations	activates	the	gene.	The	
networks	state	space	shows	all	possible	transitions	of	network	configurations	when	
simulated	with	 a	 synchronous	updating	 scheme.	 In	 this	 example,	 there	 exist	 three	
point	attractors	(blue)	and	one	cyclic	attractor	(yellow).	
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3.2 Reconstruction of cell-type specific gene regulatory network models 	 Gene	 regulatory	 networks	 and,	 more	 particularly,	 transcriptional	 regulatory	networks	 represent	 the	 activatory	 or	 inhibitory	 effect	 of	 genes	 on	 each	 other.	 The	reconstruction	 of	 condition	 specific	 networks	 thus	 requires	 determining	 the	interactions	between	genes	that	take	place	in	a	particular	condition	while	not	including	those	specific	to	other	conditions.	The	combination	of	these	interactions	gives	then	rise	to	a	specific	phenotype	partly	defining	the	condition	under	study.		 The	 reconstruction	 of	 gene	 regulatory	 networks	 foremost	 requires	 a	mathematical	 modeling	 formalism	 representing	 the	 condition	 under	 study.	 The	formalism	chosen	here	is	that	of	Boolean	networks	introduced	in	the	previous	section	of	this	thesis.	Recall	that	nodes	of	the	network	represent	genes	while	interactions	specify	a	gene	regulatory	effect	of	one	gene	on	another,	i.e.	activating	or	inhibiting	another	gene.	Depending	on	 the	amount	of	mRNA	of	each	gene	 in	 the	network	 it	 is	assigned	a	node	state	of	0	(inactive)	or	1	(active).	The	state	of	the	network	consists	of	the	states	of	the	individual	nodes.		It	 is	 important	 to	 note	 that	 employing	 Boolean	 networks	makes	 a	 number	 of	assumptions	and	simplifications	that	have	to	be	recognized.	First,	by	using	the	amount	of	mRNA	to	define	the	network	state,	the	model	assumes	that	the	amount	of	proteins	is	high	if	the	gene	is	labeled	active	and	low	if	it	is	labeled	inactive,	and	these	proteins	are	able	 to	actively	 regulate	 the	 expression	of	 other	 genes.	 Second,	Boolean	networks	 are	deterministic	 and,	 thus,	 do	 not	 account	 for	 the	 inherent	 stochasticity	 of	 the	 gene	regulatory	mechanisms	within	the	cells.	Finally,	 the	strength	of	each	 interaction	 is	the	same	and	does	not	account	for	different	affinities	of	proteins	to	the	DNA.	The	 approach	 for	 reconstructing	 cell	 type	 specific	 networks	 followed	 in	 this	thesis	 selects	 a	 set	 of	 interactions	 from	 a	 prior	 knowledge	 network	 such	 that	 the	underlying	Boolean	network	is	compatible	with	a	given	binary	gene	expression	profile.	Specifically,	 the	 network	 composed	 of	 the	 selected	 interactions	 is	 required	 to	 have	 a	point	attractor	corresponding	to	a	discretized	gene	expression	profile,	which	reflects	the	stability	 of	 the	 condition	 under	 study.	 The	 method	 presented	 here	 utilizes	 a	 genetic	algorithm	for	reconstructing	condition	specific	networks,	which	will	be	detailed	 in	 the	remainder	of	this	section.		
3.2.1 Prior knowledge network 	 The	network	reconstruction	process	relies	on	the	information	of	potential	gene	regulatory	effects	stabilizing	the	cell	type	under	study.	Given	a	set	of	genes	that	should	
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be	 part	 of	 the	 network,	 experimentally	 validated	 interactions	 are	 compiled	 from	scientific	 publications.	 In	 particular,	 MetaCoreTM	 from	 Thomson	 Reuters,	 a	 highly	curated	database	of	molecular	interactions	reported	in	literature,	is	queried	to	obtain	all	experimentally	 validated	 direct	 interactions	 among	 these	 genes.	 The	 selected	interactions	are	classified	to	be	directly	involved	in	the	regulation	of	the	target	gene	and	their	 effect,	 i.e.	 activation	 or	 inhibition,	 is	 mostly	 experimentally	 supported.	 Those	interactions	whose	effect	is	unspecified,	i.e.	unsigned	interactions,	can	also	be	included	in	the	prior	knowledge	network.	The	mode	of	action	is	then	subject	to	inference	during	the	 reconstruction	 of	 the	 network.	 Importantly,	 even	 though	 literature-based	interactions	are	used	in	the	work	presented	in	this	thesis,	the	prior	knowledge	network	could	be	generated	using	different	approaches.		
3.2.2 Genetic Algorithm for Boolean network reconstruction 	 The	prior	knowledge	networks	from	MetaCoreTM	are	rather	heterogeneous	due	to	 their	composition	of	 interactions	 from	different	cell	 lines,	cell	 types	or	 tissues	with	different	 experimental	 conditions,	 which	 necessitates	 a	 procedure	 for	 selecting	 the	interactions	 giving	 rise	 to	 the	 phenotype	 under	 study.	 For	 determining	 the	 network	dynamics,	the	majority	rule	is	selected	as	the	logic	scheme	for	each	gene.	With	it,	a	gene	is	active	if	the	number	of	active	activators	exceeds	the	number	of	active	repressors.	In	the	context	of	Boolean	networks,	the	point	attractors	of	the	prior	knowledge	network	do	not	 necessarily	 match	 the	 binary	 gene	 expression	 profile	 of	 the	 studied	 biological	condition.	For	obtaining	a	network	that	does	have	a	corresponding	attractor,	the	prior	knowledge	network	must	be	 contextualized	 to	 the	phenotype.	 In	order	 to	 accomplish	this	task,	the	proposed	method	utilizes	a	genetic	algorithm	for	finding	a	sub-network	by	iteratively	refining	the	result.	With	regard	to	its	usage	for	identifying	instructive	factors	of	 cellular	 conversions	 given	 an	 initial	 and	 final	 cell	 type	 or	 condition,	 the	 method	reconstructs	 both	 corresponding	 networks	 at	 the	 same	 time	 to	 save	 computational	resources.		 As	previously	described,	 the	prior	knowledge	network	might	contain	unsigned	interactions	with	 unspecified	mode	 of	 action.	 A	 sign	 for	 these	 interactions	 has	 to	 be	determined	 during	 the	 contextualization	 process	 since	 the	 attractors	 of	 the	 network	depend	on	them.	Therefore,	the	mode	of	action	is	inferred	such	that	it	is	consistent	with	both	the	initial	and	final	network.		 The	 method	 for	 reconstructing	 the	 cell	 type	 specific	 networks	 is	 based	 on	 a	genetic	 algorithm	 comprised	 of	 a	 population	 of	 individuals.	 Each	 individual	 is	
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implemented	 as	 a	 binary	 array	 representing	 the	 presence	 or	 absence	 of	 interactions	from	the	prior	knowledge	network	for	both	conditions	and	an	inferred	sign	assignment	(Figure	3.2).	
Figure	3.2.	Workflow	of	the	genetic	algorithm	
	
		 The	presence	of	interactions	is	encoded	in	a	binary	scheme	where	‘1’	represents	their	 presence	 and	 ‘0’	 their	 absence.	 Similarly,	 for	 the	 mode	 of	 action	 ‘1’	 represents	activation	and	‘0’	inhibition	(denoted	as	‘+’	and	‘-‘	in	Figure	3.2).	Thus,	one	individual	in	the	genetic	algorithm	is	divided	into	three	sub-arrays,	the	network	corresponding	to	the	first	phenotype	(green),	the	network	corresponding	to	the	second	phenotype	(blue)	and	the	inferred	mode	of	action	of	unsigned	interactions	(yellow).	
The	 genetic	 algorithm	 for	 reconstructing	 networks	 contains	 an	 initial	 population	 of	
random	 individuals.	 Each	 individual	 contains	 three	 parts,	 the	 network	 for	 the	 first	
phenotype,	the	network	for	the	second	phenotype	and	a	predicted	mode	of	action	for	
each	 unsigned	 interaction	 (activation:	 ‘+’,	 inhibition:	 ‘-‘).	 If	 an	 interaction	 from	 the	
prior	 knowledge	 network	 is	 present	 it	 is	 denoted	 by	 ‘1’	 and	 ‘0’	 if	 it	 is	 absent.	 The	
population	 is	updated	 iteratively	 following	a	 three-step	approach	 for	producing	new,	
better	individuals.	First,	two	individuals	are	selected.	These	individuals	are	randomly	
changed	 and	 subsequently	 recombined	 giving	 rise	 to	 two	 new	 individuals.	 This	
procedure	is	repeated	for	a	pre-defined	number	of	times.	
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Besides	 having	 an	 efficient	 encoding	 of	 the	 network,	 the	 choice	 of	 the	background	algorithm	plays	a	 key	 role	 for	a	 reasonable	performance.	 For	 this	 reason,	the	 jMetal	(Durillo	and	Nebro,	2011)	 implementation	of	NSGA-II	 (Deb	et	al.,	2002),	an	elitist	multiobjective	 genetic	 algorithm,	 has	 been	 chosen	 as	 it	 reduces	 the	 complexity	compared	 to	other	 implementations	 (Deb	et	al.,	 2002).	Moreover,	NSGA-II	 is	 an	 elitist	algorithm	so	that	the	best	individuals	are	kept	for	the	next	iteration	and	are	not	subject	to	the	three	main	steps	of	the	algorithm.	The	fitness	function,	or	score,	for	determining	the	best	individuals	is	composed	of	three	distinct	parts.	First,	the	manhattan	distance	of	the	 network	 attractor	 and	 the	 required	 discrete	 phenotype	 it	 should	 represent	 for	reducing	the	mismatch	with	the	experimental	data.	Second,	the	closeness	of	the	reached	attractor	upon	simulation	starting	from	the	network	state	corresponding	to	the	desired	discretized	phenotype.	Finally,	the	number	of	removed	interactions	is	minimized,	which	ensures	 that	 only	 inconsistent	 interactions	 are	 pruned.	 After	 scoring,	 the	 genetic	algorithm	 iteratively	 evolves	 following	 a	 three-step	 approach	 until	 a	 user-defined	number	of	iterations	is	exceeded.		
3.2.2.1 Selection 	 The	first	step	in	each	iteration	of	the	genetic	algorithm	constitutes	the	selection	of	two	individuals	from	the	entire	population.	Cooperative	selection	(Nepomuceno	et	al.,	2007)	 is	a	scheme	that	preserves	diversity	while	ensuring	 the	selection	of	 individuals	whose	 attractors	 are	 closest	 to	 the	 phenotype	with	 respect	 to	 the	 previously	 defined	fitness.	 Briefly,	 this	 strategy	 selects	 the	 best	 individual	 and	 updates	 its	 score	 to	 the	average	score	of	the	second-	and	third-best	individuals,	which	implies	the	selection	of	a	different	individual	in	the	next	iteration.	Importantly,	multiple	individuals	may	have	the	same	 score	 so	 that	 the	 selected	 individual	 is	 not	necessarily	 the	 third	network	 in	 the	queue	after	the	score	was	updated.	Following	this	approach	guarantees	the	selection	of	the	best	individuals	in	the	population	while	preserving	diversity	in	the	next	generation.		
3.2.2.2 Mutation 	 The	second	step	constitutes	the	mutation	of	the	selected	individuals.	Each	entry	of	 the	 individual	 arrays	 is	 probabilistically	altered,	 i.e.	 a	 present	 interaction	 is	pruned	while	 an	 absent	 interaction	 is	 re-introduced,	 or	 the	 inferred	 sign	 of	 an	 unsigned	interaction	is	transposed	with	a	certain	probability.	Here,	the	selection	of	an	appropriate	mutation	 rate	 is	 crucial	 for	 the	performance	of	 the	 genetic	 algorithm.	A	 low	mutation	
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rate	leads	to	faster	convergence	of	the	entire	population	towards	a	single	solution	while	higher	 mutation	 rates	 lead	 to	 a	 greater	 exploration	 of	 the	 state	 space	 and	 slower	convergence.	Low	mutation	rates	bear	the	risk	of	identifying	local	minima	instead	of	the	globally	optimal	solution.		
3.2.2.3 Crossover 	 The	 last	 step	 of	 the	 genetic	 algorithm	 constitutes	 the	 crossover,	 i.e.	 a	probabilistic	 recombination,	 of	 the	 two	 selected	 individuals.	Given	 a	probability	p	 the	two	individuals	are	recombined	and,	consequently,	left	unchanged	with	probability	1-p.	Typically,	one	position	in	the	array	is	chosen	at	which	the	two	individuals	are	split	with	new	 individuals	 created	 from	 the	 first	 part	 of	 the	 first	 individual	 together	 with	 the	second	part	of	 the	second	 individual	and	vice	versa.	However,	since	 the	arrays	 in	 this	implementation	of	 the	genetic	algorithm	are	composed	of	 three	different	components,	the	 single-point	 crossover	 strategy	 has	 been	 adapted	 to	 a	 three-point	 crossover	 that	selects	 a	 split	 position	 in	 each	part	 of	 the	 array.	Thus,	 the	 strategy	 for	 combining	 the	split	 parts	 is	 the	 same	 as	 for	 the	 single-point	 crossover	 treating	 the	 subarrays	individually.	
3.3 Inference of candidate instructive factors for cellular conversions 	 Network	motifs,	such	as	positive	and	negative	feedback	loops,	have	an	important	role	 in	 maintaining	 network	 stability.	 While	 positive	 feedback	 loops	 are	 typically	associated	with	 the	stabilization	of	point	attractors	(Plahte	et	al.,	1995;	Snoussi,	1998;	Gouzé,	1998;	Soulè,	2003;	Thomas,	1994),	negative	feedback	is	a	necessary	condition	for	a	network	to	possess	at	least	one	cyclic	attractor	(Thomas,	1981)	and	a	combination	of	both	 is	 implicated	 in	 maintaining	 a	 stable	 network	 state	 (Remy	 and	 Ruet,	 2008).	 In	order	to	detect	these	feedback	loops,	the	proposed	methodology	implements	Johnson’s	algorithm	 (Johnson,	 1975)	 for	 identifying	 all	 elementary	 cycles	 of	 both	 reconstructed	networks.	Elementary	cycles	can	be	defined	as	a	path	starting	and	ending	 in	 the	same	network	node	while	all	nodes	 in	 the	path	only	occur	once.	Definition	7	 formalizes	 this	notion	in	the	context	of	Boolean	Networks.		
Definition	7	(Elementary	cycle).	Let	G	=	(V,E,F,s)	be	a	Boolean	network	and	𝑥, 𝑥Q, … , 𝑥4 ∈𝑉	nodes	 in	 the	network.	An	 elementary	 cycle	 is	 either	 a	 self-loop,	 i.e.	(𝑥, 𝑥) ∈ 𝐸	or	 fulfills	
the	condition	 (𝑥, 𝑥Q) ∈ 𝐸 ∧ (𝑥4, 𝑥) ∈ 𝐸 ∧ ∀𝑖. 1 ≤ 𝑖 ≤ 𝑛 − 1. (𝑥., 𝑥.BQ) ∈ 𝐸	
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where	𝑥, 𝑥Q, … , 𝑥4are	pairwise	unequal.	An	elementary	cycle	is	called	positive	 if	𝑠(𝑥, 𝑥Q) ⋅𝑠(𝑥4, 𝑥) ⋅ ∏ 𝑠(𝑥., 𝑥.BQ) = 14<Q.`Q 	and	negative	otherwise.		 Feedback	loops	common	to	both	cell	type	specific	networks	are	determined	and	all	genes	they	are	composed	of	are	assumed	to	be	candidate	instructive	factors.	Further,	the	 approach	must	 take	 into	 account	 the	 topological	 differences	of	 the	 two	networks.	Therefore,	differentially	regulated	genes,	 i.e.	genes	being	regulated	by	different	sets	of	transcription	 factors,	 are	 identified	 as	 they	 are	 predestined	 targets	 that	 cannot	 be	explained	within	the	same	network	topology.	It	is	 important	to	note	that	the	identified	genes	are	not	necessarily	responsible	for	disease	onset	or	maintenance,	in	the	context	of	diseases	as	cellular	conversions,	but	are	rather	expected	to	revert	the	disease	phenotype	upon	perturbation.	A	minimal	multitarget	combination	of	candidate	 instructive	 factors	 is	obtained	by	 randomly	 sampling	 from	 all	 possible	 combinations.	 For	 keeping	 the	 runtime	tractable,	the	maximum	number	of	simulated	perturbations	is	limited	to	one	million	per	combination	size.	Here,	the	size	of	a	combination	refers	to	the	number	of	genes	included	in	the	perturbation.	Networks	are	in	silico	perturbed	with	each	combination	individually	and	 the	 propagated	 effect	 is	 simulated	 until	 a	 point-attractor	 is	 reached	 or	 for	 a	maximum	of	1000	steps.	The	difference	between	the	last	state	of	the	simulation	and	the	desired	 phenotype	 constitutes	 the	 effect	 of	 the	 combination	 and	 is	 penalized	 by	 the	number	 of	 nodes	 in	 the	 network	 if	 no	 point-attractor	 has	 been	 reached.	 Of	 note,	 the	perturbation	 effect	 is	 assumed	 to	 be	 dominant,	 i.e.	 an	 up-regulated	 gene	 is	 kept	 up-regulated	 regardless	 of	 its	 underlying	 logic	 rule.	 Therefore,	 larger	 perturbations	 are	prompt	 to	 artificially	 increase	 their	 effect.	 In	 order	 to	provide	 a	 comparable	measure,	the	absolute	perturbation	effect	is	defined	by	the	number	of	inflicted	in	silico	changes	to	the	phenotype	subtracted	by	the	number	of	perturbed	genes.	Importantly,	the	absolute	perturbation	 effects	 can	 become	 negative	 if	 the	 number	 of	 induced	 changes	 on	 the	phenotype	is	lower	than	the	number	of	perturbed	genes.	Furthermore,	the	normalized	perturbation	 effect	 is	 defined	 as	 the	 absolute	 perturbation	 effect	 of	 a	 multitarget	combination	 divided	 by	 the	 highest	 observed	 absolute	 perturbation	 effect	 of	 all	multitarget	combinations,	resulting	in	a	scaling	between	0	and	1.		
3.3.1. Ranking of small compounds for inducing cellular conversions 	 The	 identification	of	 potential	 drugs	 for	 inducing	 a	desired	 cellular	 conversion	utilizes	 the	 aforementioned	 multitarget	 perturbation	 effects	 to	 provide	 a	 qualitative	
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measure	 of	 whether	 important	 genes	 are	 targeted.	 In	 summary,	 the	 enrichment	 of	reported	drug	effects	contained	in	simulated	multitarget	perturbations	is	computed	by	weighting	the	drug	effects	based	on	their	individually	induced	change	of	the	phenotype	upon	 perturbation.	 Those	 drugs	 showing	 more	 influential	 effects	 in	 high	 scoring	multitarget	 combinations	 and	 low	 enrichment	 in	 low	 scoring	 combinations	 are	considered	to	have	greater	effects	on	the	overall	phenotype.		 More	 formally,	 first,	 a	 weight	𝑤b 	is	 assigned	 to	 every	 candidate	 instructive	factors	 corresponding	 to	 the	normalized	 single-gene	perturbation	 effect.	Given	drug	d	and	 a	 set	 of	 reported	 drug	 effects	 D,	 the	 enrichment	 of	 drug	 effects	 in	 multitarget	combination	 I	 can	 be	 defined	 as	𝑚de = ∑ 𝑤YY∈d∧Y∈g ,	 i.e.	 the	 sum	 of	 weights	 of	 genes	contained	in	I	having	a	reported	drug	effect.	In	order	to	obtain	values	between	0	and	1,	these	 enrichment	 scores	 are	 normalized	 by	 the	 total	 sum	 of	 weights	 yielding	𝑚hde =𝑚de ∑ 𝑤YY∈gi .	 From	 the	 normalized	 enrichment	 and	 perturbation	 effects	 for	 each	multitarget	 combination,	 the	 enrichment	 distribution	 of	 drug	 d	 over	 the	 space	 of	induced	phenotypic	changes	can	be	computed.	Informally,	the	probability	mass	function	𝑝e	of	 this	distribution	 can	 be	defined	 as	 the	 fraction	 of	 all	 drug	 effect	 enrichments	 in	multitarget	 combinations	 having	 a	 particular	 score	 divided	 by	 the	 sum	 of	 all	enrichments	 of	 all	 scores.	 Thus,	 𝑝e(𝑥) = 𝑀e(𝑥) ∑ 𝑀e(𝑦)m∈ℤ⁄ 	with	 𝑀e(𝑥) =	∑ 𝑚hded∈{.	|	bpq(.)`r} 	where	 gec(i)	 refers	 to	 the	 normalized	 perturbation	 effect	 of	multitarget	 combination	 i.	 With	 it,	 the	 cumulative	 enrichment	 in	 multitarget	combinations	 inducing	less	phenotypic	changes	 than	a	given	 threshold	can	be	directly	derived	as	𝑐e(𝑥) = 	∑ 𝑝e(𝑗)uvw	(T∈ℤ|Txr)Y`y .			 The	 final	 quality	 score	 of	 a	 drug,	 with	 respect	 to	 its	 predicted	 potential	 of	inducing	desired	phenotypic	changes,	can	eventually	be	determined	by	considering	the	area	 under	 the	 cumulative	 enrichment	 function	 𝑐e(𝑥), 	defined	 as	 𝐴𝑈𝐶e =	∑ 𝑐e(𝑥)u}~𝑦𝑐e(𝑦) = 1<Qr`u}~	(m|q(m)y) .	 Here,	 lower	 values	 of	𝐴𝑈𝐶e	correspond	 to	more	 favorable	drugs	while	higher	 values	predominantly	 show	enrichment	 in	 low	 scoring	multitarget	combinations.	 For	 example,	 a	 drug	 having	 an	 area	 under	 the	 cumulative	 enrichment	curve	 of	 zero	 has	 reported	 effects	 solely	 in	 genes	 contained	 in	 the	 highest	 scoring	multitarget	combinations.	Similarly,	drugs	with	an	AUC	of	one	only	have	reported	effects	in	genes	inducing	subtle	changes	on	the	phenotype	in	silico.	
3.4 Prediction of binary accessibility measures The	 identification	 of	 accessible	 and	 inaccessible	 genes	 is	 an	 inevitable	 step	towards	 condition	 specific	 networks	 due	 to	 the	 heterogeneity	 of	 the	 epigenetic	
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landscape	in	different	cell	types.	State-of-the-art	experimental	methods,	like	DNase-seq	and	ATAC-seq,	are	based	on	cutting	exposed	regions	of	the	DNA	that	are	subsequently	sequenced	 and	 aligned	 to	 the	 genome.	 Peaks	 corresponding	 to	 regions	 enriched	 in	aligned	 reads	 can	 then	 be	 identified	 to	 pinpoint	 accessible	 chromatin	 regions	throughout	the	genome.	However,	due	to	the	employed	experimental	techniques,	these	peaks	 are	 typically	 not	 distributed	 over	 complete	 genes	 but	 rather	 identify	 active	regulatory	 regions	 (Song	 et	 al.,	 2011).	 When	 working	 with	 gene	 regulatory	 Boolean	networks	 where	 nodes	 represent	 genes,	 the	 peaks	 throughout	 the	 genome	 must	 be	related	 to	 genes	 and	 translated	 to	 gene-level	 accessibility.	 Another,	 more	 important,	impediment	constitutes	the	unavailability	of	experimental	data	for	many	cell	types	and	conditions	under	study	hindering	the	refinement	of	reconstructed	regulatory	networks.		 The	 method	 presented	 in	 the	 remainder	 of	 this	 section	 addresses	 these	limitations	by	defining	a	consistent	gene-level	accessibility	measure	that	can	be	readily	used	 in	 the	context	of	Boolean	networks	and	provides	a	 tool	 for	predicting	gene-level	accessibility	 from	gene	 expression	data.	 For	 this	purpose,	 a	 stacked	 classification	 tree	model	was	 developed	 that	 learns	 the	 relationship	between	 expression	 and	 chromatin	accessibility	data	and	can	be	applied	to	unseen	transcriptomics	datasets	for	predicting	the	chromatin	accessibility	of	genes.		
3.4.1 Dataset for model training 	 For	training	the	stacked	classification	tree	model,	it	is	necessary	to	compile	a	dataset	including	both	gene	expression	and	chromatin	accessibility	data	of	a	particular	organism.	The	training	data	used	for	validating	the	approach	are	human	RNA-seq	and	DNase-seq	samples	from	ENCODE	(Dunham	et	al.,	2012)	aligned	to	Human	Genome	Version	19	(hg19).	In	total	18	samples	have	been	processed	including	various	cell	lines	and	cell	types	ranging	from	alveolar	basal	epithelial	cells	over	skeletal	muscle	cells	up	to	embryonic	stem	cells.	A	complete	list	of	obtained	cell	lines/types	and	corresponding	Gene	Expression	Omnibus	(GEO)	accession	numbers	can	be	found	in	Table	3.1.						
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Table	3.1.	Training	dataset	for	predicting	gene-level	accessibility	
Cell	line/Cell	type RNA-Seq	(GEO-Accession) DNase-seq	(GEO-Accession) 
A549	 GSM758564	 GSM736580, GSM736506	
AG04450	 GSM758561	 GSM736514, GSM736563	
BJ	 GSM758562	 GSM736518, GSM736596	
Monocytes CD14+	 GSM984609	 GSM1008582	
GM12878	 GSM758559	 GSM736496, GSM736620	
H1-hESC	 GSM758566	 GSM736582	
HeLa-S3	 GSM765402	 GSM736564, GSM736510	
HepG2	 GSM758575	 GSM736637, GSM736639	
HMEC	 GSM758571	 GSM736634, GSM736552	
HSMM	 GSM758578	 GSM736560, GSM736553	
HUVEC	 GSM758563	 GSM736575, GSM736533	
IMR90	 GSM981249	 GSM1008586	
K562	 GSM765405	 GSM736629, GSM736566	
MCF7	 GSM765388	 GSM736581, GSM736588	
NHEK	 GSM765401	 GSM736545, GSM736556	
NHLF	 GSM765394	 GSM736612, GSM736536	
SK-N-SH	 GSM981253	 GSM1008585	
SK-N-SH (Retinoid Acid) GSM765395 GSM736559, GSM736578 		 DNase-seq	sequences	aligned	to	the	hg19	genome	were	obtained	from	ENCODE	(Dunham	 et	 al.,	 2012;	 ENCODE	 Datasets)	 and	 further	 processed	 to	 identify	 enriched	genomic	 regions,	 also	 known	 as	 hypersensitive	 regions,	 using	 the	 HotSpot	 algorithm	(version	5.1)	 (John	et	al.,	2011;	Sabo	et	al.,	2004)	with	default	parameters	 imposing	a	false	discovery	rate	of	1%	on	all	 identified	sites.	Subsequently,	these	identified	regions	were	annotated	with	genomic	information	relating	the	position	with,	for	example,	gene	names,	introns,	exons	and	gene	types,	using	HOMER	(Heinz	et	al.,	2010).	A	gene	is	then	labeled	 accessible	 if	 the	 gene-coding	 region,	 including	 the	 3’	 and	5’	 UTR	 exons	 or	 its	promoter	 region,	 contains	 at	 least	 one	 DNase	 hypersensitive	 site,	 and	 inaccessible	otherwise.		 RNA-Seq	samples	were	obtained	from	ENCODE	(Dunham	et	al.,	2012)	as	aligned	long	 PolyA+	 sequences.	 Transcript	 abundance	was	 estimated	 using	HOMER	 in	 a	 two-step	approach.	First,	a	tag	directory	was	created	transforming	the	aligned	reads	into	a	data	 structure	 that	 can	 be	 interpreted	 by	 HOMER	 using	 the	 ‘makeTagDirectory’	command.	 Second,	 transcript	 abundance	 was	 quantified	 as	 fragments	 per	 kilobase	 of	exon	 per	 million	 reads	 mapped	 (Mortazavi	 et	 al.,	 2008)	 (FPKM)	 running	 the	
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‘analyzeRepeats’	program.	Consequently,	only	reads	mapping	to	exons	on	either	strand	of	the	DNA	were	counted	and	different	transcripts	of	the	same	gene	were	condensed	to	the	gene	level.		
3.4.2 Stacked classification tree model 	 The	 model	 for	 predicting	 gene-level	 accessibility	 contains	 three	 classification	layers	 that	 are	 stacked,	 i.e.	 hierarchically	 combined,	 in	 order	 to	 obtain	 the	 final	predictions.	 For	 convenience,	 we	 denote	 the	 bottom,	 middle	 and	 upper	 layer	classification	 trees	 as	𝐿, 𝐿	and	𝐿 ,	 respectively.	 While	𝐿 	classifiers	 operate	 directly	on	 the	 gene	 expression/chromatin	 accessibility	 training	 data,	 upstream	 classification	layers	 relate	 the	 predictions	 of	 the	 lower	 layers	 to	 gene-level	 accessibility.	 Figure	 3.3	illustrates	the	workflow	of	the	stacked	classification	model.		 For	the	first	classification	layer,	each	training	sample	is	sub-sampled	1000	times	where	 each	 sub-sample	 contains	 1000	 expression/accessibility	 pairs.	 The	 number	 of	sub-samples	 drawn	 for	 each	 training	 sample	 was	 empirically	 estimated	 to	 guarantee	that	each	gene	 is	selected	 in	at	least	one	sample	and	multiplied	by	 four	 to	obtain	well	mixed	training	datasets.	This	step	is	necessary	to	ensure	that	the	resulting	classification	trees	 do	 not	 contain	 too	 fine-grained	 conditions	 for	 classifying	 genes	 into	 being	accessible	or	inaccessible	and	are,	thus,	less	likely	to	overfit	the	data.	To	 address	 this	 issue,	 each	 sub-sample	 contains	 only	 1000	expression/accessibility	 pairs	 for	 training	 to	 reduce	 the	 number	 of	 similar,	 low	expression	values	while	preserving	the	distribution	of	the	whole	sample.	Besides	 the	 raw	 gene	 expression	 values,	 another	 predictor	 is	 included	 in	 the	training	 set,	 that	 is	 derived	 from	 both	 expression	 and	 accessibility.	 In	 particular,	 the	empirical	 expression	 distributions	 of	 accessible	 and	 inaccessible	 genes	 are	 computed	and	the	distance	of	each	gene	expression	value	 to	both	distributions	 is	determined	by	the	 Mahalanobis	 distance	 (Mahalanobis,	 1936).	 For	 an	 expression	 value	 e	 the	Mahalanobis	 distance	 to	 any	 empirical	 distribution	 X	 is	 defined	 as	𝑑(𝑒) = (𝑒 − 𝜇) ⋅𝑆<Q ⋅ (𝑒 − 𝜇)C.	Here,	𝜇 	represents	 the	mean	of	 the	empirical	distribution	X	and	𝑆<Q	is	the	inverse	of	the	sample	covariance	matrix	of	X.	
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Figure	3.3.	Illustration	of	stacked	classification	tree	model	
	
	 After	 sub-sampling	 the	 initial	 samples	 and	 training	 a	 classifier	 for	 each	 of	 the	sub-sampled	 datasets,	 which	 constitute	 the	 first	 classification	 layer	 (𝐿 ),	 the	𝐿	classifiers	are	trained	by	relating	the	predicted	probabilities	for	a	gene	to	be	accessible	or	inaccessible	to	the	experimentally	determined	gene-level	accessibility.	As	a	result,	𝐿	classifiers	return	the	probability	that	the	probabilities	predicted	by	𝐿 	trees	are	correct.	
The	 stacked	 learning	 framework	 for	 predicting	 gene-level	 accessibility	 treats	 each	
sample	in	the	training	set	separately.	First,	the	sample	is	sub-sampled	1000	times	for	
constructing	a	classification	tree.	The	predictions	of	each	tree	for	the	whole	sample	are	
then	 used	 as	 an	 input	 for	 constructing	 a	 single	 classifier	 for	 the	whole	 sample.	 The	
predictions	 of	 whole-sample	 classifiers	 are	 then	 combined	 in	 a	 meta-classifier	 to	
obtain	the	final	predictions.	
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As	depicted	in	Figure	3.3,	the	second	classification	layer	contains	as	many	trees	as	the	number	of	samples	in	the	original	training	set.	The	algorithm	employed	for	training	the	second	 classification	 layer,	 RUSBoost	 (Seiffert	 et	 al.,	 2010),	 addresses	 an	 important,	inherent	 issue	with	 the	 training	samples.	Based	on	 the	 experimental	data,	 there	 is	 an	uneven	ratio	of	accessible	and	inaccessible	genes,	which	typically	leads	to	a	prediction	bias.	RUSBoost	overcomes	this	limitation	by	randomly	removing	training	data	from	the	majority	class	for	each	of	constructed	classification	tree.			 As	 a	 final	 step,	 the	 predictions	 based	 on	 the	 individual	 samples	 are	 combined	using	a	single	meta-classifier	𝐿 .	 In	accordance	with	the	 first	and	second	classification	layer,	a	classification	tree	is	constructed	by	employing	the	RUSBoost	algorithm	(Seiffert	
et	al.,	2010),	but	this	time	on	the	predictions	of	the	second	layer	(𝐿)	predictions.		
3.5 Reference-based binarization of gene expression 	 The	 use	 of	 Boolean	 networks	 as	 models	 of	 gene	 regulation	 requires	 the	classification	of	continuous	gene	expression	measurements	from	RNA-seq	or	microarray	experiments	 into	discrete	 values	 reflecting	whether	 the	 gene	 is	 active	or	 inactive.	For	enabling	the	consistent	comparison	of	more	than	two	conditions	a	novel	approach	has	been	 developed	 that	 utilizes	 a	 user-defined	 gene	 expression	 library	 serving	 as	 a	reference	 for	 classifying	 active	 and	 inactive	 genes.	 Definition	 8	 provides	 a	 formal	introduction	of	a	reference	library	that	is	considered	in	this	method.		
Definition	 8	 (Reference	 library).	 Let	 ?⃗? 	be	 an	 expression	 profile	 of	 a	 single	 gene	
throughout	different	cell	types/lines	and	conditions.	Then	𝐺 = {𝑔𝑒𝑛𝑒 ∶ 	 ?⃗? = (𝑔Q, 𝑔R, … , 𝑔4)	|	𝑔Q = 𝑆Q(𝑔𝑒𝑛𝑒) ∧ 𝑔R = 𝑆R(𝑔𝑒𝑛𝑒) ∧ …∧ 𝑔4= 𝑆4(𝑔𝑒𝑛𝑒)	}	
is	a	reference	library	where	𝑆Q, … , 𝑆4 	representing	gene	expression	profiles	of	different	cell	
types/lines	or	conditions.			 The	 gene	 expression	 profile	𝑆. 	in	 the	 definition	 of	 the	 reference	 libraries	 is	 a	function	returning	the	expression	value	of	a	gene	for	phenotype	i.	For	convenience,	each	gene	?⃗?	is	 labeled	with	 its	 corresponding	 gene	name.	Of	note,	 typically	 all	genes	 in	 the	reference	 have	 the	 same	number	of	 expression	values,	 i.e.	 all	 vectors	 are	of	 the	 same	length,	since	they	were	derived	from	the	same	transcriptomics	datasets.	Thus,	G	can	be	regarded	 as	 a	 matrix	 with	 rows	 corresponding	 to	 genes	 and	 columns	 to	 different	expression	samples.	
	 53	
The	distribution	given	by	the	gene	expression	profiles	contained	in	the	reference	library	 is	 assumed	 to	 be	 the	 same	 as	 the	 real,	 unknown	 distribution	 that	 would	 be	obtained	by	performing	gene	expression	experiments	for	every	possible	cell	type.	Given	this	 assumption,	 the	method	performs	 three	main	 steps	 to	discretize	 gene	 expression	values	 (Figure	 3.4).	 (1)	 Due	 to	 the	 undeniable	 incompleteness	 of	 the	 reference,	 the	empirical	 distribution	 for	 each	 gene	 in	 G	 is	 smoothed	 by	 selecting	 the	 best	 fitting	parametric	distribution	to	represent	it.	(see	Figure3.4	part	1	and	2)	(2)	This	process	is	repeated	 for	 a	 pre-defined	 number	 of	 bootstrap-samples	 in	 order	 to	 obtain	 a	distribution	of	parameter	values	for	the	parametric	distribution.	(see	Figure	3.4	part	3)	(3)	To	identify	thresholds	for	calling	a	gene	active	or	inactive,	the	method	approximates	each	bootstrapped	distribution	by	two	step-functions.	The	first	step	function	minimizes	the	number	of	 false	positive	 assignments,	 i.e.	 classifying	a	 gene	 as	being	 active	 if	 it	 is	inactive,	while	the	second	function	minimizes	the	number	of	false	negative	assignments,	i.e.	classifying	a	gene	inactive	while	it	is	actually	active.	The	gene	expression	value	at	the	jump	 discontinuity	 of	 each	 step	 function	 is	 then	 defined	 as	 the	 threshold	 for	discretization.	 This	 procedure	 is	 conducted	 on	 all	 the	 bootstrapped	 distributions	 and	gives	 rise	 to	 the	 threshold	 distribution	 used	 for	 classifying	 the	 individual	 genes.	 (see	Figure	3.4	part	4	and	5)	The	remainder	of	this	section	describes	the	main	steps	of	the	method	and	how	statistical	significance	measures	are	 assigned	 to	query	 expression	values.	 It	 concludes	with	a	statistical	assessment	of	how	many	expression	profiles	from	different	cell	types	are	needed	for	approximating	the	real,	unobservable	distribution	closely.			
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Figure	3.4.	Workflow	for	discretizing	gene	expression	data	
	
	
3.5.1 Smoothing of empirical gene expression distributions 	 The	 chosen	 reference	 library	 G	 is	 usually	 not	 covering	 all	 cell	 types	 of	 an	organism	 leading	 to	 an	 inherent	 uncertainty	 in	 the	 empirical	 gene	 expression	distribution.	Particularly	those	expression	ranges	that	have	not	been	profiled,	appearing	as	no	increase	in	the	empirical	cumulative	distribution	function	(Definition	10),	could	be	explained	by	two	different	assumptions.		
The	workflow	for	discretizing	gene	expression	requires	the	computation	of	thresholds	
obtained	 within	 five	 steps.	 The	 gene	 expression	 distribution	 is	 approximated	 by	 a	
parameterized	distribution	 family.	After	 the	best	 fitting	distribution	 family	has	been	
determined,	 parameters	 are	 obtained	 for	 several	 bootstrap	 samples	 of	 the	 gene	
expression	and	lower	and	upper	thresholds	are	computed	for	each	fitted	distribution.	
The	resulting	cumulative	threshold	distribution	provides	the	statistical	significance	for	
a	query	expression	value	to	be	active	or	inactive.	
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Definition	 9	 (Indicator	 function).	 Let	 X	 be	 a	 set	 and	𝐴 ⊆ 𝑋.	 The	 indicator	 function	𝐼: 𝑋 → {0,1}	is	defined	as	 𝐼(𝑥) = 	 1					if	𝑥 ∈ 𝐴,0					if	𝑥 ∉ 𝐴		
	
Definition	 10	 (Empirical	 cumulative	 distribution	 function).	 Let	?⃗? ∈ 𝐺 	be	 a	 gene	
expression	sample	for	a	gene	and	I	be	the	indicator	function.	Then	𝑒𝑐𝑑𝑓b⃗ (𝑥) = 	 1𝑛𝐼bxr(𝑔.)4.`Q 	
is	the	empirical	distribution	function	of		?⃗?.	
		 Either	 there	 exists	 any	 cell	 type	 or	 condition	 in	 which	 the	 gene	 under	consideration	 takes	 on	 these	 expression	 values	 but	 G	 does	 not	 contain	 it	 or	 these	expression	 values	 do	 not	 occur	 at	 all.	 Based	 on	 previous	 studies	 defining	 gene	expression	as	a	stochastic	process	(Blake	et	al.,	2003;	Eldar	and	Elowitz,	2010;	Elowitz,	2002;	Syeed	et	al.,	2010;	Kærn	et	al.,	2005;	McCullagh	et	al.,	2009;	Paulsson,	2005;	Raj	and	van	Oudenaarden,	2008),	 the	basic	assumption	of	 the	method	 is	 that	 these	values	have	not	been	sampled	and,	thus,	the	distribution	for	these	expression	ranges	should	be	approximated	 to	 account	 for	 this	 insufficient	 sampling.	 Therefore,	 the	 empirical	distribution	 is	 replaced	 by	 the	 best	 fitting	 parametric	 distribution	 (Table	 3.2)	 with	respect	to	a	maximum	likelihood	estimator	(Wilks,	1938).	In	the	remainder,	we	denote	the	best	fitting	probability	distribution	of	gene	g	parameterized	by	?⃗?	as	𝐷b(𝑥|?⃗?).		
Definition	11	 (Negative	Log-Likelihood).	The	 likelihood	of	a	 set	of	parameters	?⃗?	given	
(an	expression	value)	x	is	the	probability	of	observing	x	given		?⃗?,	i.e.	ℒ(?⃗?|𝑥) = 𝑃(𝑥|?⃗?)	
with	𝑃(𝑥|?⃗?) = 	𝐷b(𝑥|?⃗?) eer.	The	negative	log-likelihood	is	then	defined	as	−log	(ℒ(?⃗?|𝑥))		The	typical	goodness-of-fit	measure	for	assessing	the	suitability	of	a	fitted	distribution	is	the	negative	log-likelihood	(Definition	11).	However,	this	measure	does	not	account	for	the	 different	 number	 of	 parameters	 of	 different	 distribution	 types.	 For	 example,	 the	exponential	 distribution	 family	 constitutes	 a	 special	 case	 of	 generalized	 pareto	distributions	with	shape	and	location	parameters	equal	to	zero.	Therefore,	a	generalized	pareto	distribution	never	provides	a	worse	fit	because	the	other	two	parameters	can	be		
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Table	3.2.	Candidate	distributions	fitted	to	empirical	distributions	
Distribution	 1st	parameter	 2nd	parameter	 3rd	parameter	
Beta	 	 1st	shape	–	𝑎 > 0	 2nd	shape	–	𝑏 > 0	 –		
Birnbaum-Saunders	 Scale	–	𝛽 > 0	 Shape	–	𝛾 > 0	 –	
Burr	 Scale	–	𝛼 > 0	 1st	shape	–	𝑐 > 0	 2nd	shape	–𝑘 > 0	
Exponential	 Mean	–	𝜇 > 0	 –	 –	
Extreme	Value	 Location	–	−∞ <𝜇 < ∞	 Scale	–	𝜎 ≥ 0	 –	
Gamma	 Shape	–	𝑎 > 0	 Scale	–	𝑏 ≥ 0	 –	
Generalized	Extreme	Value	 Shape	–	−∞ <𝑘 < ∞	 Scale	–	𝜎 ≥ 0	 Location	–	−∞ <𝜇 < ∞	
Generalized	Pareto	 Shape	–	−∞ <𝑘 < ∞	 Scale	–	𝜎 ≥ 0	 Location	–	−∞ <𝜇 < ∞	
Inverse	Gaussian	 Scale	–	𝜇 > 0	 Shape	–	𝜆 > 0	 –	
Logistic	 Mean	–	−∞ < 𝜇 <∞	 Scale	–	𝜎 ≥ 0	 –	
Log-Logistic	 Log	mean	–	𝜇 > 0	 Log	scale	–	𝜎 > 0	 –	
Lognormal	 Log	mean	–	−∞ <𝜇 < ∞	 Log	stdev	–	𝜎 ≥0	 –	
Nakagami	 Shape	–	𝜇 > 0	 Scale	–	𝜔 > 0	 –	
Normal	 Mean	–	−∞ < 𝜇 <∞	 Stdev	–	𝜎 ≥ 0	 –	
Rayleigh	 Defining	parameter	–	𝑏 >0	
–	 –	
Rician	 Noncentrality	–	𝑠 ≥ 0	 Scale	–	𝜎 > 0	 –	
T	Locations-Scale	 Location	–	−∞ <𝜇 < ∞	 Scale	–	𝜎 > 0	 Shape	–	𝜈 > 0	
Weibull	 Scale	–	𝑎 > 0	 Shape	–	𝑏 > 0	 –	
Gaussian	
Mixture	Model	
Means	–	see	Normal	Distribution	
Stdevs	–	see	Normal	Distribution	
Weights	
The	empirical	distribution	is	fitted	to	the	19	different	distribution	types	in	this	table.	Each	
distribution	 is	 defined	 by	 at	 most	 three	 parameters	 with	 its	 corresponding	 parameter	
ranges	 shown.	 The	 exponential	 distribution	 constitutes	 a	 special	 case	 of	 generalized	
pareto	distributions.		
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adjusted	 accordingly,	 even	 though	 the	 uncertainty	 in	 the	 parameter	 estimation	increases.	More	generally,	distributions	with	more	parameters	are	more	likely	to	fit	the	empirical	 distribution	 under	 negative	 log-likelihood	 scoring,	 as	 they	 possess	 more	degrees	of	freedom	for	making	them	compatible	with	the	observations.	 	The	approach	taken	in	this	thesis	instead	uses	the	Akaike	Information	Criterion	(Akaike,	1974)	(AIC)	that	 incorporates	 the	 number	 of	 parameters	 in	 the	 calculation	 of	 the	 goodness-of-fit	calculation	 (Definition	12).	The	distribution	 family	of	 the	distribution	with	 the	 lowest	AIC	is	then	selected	for	further	processing.		
Definition	 12	 (Akaike	 Information	 Criterion).	 Given	 a	 parameterization	 ?⃗? 	that	
minimizes	 the	 negative	 log-likelihood	 function	 – logWℒ(?⃗?|𝑥)X 	and	 k	 the	 number	 of	
parameters,	the	Akaike	Information	Criterion	is	defined	as	𝐴𝐼𝐶 = 2(𝑘 − logWℒ(?⃗?|𝑥)X)	
	
3.2.2 Parameter Distribution Approximation 	 After	 the	best	fitting	distribution	 family	 is	derived	for	each	gene,	 the	empirical	parameter	 distributions	 are	 computed	 by	 bootstrapping	 the	 gene	 expression	 samples	?⃗? ∈ 𝐺.	This	procedure	allows	the	estimation	of	the	parameter	variability	that	intuitively	corresponds	 to	 how	 well	 the	 previously	 identified	 distribution	 family	 is	 suited	 to	represent	the	given	expression	sample.	In	particular,	the	lower	the	individual	parameter	variance	 the	 more	 defined	 the	 real	 distribution	 is.	 Besides	 these	 theoretical	considerations,	this	approach	enables	a	statistical	significance	analysis	of	the	discretized	values	after	applying	all	subsequent	steps.		 Bootstrapping	 essentially	 is	 a	 resampling	 technique	 in	 which	 elements	 of	 a	sample	 are	 randomly	 selected	 with	 replacement.	 With	 respect	 to	 a	 gene	 expression	sample	?⃗? = (𝑔Q, 𝑔R, … , 𝑔4) ∈ 𝐺 	the	 set	 of	 bootstrap	 samples	 can	 be	 defined	 as	𝐵b =	­𝑔®⃗ 	|	𝑔®⃗ = 	 W𝑔Q¯, 𝑔R¯, … , 𝑔4¯X°	where	±𝐵b±	constitutes	the	number	of	samples	drawn.	All	analysis	in	this	thesis	are	carried	out	using	1000	bootstrap	samples,	which	is	sufficient	for	 approximating	 the	parameter	distribution.	For	 each	of	 the	bootstrap	samples	𝑔®⃗ ∈𝐵b 	a	 parameterization	 of	 the	 previously	 identified	distribution	 family	𝑝b¯⃗ 		 is	 obtained.	The	parameter	distribution	sample	is	then	defined	as	𝑃² = ­𝑝b¯⃗ 	|	𝑔®⃗ ∈ 𝐵b°.		
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Figure	3.5.	Idealized	representation	of	threshold	computation	
	
3.2.3 Derivation of Thresholds 	 The	 parameter	 distribution	 samples	 serve	 as	 the	 basis	 for	 the	 derivation	 of	thresholds	 for	active	and	 inactive	gene	expression	by	approximating	each	distribution	from	 the	 sample	with	 two	 step-functions.	 The	 first	 step	 function	minimizes	 the	 error	with	 the	 left	 tail	 of	 the	 distribution	 by	 computing	 an	 optimal	 trade-off	 between	minimizing	 false	 negatives	 and	 maximizing	 the	 expression	 value	 at	 the	 jump	discontinuity	 (see	𝑥C 	in	 Figure	 3.5).	 In	 contrast,	 the	 second	 step	 function	 finds	 the	optimal	 trade-off	 between	minimizing	 the	 expression	 value	 at	 the	 jump	 discontinuity	and	minimizing	 the	number	of	 false	positives	(see	𝑥CC 	in	Figure	3.5).	 It	 is	worth	noting	that	the	terms	false	positive/negative	do	not	refer	to	a	measureable	quantity	due	to	the	absence	 of	 a	 gold	 standard	 dataset.	 Instead,	 it	 is	 based	 on	 the	 rationale	 that	increasing/decreasing	 the	 threshold	 for	 a	 gene	 to	 be	 active/inactive	 increases	 the	number	of	false	positive/negative	assignments.	
Lower	and	upper	thresholds	are	computed	by	minimizing	the	areas	A	and	B,	which	is	
equivalent	 to	 maximizing	 the	 areas	 C.	 These	 thresholds	 constitute	 the	 optimal	
tradeoffs	 between	 false	 positive	 and	 false	 negative	 assignments.	 In	 case	 of	 lower	
thresholds	 minimizing	 B	 leads	 to	 a	 minimization	 of	 false	 negatives	 while	 a	
minimization	of	A	renders	minimal	false	positives.	
	 59	
	 Computing	 the	 lower	 and	 upper	 thresholds	𝑥C 	and	𝑥CC 	(Figure	 3.5)	 described	before	corresponds	to	the	minimization	of	the	area	of	𝐴Q + 𝐵Q	and	𝐴R + 𝐵R,	respectively.	However,	this	problem	formulation	can	be	simplified	to	the	maximization	of	the	areas	𝐶Q	and	𝐶R .	Using	the	notation	in	Figure	3.5	and	defining	𝑎.(𝑥), 𝑏.(𝑥)	and	𝑐.(𝑥)	as	the	areas	of	𝐴., 𝐵.	and	𝐶. 	the	equivalency	between	both	problem	formulations	can	be	formalized	in	Lemma	1	and	Lemma	2	(Jung	et	al.,	2017).		
Lemma	 1.	 The	 minimization	 of	𝐴Q + 𝐵Q 	is	 equivalent	 with	 the	 maximization	 of	𝐶Q .	 In	
particular	 𝑥C = argminr 𝑎Q(𝑥) + 𝑏Q(𝑥) = 	argmaxr 𝑐Q(𝑥)	
Proof.	The	area	functions	𝑎Q(𝑥)	and	𝑏Q(𝑥)	can	be	expressed	in	terms	of	integrals	as	𝑎Q(𝑥) = 𝑥 − 𝑥y − · 𝐹(𝑦)𝑑𝑦 − 𝑐Q(𝑥)rr¸ 	𝑏Q(𝑥) = 𝑥R − 𝑥 − · 𝐹(𝑦) 𝑑𝑦r¹r 	
Applying	the	interval	addition	property	of	definite	integrals,	the	sum	of	the	two	functions	
can	be	written	as	 𝑎Q(𝑥) + 𝑏Q(𝑥) = 𝑥R − 𝑥y −· 𝐹(𝑦)𝑑𝑦r¹r¸ − 𝑐Q(𝑥)	
in	which	all	terms	are	constant	except	𝑐Q(𝑥).	It	follows	that	the	maximum	of	𝑐Q(𝑥)	
constitutes	the	minimum	of	𝑎Q(𝑥) + 𝑎R(𝑥).		
Lemma	 2.	 The	 minimization	 of	𝐴R + 𝐵R 	is	 equivalent	 with	 the	 maximization	 of	𝐶R .	 In	
particular	 𝑥CC = argminr 𝑎R(𝑥) + 𝑏R(𝑥) =	 argmaxr 𝑐R(𝑥)	
Proof.	Like	in	the	proof	of	Lemma	1,	the	area	functions	𝑎R(𝑥)	and	𝑏R(𝑥)	can	be	expressed	
in	terms	of	integrals	as	 𝑎R(𝑥) = 	· 𝐹(𝑦)𝑑𝑦rºr − 𝑐R(𝑥)	𝑏R(𝑥) = 	· 𝐹(𝑦) 𝑑𝑦rr¹ 	
Applying	the	interval	addition	property	of	definite	integrals	to	the	sum	of	𝑎R(𝑥)	and	𝑏R(𝑥)	
yields	 𝑎R(𝑥) + 𝑏R(𝑥) =	· 𝐹(𝑦) 𝑑𝑦rºr¹ − 𝑐R(𝑥)	
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which	resolves	to	the	area	of	𝐶R	subtracted	from	a	constant.	Thus,	𝑎R(𝑥) + 𝑏R(𝑥)	takes	on	
its	minimal	value	when	𝑐R(𝑥)	is	maximal.			 While	Lemma	1	and	2	proof	the	equivalency	of	the	problem	formulations,	they	omit	 a	 formal	 definition.	 Given	 a	 parameterization	𝑝b¯⃗ ∈ 𝑃² and	 the	 cumulative	distribution	 function,	𝑐𝑑𝑓 𝐷bW𝑥±𝑝b¯⃗ X,	 of	 the	 parameterized	 distribution,	 the	 optimal	jump	discontinuities	𝑥C	and	𝑥CC	serving	as	 lower	and	upper	 thresholds	 for	a	gene	being	active	or	inactive,	are	selected	by	solving	the	following	expressions:	𝑥C = argmaxyxrxuvw	(b⃗ ) »𝑥 ⋅ ¼1 − 𝑐𝑑𝑓 𝐷bW𝑥±𝑝b¯⃗ X½¾¿ÀÀÀÀÀÀÀÀÁÀÀÀÀÀÀÀÀÂÃ¹ 	𝑥CC = argmaxyxrxuvw	(b⃗ ) ¼𝑐𝑑𝑓 𝐷bW𝑥±𝑝b¯⃗ X ⋅ (max(?⃗?) − 𝑥)½¿ÀÀÀÀÀÀÀÀÀÀÁÀÀÀÀÀÀÀÀÀÀÂÃº 	It	 is	 important	 to	 note	 that	 both	 expressions	 are	 varying	 in	 the	 presence	 of	 outliers	because	the	maximum	is	constrained	by	the	maximum	observed	expression	value	in	?⃗?.	Consequently,	 the	method	 prioritizes	 the	minimization	 of	 false	 assignments	 over	 the	minimization	 of	 the	 expression	 value	 at	 the	 jump	 discontinuity.	 Especially	 the	 upper	threshold	𝑥CC 	is	constant	or	decreases	upon	removal	of	outliers.	The	results	in	this	thesis	are	based	on	the	complete	reference	library	without	removing	outliers	and	can,	thus,	be	considered	to	be	more	conservative	thresholds.		 Two	 of	 the	 distribution	 families	 described	 in	 Table	 3.2,	 generalized	 Pareto	distributions	 and	 Gaussian	 Mixture	 Models,	 require	 distinct	 treatments	 that	 will	 be	discussed	in	the	following.			 The	unimodality	of	distributions	typically	guarantees	that	the	maxima	of	𝐶Q	and	𝐶R	correspond	to	extreme	values	of	the	distributions	(proof	omitted	here).	However,	this	assertion	 is	 not	 valid	 for	 generalized	 Pareto	 distributions	 including	 the	 exponential	distribution.	Due	to	the	mode	being	located	at	the	boundary	of	the	expression	range,	i.e.	it	 is	 located	 at	 zero	 expression,	 the	 local	maximum	of	𝐶Q	might	be	 located	 at	negative	expression	 values.	 Instead	 of	 taking	 the	 negative	 expression	 value	 as	 a	 threshold,	 the	method	 sets	 it	 to	 zero	 since	 a	 gene	 not	 undergoing	 active	 transcription	 cannot	 be	translated	into	proteins	and,	thus,	must	be	inactive.		 Gaussian	Mixture	Models	differ	from	all	other	distribution	families	in	that	they	possess	multiple	modes	requiring	adapting	the	strategy	for	lower	and	upper	thresholds.	In	 particular,	 a	 Gaussian	 Mixture	 Model	 is	 defined	 as	 the	 weighted	 sum	 of	 normal	distributions	 possibly	 possessing	 different	 means	 and	 standard	 deviations.	 In	
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accordance	with	the	approach	for	unimodal	distributions,	multimodal	distributions	are	decomposed	into	their	individual	components	of	which	lower	and	upper	thresholds	are	derived.	When	 solving	 the	 expressions	 of	𝑥C	and	𝑥CC	for	 all	 parameterizations	 obtained	from	the	bootstrap	samples,	the	empirical	threshold	distribution	can	be	defined	by	the	sets	 of	 lower	 and	 upper	 thresholds	 as	 𝑇bÅ = Æ𝑥C|𝑥C = argmaxyxrxuvw	(b⃗ ) »𝑥 ⋅ ¼1 −𝑐𝑑𝑓 𝐷bW𝑥±𝑝b¯⃗ X½¾ ∧ 𝑝b¯⃗ ∈ 𝑃²Ç 	and	 𝑇bÈ = Æ𝑥CC|𝑥CC = argmaxyxrxuvw	(b⃗ ) ¼𝑐𝑑𝑓 𝐷bW𝑥±𝑝b¯⃗ X ⋅(max(?⃗?) − 𝑥)½ ∧ 𝑝b¯⃗ ∈ 𝑃²Ç ,	 respectively,	 and	 are	 used	 to	 quantify	 the	 statistical	significance	of	the	classification.		
3.5.4. Statistical Significance Computation 
Figure	3.6.	Threshold	distribution	used	for	classification	
	
The	derived	threshold	distributions	define	three	discrete	states.	A	gene	is	(1)	inactive	if	its	
expression	is	below	𝒙C,	(2)	active	if	its	expression	is	greater	than	𝒙CC	and	(3)	intermediately	
expressed	 if	 its	 expression	 is	 between	𝒙𝒊C	and	𝒙𝒊CC.	 Expression	 values	 close	 to	 the	mean	of	
the	 lower	 (red)	 and	 upper	 thresholds	 (green)	 cannot	 be	 reliably	 determined.	 The	 pre-
defined	significance	values	determine	the	location	of	these	thresholds.		
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The	 derivation	 of	 lower	 and	 upper	 thresholds	 leads	 to	 a	 threshold	 distribution	consisting	of	three	parts:	(i)	the	lower	threshold	mode	with	its	associated	distribution,	(ii)	the	upper	threshold	distribution	mode	with	its	associated	distribution	and	(iii)	the	area	between	these	distributions	containing	a	 low	proportion	of	 the	probability	mass.	Figure	3.6	shows	a	threshold	distribution	illustrating	the	aforementioned	three	parts.		 The	 lower	 threshold	 distribution	 (red)	 is	 defined	 as	 the	 empirical	 cumulative	distribution	function	of	𝑇bÅ ,	𝑒𝑐𝑑𝑓Ë²Ì (𝑥),	and	is	utilized	to	define	the	statistical	significance	of	assigning	a	gene	g	with	gene	expression	𝑦bto	be	inactive.	In	particular,	a	p-value	for	gene	g	being	inactive	is	defined	as	 𝑝m². = 𝑒𝑐𝑑𝑓Ë²Ì (𝑦b)	and	 can	 be	 interpreted	 as	 a	 one-sided	 test	 against	 the	 null	 hypothesis	 that	 g	 is	 not	inactive.	 Likewise,	 the	 empirical	 cumulative	 distribution	 function	 of	 upper	 threshold	distribution	(green)	𝑇bÈ ,	𝑒𝑐𝑑𝑓Ë²Í(𝑥),	defines	a	p-value	for	gene	g	being	active	as	𝑝m²È = 1 − 𝑒𝑐𝑑𝑓Ë²Í(𝑦b)	corresponding	to	a	one-sided	test	against	the	null	hypothesis	that	g	is	not	active.		 According	to	 the	p-value	definitions,	 significantly	active	and	 inactive	genes	are	solely	 defined	 based	 on	 the	 tails	 of	 the	 distribution.	 However,	 the	 intermediate	expression	range,	or	more	precisely	the	area	between	both	distributions	only	containing	a	small	amount	of	the	probability	mass,	should	be	treated	differently	than	the	area	close	to	 means	 of	 the	 distributions.	 While	 the	 expression	 range	 close	 to	 the	 means	 of	 the	lower	 and	 upper	 threshold	 distributions	 corresponds	 to	 the	 uncertainty	 in	 the	assignment,	 the	 intermediate	 expression	 range	 is	 defined	 as	having	 certainty	 that	 the	gene	is	neither	active	nor	inactive.	Thus,	 it	requires	its	own	classification	based	on	the	empirical	 cumulative	 distribution	 functions	 of	𝑇bÈ	and	𝑇bÅ .	 Given	 a	 significance	 cutoff	𝛼,	for	 any	 expression	 value	𝑦b satisfying	1 − 𝑒𝑐𝑑𝑓Ë²Ì W𝑦bX < 𝛼 	and	𝑒𝑐𝑑𝑓Ë²ÍW𝑦bX < 𝛼 	g	 is	considered	 to	 be	 intermediately	 expressed.	 Notably,	 this	 definition	 allows	 the	intermediate	expression	range	 to	be	empty	if	the	 two	distributions	are	overlapping	or	the	significance	cutoff	is	too	stringent.		
3.5.5. Statistical assessment of the reference-library size 	 The	choice	of	the	reference	distribution	is	crucial	for	the	successful	application	of	 the	 previously	 described	 methodology	 for	 classifying	 active	 and	 inactive	 genes.	Therefore,	two	questions	have	to	be	addressed.	First,	how	many	samples	are	sufficient	and,	 second,	 can	 they	 be	 randomly	 sampled?	 For	 this	 purpose	 a	 collection	 of	 27887	
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microarray	 samples	 (Torrente	 et	 al.,	2016)	was	collected	and	analyzed	with	respect	to	a	sufficient	sample	size	that	is	 statistically	 indistinguishable	 from	the	whole	set	of	samples.	In	particular,	the	 set	 of	 samples	 was	 randomly	subsampled	to	sizes	between	10	to	600	and	 compared	 to	 the	 whole	 set	 of	samples	 by	 means	 of	 a	 two-sample	Kolmogorov-Smirnoff	 test	 that	assesses	 the	 statistical	 equivalence	 of	the	 distributions.	 High	 p-values	 mean	that	 the	 distributions	 are	indistinguishable	 while	 low	 p-values	reject	 this	 hypothesis	 at	 the	 obtained	significance	 level.	 This	 step	 was	conducted	100,000	times	for	each	sub-sample	 size	 to	 obtain	 conclusive	 and	statistically	sound	results.		As	 expected,	 the	 average	 p-values	increase	 with	 increasing	 sample	 size	almost	 linearly	 while	 the	 average	standard	 deviation	 declines	exponentially	 (Figure	 3.7	 upper	 and	middle	 panel).	 Complementary	 to	 this	
The	minimal	amount	of	samples	 in	 the	
reference	distribution	was	 assessed	by	
subsampling	 27887	 microarray	
samples	 and	 comparing	 the	
subsampled	 to	 the	 complete	 reference	
using	 a	 two-sample	 Kolmogorov-
Smirnoff	test.	
With	 increasing	 subsampling	 size,	 p-
values	 increase	 (upper	 panel)	 while	
their	 standard	 deviation	 decreases	
(middle	 panel)	 suggesting	 the	
homogenization	 of	 the	 distribution.	
High	 p-values	 correspond	 to	 more	
indistinguishable	 samples	 (lower	
panel).	
Figure	3.7.	Minimal	reference	distribution	sizes	
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assessment,	 the	 fraction	 of	 samples	 that	 are	 indistinguishable	 from	 the	 complete	distribution	was	calculated,	given	a	5%	significance	level	(Figure	3.7	lower	panel).	While	already	95	percent	of	the	random	samples	are	indistinguishable	for	a	sample	size	of	10,	the	mean	p-values	of	0.5	are	indicative	of	a	high	false	discovery	rate.	However,	randomly	choosing	550	microarray	samples	guarantees	that	all	the	samples	are	indistinguishable	with	 mean	 p-values	 of	 0.93	 making	 it	 a	 reasonable	 sample	 size	 for	 selecting	 the	reference.	The	 low	and	 further	decreasing	average	standard	deviation	of	 the	p-values,	on	 the	other	hand,	 suggests	 that	 the	 choice	 of	 the	 samples	 is	 less	 important	 than	 the	sample	size,	since	the	result	is	based	on	100,000	randomly	chosen	subsets.		 	
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CHAPTER 4 Results 	 This	 chapter	 details	 the	 results	 of	 the	 developed	 methodologies	 for	reconstructing	 gene	 regulatory	 networks	 from	 transcriptomics	 data	 and	 prior	knowledge	networks	 followed	by	 the	 integration	of	gene-level	accessibility	 for	 further	refinement.	 Validation	 of	 the	 improved	 context-specificity	 of	 the	 reconstructed	networks	 compared	 to	 previously	 developed	methods	 is	 analyzed	 by	 quantifying	 the	amount	 of	 cell	 type	 specific	 protein-DNA	 interactions.	 A	 differential	 network	 analysis	approach	 is	 presented	 for	 identifying	 cellular	 stability	 determinants	 and	 candidate	combinations	 of	 instructive	 factors	 that	was	 applied	 to	 the	 prioritization	 of	 drugs	 for	inducing	desired	cellular	transitions.	Subsequently,	the	method	for	predicting	gene-level	accessibility	 is	 validated	 and	 integrated	 into	 the	 computational	 pipeline	 for	reconstructing	 condition	 specific	 gene	 regulatory	networks.	 	With	 it,	 a	 combination	of	instructive	factors	was	predicted	for	inducing	the	cellular	conversion	of	adipocytes	into	osteoblasts.	Finally,	the	developed	methodology	for	discretizing	transcriptomics	data	is	validated	 and	 its	 ability	 to	 compare	 multiple	 cell	 types	 is	 highlighted.	 All	 presented	approaches	build	on	the	work	presented	in	the	Methods	chapter.		 The	 ‘Differential	 Network	 Reconstruction	 for	 Establishing	 Disease-Gene-Drug	Relationships’	 section	 (4.1)	 details	 the	 reconstruction	 and	 validation	 of	 condition	specific	networks	 from	prior	 knowledge	networks	 and	gene	 expression	data.	 Further,	strategies	for	identifying	candidate	instructive	factors	of	cellular	conversions	are	shown	and	their	utilization	in	prioritizing	drugs	is	illustrated.	Drug	prioritizations	are	validated	with	 known	drug	 screening	 examples	 and	predictions	 are	made	 for	 two	autoimmune	diseases.	 Two	 major	 obstacles	 in	 reconstructing	 gene	 regulatory	 networks	 are	addressed	in	the	subsequent	sections.	First,	the	‘Prediction	of	Chromatin	Accessibility	in	Gene-Regulatory	Regions	from	Transcriptomics	Data’	section	(4.2)	presents	a	machine-learning	 based	 methodology	 for	 identifying	 genes	 in	 accessible	 and	 inaccessible	chromatin	 domains	 in	 the	 absence	 of	 epigenetic	 datasets.	 With	 it,	 an	 integrated	approach	 for	 identifying	 instructive	 factors	of	 the	cellular	 conversion	 from	adipocytes	into	 osteoblasts	 is	 presented	 that	 utilizes	 cell	 type	 specific	 transcriptomics	 data,	predicted	 gene-level	 accessibility	 and	 prior	 knowledge	 networks	 (4.3).	 At	 last,	 in	 the	‘Reference-based	 Discretization	 of	 Gene	 Expression	 Data’	 section	 (4.4),	 the	discretization	of	gene	expression	data	is	addressed	allowing	the	comparison	of	multiple	cell	 types	and	conditions.	A	novel,	more	accurate	approach	 is	presented	and	validated	against	current	state-of-the-art	methods.		 	
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4.1 Differential Network Reconstruction for Establishing Disease-Gene-Drug 
Relationships 	 A	method	 for	 reconstructing	 condition	 specific	 gene	 regulatory	 networks	was	developed	 that	 addresses	 the	 limitations	of	 current	methodologies	 (see	Chapter	1	 for	details).	In	particular,	the	developed	method	infers	a	Boolean	gene	regulatory	network	that	requires	only	a	prior	knowledge	network	(PKN)	and	a	discretized	gene	expression	profile	as	input	(see	in	Methods	section	3.2).	Its	utility	is	demonstrated	by	proposing	a	selection	scheme	for	candidate	instructive	factors	given	two	condition	specific	GRNs	and	subsequent	prioritization	of	drugs	targeting	these	candidate	factors.	The	analysis	of	the	network	inference	method	consists	of	four	parts:	the	validation	with	condition	specific	ChIP-seq	data,	the	comparison	of	the	reconstructed	network	against	other	methods,	the	recovery	 of	 compounds	 from	 known	drug	 screening	 experiments	 and	 the	 proposal	 of	new	compounds	for	treating	Systemic	Lupus	Erythematosus	and	Rheumatoid	Arthritis,	two	autoimmune	diseases.	
4.1.1 Network Reconstruction and Validation  	 The	 developed	 method	 for	 reconstructing	 condition	 specific	 gene	 regulatory	networks	relies	on	 the	discretized	 transcriptomics	profile	of	cell	or	 tissue	 types	and	a	prior	knowledge	network	containing	directed	interactions	among	genes.	Here,	the	PKN	is	 compiled	 from	 MetaCoreTM	 from	 Thomson	 Reuters,	 a	 proprietary	 database	 of	manually	 curated	 and	 experimentally	 validated	 gene-gene	 interactions	 observed	 in	various	cell	 lines,	cell	 types	or	 tissues.	The	selected	 interactions	are	constrained	to	be	implicated	 in	 the	 direct	 regulation	 of	 the	 target	 gene	 for	 explicitly	 excluding	 indirect	effects.	To	obtain	reconstructed	gene	regulatory	networks,	the	method	prunes	the	PKN	such	 that	 it	 is	 consistent	 with	 the	 observed,	 discretized	 phenotype,	 i.e.	 it	 is	 a	 point-attractor	in	the	Boolean	network	(see	Methods	section	3.2).		 For	 validating	 the	 network	 reconstruction	 approach,	 two	main	 analyses	were	conducted	showing	that	the	vast	majority	of	cell	type	specific	interactions	are	retained	after	pruning	and	that	the	reconstruction	 is	more	accurate	compared	to	other,	 similar	methods.	A	gold	standard	dataset	of	condition	specific	interactions	and	phenotypes	was	obtained	for	four	highly	studied	cell	lines	included	in	the	Encyclopedia	Of	DNA	Elements	(ENCODE)	(Dunham	et	al.,	2012).	In	order	to	increase	the	diversity	of	datasets	included	in	the	analysis,	the	selected	cell	lines	are	composed	of	embryonic	stem	cells	(H1-hESC),	B-lymphocytes	(GM12878),	leukemic	erythromyeloblastoids	(K562)	and	hepatocellular	carcinoma	cells	(HepG2).	A	phenotypic	representation	of	each	cell	line	was	gathered			
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Table	4.1.	ChIP-seq	validated	interactions	of	condition	specific	network	reconstruction	algorithm	
	 HepG2/	
GM	
HepG2/	
H1	
HepG2/	
K562	
GM/	
H1	
GM/	
K562	
H1/	
K562	
	 HepG2	 GM	 HepG2	 H1	 HepG2	 K562	 GM	 H1	 GM	 K562	 H1	 K562	
Raw	 92	 36	 122	 20	 74	 0	 2	 0	 88	 18	 4	 4	
Pruned	 86	 30	 111	 13	 71	 0	 2	 0	 79	 13	 4	 3	
Re-
tained	
(in	%)	
93.5	 83.3	 91	 65	 95.9	 -	 100	 -	 89.8	 72.2	 100	 75	
from	quantified	gene	expression	data	of	Duke	Affy	Exon	experiments	also	contained	in	ENCODE	 (Table	 S1).	 All	 cell	 lines	 were	 pairwise	 combined,	 resulting	 in	 six	 different	examples,	for	obtaining	discretized	phenotypes	by	differential	expression	analysis	with	strict	cutoffs	(p-value	<	0.001	and	fold	change	>	4).	Cell	line	specific	interactions	where	obtained	 associating	 genomic	 regions	 enriched	 in	 aligned	 reads	 of	 chromatin	immunoprecipitation	 followed	by	 sequencing	(ChIP-seq)	 experiments	 to	 the	promoter	regions	of	genes.	Up	to	122	identified	interactions	are	contained	in	the	prior	knowledge	networks	 of	 the	 different	 examples	 that	 serve	 as	 validation	 of	 context	 specificity.	 Of	note,	 due	 to	 the	 differential	 expression	 analysis,	 the	 number	 of	 validated	 interactions	does	not	only	depend	on	the	cell	line	the	experiment	had	been	conducted	in	but	also	on	the	cell	line	it	is	compared	to.	After	 network	 reconstruction	 the	 analysis	 revealed	 that,	 on	 average,	 89.6%	 of	ChIP-seq	validated	 interactions	are	preserved,	which	demonstrates	 that	 the	 algorithm	can	 reconstruct	 fairly	 reliable	 networks	 (Table	 4.1).	 In	 addition,	 the	 reconstructed	networks	 show	 highly	 variable	 characteristics	 of	 common	 and	 phenotype-specific	interactions,	 in	the	six	examples	(Table	4.2).	On	average,	18.8%	of	the	interactions	are	phenotype	specific	underlining	that	a	unique	GRN	topology	is	not	sufficient	to	accurately	model	both	phenotypes.	Despite	 the	 ability	 of	 preserving	 validated	 interactions	 after	 network	reconstruction,	 it	 is	 essential	 to	 demonstrate	 the	 increased	 accuracy	 of	 the	 method	compared	to	other,	 state-of-the-art	approaches.	 In	order	 to	provide	a	 fair	comparison,	two	methods,	 CellNOptR	 (Terfve	 et	 al.,	 2012)	 and	 SignetTrainer	 (Melas	 et	 al.,	 2013),	were	selected	that	aim	at	the	reconstruction	of	directed,	signed	networks	from	PKNs,	as		
Analysis	 of	 retained	 ChIP-seq	 validated	 interactions	 after	 differential	 network	
reconstruction.	 Raw	 values	 correspond	 to	 the	 number	 of	 interactions	 in	 the	 prior	
knowledge	 while	 pruned	 values	 denote	 the	 number	 of	 retained	 interactions	 after	
network	reconstruction.	Pairwise	analysis	of	four	cell	lines	shows	average	retention	of	
89.6%.	
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Table	4.2.	Regulatory	interaction	statistics	of	reconstructed	networks	
	 HepG2/	
GM	
HepG2/	
H1	
HepG2/	
K562	
GM/	
H1	
GM/	
K562	
H1/	
K562	
Common	 424	 608	 430	 298	 662	 594	
Phenotype	1	(total)	 530	 824	 520	 324	 999	 859	
Phenotype	1	(specific)	 106	 216	 90	 26	 337	 265	
Phenotype	1	(ratio)	 20.00%	 26.20%	 17.30%	 8.00%	 33.70%	 30.80%	
Phenotype	2	(total)	 508	 707	 498	 323	 819	 720	
Phenotype	2	(specific)	 84	 99	 68	 25	 157	 126	
Phenotype	2	(ratio)	 16.50%	 14.00%	 13.70%	 8.30%	 19.20%	 17.50%	
well.	 In	 the	 comparison,	 the	number	of	preserved	validated	ChIP-seq	 interactions	 and	the	agreement	of	the	booleanized	phenotypes	was	assessed	using	the	same	cell	lines	as	for	the	network	validation.	However,	both	CellNOptR	and	SignetTrainer	were	unable	to	handle	 prior	 knowledge	 networks	 including	 more	 than	 300	 interactions.	 The	 six	examples	were	 therefore	 subsampled	 to	 networks	 encompassing	 between	 11	 and	 78	genes	and	27	to	164	interactions.	Additionally,	a	manually	curated,	self-consistent	core	network	of	MEP	(myeloid	erythroid	progenitor)	cell	fate	commitment	was	included	that	does	 not	 require	 pruning	 (Doré	 and	 Crispino,	 2011).	 The	 results	 of	 this	 assessment	confirm	 that	 the	 proposed	 methodology	 for	 reconstructing	 condition	 specific	 gene	regulatory	networks	resembles	the	given	phenotypes	more	accurately.	On	average,	94%	of	 genes	 in	 the	 network	 showed	 consistent	 expression	 levels,	 with	 respect	 to	 the	discretized	gene	expression	profile,	compared	to	48%	and	88%	obtained	by	CellNOptR	and	SignetTrainer,	respectively.	Furthermore,	the	preservation	of	ChIP-Seq	interactions	is	significantly	elevated	(94%)	in	comparison	with	CellNOptR	(58%)	and	SignetTrainer	(83%).		
4.1.2 Inference and Validation of Disease-Gene-Drug Relationships 	 The	 utility	 of	 condition	 specific	 gene	 regulatory	 networks	 lies	 in	 its	 ability	 to	systematically	assess	 the	 effect	 of	 perturbations	 to	 the	 cellular	system	 through	model	simulation.	Network	stability	determinants	such	as	positive	and	negative	feedback	loops	have	been	experimentally	validated	in	living	cells	and	play	an	important	role	in	the		
Differential	interaction	statistics	of	the	reconstructed	networks	in	six	examples.	While	
most	of	the	interactions	are	common	to	both	networks,	around	18.8%	of	interactions	
are,	on	average,	specific	to	the	individual	networks.	Comparison	of	cancer	cell	lines	
(K562	and	HepG2)	to	normal	cell	lines	(GM12878	and	H1)	typically	yields	higher	ratio	
of	network	specific	interactions	than	the	comparison	of	normal	cells	or	cancer	cells	
among	themselves.	
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Figure	4.1.	Drug	enrichment	in	six	validation	examples	
formation	of	attractors	(Bateman,	1998).	Therefore,	the	strategy	for	inferring	candidate	instructive	 factors	 of	 desired	 cellular	 conversions	 is	 based	 on	 the	 identification	 of	common	stability	determinants	and	differentially	regulated	genes	of	 the	reconstructed	networks	 (see	 Methods	 section	 3.3).	 These	 candidate	 factors	 were	 subsequently	contrasted	with	known	compound	effects	to	systematically	prioritize	drugs	for	inducing	cellular	 conversions.	 In	 particular,	 the	 strategy	 consists	 of	 three	 parts.	 First,	 drugs	having	 reported	 effects	 on	 candidate	 instructive	 factors	 were	 identified	 from	 the	Comparative	Toxicogenomics	Database	(Davis	et	al.,	2014),	a	compendium	of	reported	drug	modes	of	action.	Second,	millions	of	combinations	of	candidate	 factors,	coined	as	multitarget	 combinations,	 were	 simulated	 as	 perturbations	 to	 the	 network	 attractor	corresponding	to	the	cellular	phenotype.	Finally,	simulated	multitarget	combinations		
Drug	enrichment	results	in	six	validation	examples	of	drug-induced	phenotypes	from	
the	 CMap.	 The	 cumulative	 enrichments	 of	 the	 drug	 effects	 in	 the	 multitarget	
combinations	are	shown.	In	silico	effects	of	the	multitarget	combinations	are	depicted	
on	 the	 x-axis	 and	are	 normalized	with	 respect	 to	 the	 highest	 observed	 effect	 of	 any	
combination.	Drugs	more	specific	to	genes	in	multitarget	combinations	inducing	high	
phenotypic	 changes	 are	 favorable.	Due	 to	potential	combinatorial	 effects	 of	multiple	
drugs,	 the	 examples	 of	 celastrol/gedunin	 and	 androgen	 are	 not	 compared	 to	 other	
drugs.	
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Table	4.3.	Comparison	of	simulated	drugs	in	validation	examples	
Case	 Drug	 AUC	 Difference	from	AUC	
of	uniform	
distribution	
Celastrol+Androgen	 Celastrol+Androgen	 	37.193	 25.61%	
Gedunin+Androgen	 Gedunin+Androgen	 	37.225	 25.55%	
Estradiol	 Arachidonic	acid	 54.950	 -0.99%	
Estradiol	 		36.887	 26.22%	
Genistein	
	
Cobalt	chloride	 	47.188	 5.62%	Estradiol	 	44.426	 11.15%	
Genistein	 	41.468	 17.06%	Tacrolimus	 	46.877	 0.62%	
Cobalt	chloride	 Cobalt	chloride	 	36.364	 27.27%	Genistein	 	43.940	 12.12%	Tretinoin	 	37.586	 24.83%	
Celastrol	 Celastrol	 42.076	 	15.85%	Parthenolide	 46.688	 	0.66%	Whitaferin	A	 52.067	 	-0.41%	
were	linked	to	compounds	through	computing	the	enrichment	of	compound	targets	in	these	combinations	(see	Methods	section	3.3	for	details).	To	underline	the	utility	of	the	developed	strategy	for	linking	genes	and	drugs	to	induce	 cellular	 transitions,	 six	 examples	 were	 selected	 from	 the	 Connectivity	 Map	(CMap)	 (Lamb	 et	 al.,	 2006),	 a	 database	 embodying	 gene	 expression	 changes	 upon	chemical	 perturbation.	 These	 examples	 include	 LNCap	 and	 MCF7	 cells	 treated	 with	celastrol,	 cobalt	chloride,	estradiol	and	genistein	as	well	as	cells	treated	with	multiple	compounds	at	the	same	time,	such	as	celastrol	+	androgen	and	gedunin	+	androgen.	To	obtain	 a	 conclusive	 validation,	 drugs	 showing	 similar	differential	 expression	 patterns	according	 to	 the	 CMap	 were	 selected	 for	 comparison.	 After	 reconstructing	 condition	specific	gene	regulatory	networks	 for	 the	phenotypes	before	and	after	drug	 induction,	the	areas	under	the	cumulative	multitarget	enrichment	curves	were	compared	to	rank	the	 drugs	 according	 to	 their	 predicted	 efficacy	 in	 generating	 the	 compound-induced	phenotype.		
Enrichment	results	of	drugs	for	six	drug-induced	phenotypes.	In	all	cases,	the	area	under	
the	cumulative	enrichment	curve	(AUC)	is	lower,	i.e.	more	favorable,	compared	to	other	
drugs	inducing	similar	phenotypes	(highlighted	in	bold).	The	difference	from	an	AUC	of	a	
uniform	distribution	shows	the	non-randomness	of	the	enrichments.	Combinations	of	
drugs	where	not	compared	to	other	drugs,	but	show	significant	differences	from	an	
uninformed	distribution.	
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Figure	4.2.	Core	network	of	untreated	cells	 in	 case	
of	cobalt	chloride	
	Figure	4.1	depicts	the	cumulative	enrichment	curves	of	drug	effects	according	to	
in	silico	 perturbation	 effects.	Recall	 that	normalized	perturbation	effects	 refer	here	 to	the	 number	 of	 induced	 changes	 to	 the	 network	 attractor	 of	 non-perturbed	 genes	normalized	by	the	highest	observed	effect.	In	all	studied	examples,	the	applied	drug	was	correctly	predicted	using	 the	proposed	strategy	and	show	significant	differences	 from	the	 AUCs	 of	 a	 uniform	 distribution	 corresponding	 to	 uninformed	 strategy	 (see	 Table	4.3).	However,	 two	 important	remarks	must	be	made.	On	one	hand,	the	combinatorial	effect	of	celastrol/gedunin	and	androgen	underlines	the	utility	in	the	presence	of	drug	combinations.	Nevertheless,	in	general,	the	combinatorial	effects	of	multiple	compounds	need	 to	 be	 taken	 into	 account	 but	 can	 be	 neglected	 in	 case	 of	 celastrol/gedunin	 and	androgen	as	they	do	not	possess	reported	antagonistic	effects	with	respect	to	the	genes	in	the	network.	However,	in	order	to	avoid	inconclusive	results,	no	comparison	to	other	drug	 combinations	 has	 been	 carried	 out	 in	 these	 examples.	 Despite	 the	 absence	 of	comparable	drugs,	a	decrease	of	more	than	25%	of	the	area	under	curves	with	respect	to	an	uninformative	uniform	distribution	and	the	increased	enrichment	in	high	ranking	multitarget	combinations	indicate	the	predicted	efficacy	(see	Table	4.3).	On	 the	other	hand,	 the	normalized	perturbation	 effects	 are	 comparably	 low	 in	case	 of	 cobalt	 chloride.	 In	 silico	 perturbation	 of	 all	 identified	 candidate	 instructive	factors	 (RUNX1,	 FOSL2,	 ASCL1	 and	 SOX2)	 leads	 to	 an	 attractors	 that	 resembles	 only	35%	of	 the	compound-induced	gene	expression	pattern.	Of	note,	ASCL1	and	SOX2	are	pioneer	 factors	whose	perturbation	 is	likely	 involving	major	changes	of	 the	accessible	chromatin	landscape.	However,	this	cannot	be	reflected	by	the	current	approach,	which	
The	 core	 network	 of	 the	 control	
phenotype	 is	 not	 responsive	 to	 the	
perturbation	of	candidate	 instructive	
factors.	Only	four	genes	are	identified	
(green)	that	are	contained	in	common	
stability	 determinants	 (red),	 the	
negative	 autoregulation	 of	 RUNX1	
and	 two	 positive	 circuits	 between	
RUNX1	 and	 FOSL2,	 and	 ASCL1	 and	
SOX2.	 The	 poor	 circuit	 coverage	 of	
the	 network	 and	 many	 activating	
interactions	result	in	high	stability.	
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solely	relies	on	the	utilization	of	transcriptomics	data	and	prior	knowledge	networks.	By	inspecting	the	reconstructed	network	of	the	cellular	phenotype	before	drug	induction,	it	can	 be	 seen	 that	 the	 majority	 of	 the	 network	 consists	 of	 regulatory	 interactions	activating	 their	 target	 genes	 (Figure	 4.2).	 Therefore,	 changes	 to	 the	 gene	 expression	pattern	 can	only	be	modulated	by	down-regulation	of	 the	 activators,	which	 cannot	be	achieved	through	targeting	the	genes	in	the	network	stability	determinants	alone.		
4.1.3. Prediction of Candidate Compounds for Treating Autoimmune Diseases 
Table	4.4.	Comparison	of	drug	enrichments	for	Systemic	Lupus	and	Rheumatoid	Arthritis	
Case	 Drug	 AUC	 Difference	from	AUC	of	
uniform	distribution	
Systemic	Lupus	 Cyclosporine	 43.416	 13.17%	
Resveratrol	 33.030	 33.94%	Tetrachlorodibenzodioxin	 43.001	 14.00%	
Rheumatoid	
Arthritis	
Benzo(a)pyrene	 42.473	 15.05%	
Copper	sulfate	 41.351	 17.30%	Cyclosporine	 43.460	 13.08%	Tetrachlorodibenzodioxin	 43.156	 13.69%	Valproic	acid	 45.340	 9.32%	
	 The	validated	drug	prioritization	strategy	was	subsequently	applied	to	Systemic	Lupus	 and	 Rheumatoid	 Arthritis	 for	 predicting	 compounds	 that	 revert	 the	 disease	phenotype.	 Following	 this	 approach,	 networks	 were	 reconstructed	 for	 disease	 and	control	phenotypes	 of	 both	 diseases	 and	 candidate	 instructive	 factors	were	 predicted	whose	 multitarget	 combinations	 were	 able	 to	 revert	 the	 disease	 phenotype	 in	 silico.	Information	about	drugs	having	reported	effects	on	these	genes	was	obtained	from	the	Comparative	Toxicogenomics	Database	(Davis	et	al.,	2014).	Rheumatoid	Arthritis	was	analyzed	on	the	basis	of	healthy	and	pathologic	B	cells	(GEO:	GSE4588).	Twenty-seven	candidate	instructive	factors	were	identified,	 including	TCF7L2,	which	is	associated	to	Arthritis	(Mota	et	al.,	2012),	and	CDKN1A	whose	down-regulation	results	in	an	increased	risk	for	developing	autoimmune	diseases	(Perlman	et	
al.,	 2003).	 The	 drugs	 having	 the	 most	 reported	 effects	 on	 the	 candidate	 factors	 are	
Comparison	 of	 drug	 enrichments	 for	 candidate	 drugs	 in	 Systemic	 Lupus	 and	
Rheumatoid	 Arthritis	 by	 means	 of	 their	 area	 under	 the	 curve.	 Lower	 AUC	 values	
correspond	to	more	pronounced	enrichment	in	high	scoring	multitarget	combinations	
and	are	more	favorable.	The	difference	to	the	AUC	of	a	uniform	distribution	shows	that	
the	enrichment	is	non-random.	For	Rheumatoid	Arthritis,	all	drugs	except	for	Valproic	
acid	 show	 similar	 enrichments	 while	 Resveratrol	 is	 clearly	 superior	 for	 Systemic	
Lupus.	Prioritized	drugs	are	highlighted	in	bold.	
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benzo(a)pyrene	 (14	 targets),	 copper	 sulfate	 (12	 targets),	 Tetrachlorodibenzodioxin	(TCDD,	12	targets),	valproic	acid	(12	targets)	and	cyclosporine	(10	targets).	According	to	 the	 area	 under	 the	 enrichment	 curve	 (Table	 4.4),	 copper	 sulfate	 has	 the	 most	pronounced	effect	 on	 the	phenotype,	which	 is	 further	 supported	by	53%	reversion	of	the	 pathological	 phenotype	 upon	 in	 silico	 perturbation	 of	 all	 known	 drug	 effects.	Additionally,	copper	sulfate	targets	most	of	the	genes	in	the	core	disease	network	(see	Figure	4.3)	and	as	such	constitutes	a	novel,	predicted	treatment	for	Rheumatoid	Athritis	whose	therapeutic	effect	needs	to	be	further	elucidated	(Fernández-Madrid,	1998).	On	the	other	hand,	cyclosporine	is	a	broadly	applied	drug	for	treating	arthritis	(Wells	et	al.,	1998),	but	shows	a	less	pronounced	effect	with	respect	to	the	analysis.		
Figure	4.3.	Drug	prioritization	results	for	Systemic	Lupus	and	Rheumatoid	Arthritis	
	
Cumulative	enrichment	distributions	of	candidate	drugs	 for	 treating	 the	pathologic	
phenotypes	of	 Systemic	 Lupus	Erythematosus	 and	 Rheumatoid	Arthritis	 in	B	 cells.	
Normalized	perturbation	effects	refer	to	the	absolute	changes	induced	by	multitarget	
combinations	normalized	by	the	highest	observed	effect.	Drugs	more	highly	enriched	
in	 multitarget	 combinations	 reverting	 the	 disease-phenotype	 the	 most	 are	 more	
favorable	compared	to	others.	(Upper	Panel)	Similar	enrichment	patterns	are	found	
for	 Cyclosporine,	 Copper	 sulfate	 and	 Benzoapyrene.	 Copper	 sulfate	 shows	 a	
pronounced	in	silico	effect	as	it	has	reported	effects	on	almost	the	complete	disease	
network	(green	nodes).	Perturbation	of	reported	effects	of	Benzoapyrene	results	in	a	
cyclic	attractor	and	is	therefore	not	considered.	(Lower	Panel)	For	Systemic	Lupus	in	
B	cells,	Resveratrol	is	the	top-ranking	drug	having	reported	effects	on	five	genes	in	
the	core	disease	network	(green	nodes).	The	perturbed	genes	are	covering	most	of	
the	common	circuits	in	the	network.		
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Similar	to	the	analysis	conducted	for	Rheumatoid	Arthritis,	healthy	and	disease	phenotypes	 of	 Systemic	Lupus	 in	 B	 cells	 have	 been	 obtained	 (GEO:	 GSE4588).	 Eleven	candidate	instructive	factors	were	identified	among	which	STAT1	constitutes	a	marker	for	 onset	 and	 progression	 of	 the	 disease	 pathology	 (Liang	 et	 al.,	 2014).	 Moreover,	 a	positive	 feedback	 loop	 containing	 STAT1,	 IRF7	 and	 ISG15	 has	 been	 detected	 in	 the	reconstructed	 networks	 of	 the	 pathological	 and	 control	 phenotypes	 (see	 Figure	 4.3).	This	 feedback	seems	to	be	of	particular	 importance	 for	 the	activity	of	Systemic	Lupus.	IRF7	was	 functionally	 associated	with	 Systemic	 Lupus	 and	 results	 in	 increased	 type	 I	interferon	 (IFN)	 induction	 upon	 up-regulation	 (Xu	 et	al.,	 2012).	 Several	 IFN	 inducible	genes,	such	as	ISG15,	were	significantly	up-regulated	in	the	disease	pathology	and	serve	as	markers	of	disease	activity	(Feng	et	al.,	2006).	The	drugs	having	the	most	reported	effects	among	these	candidate	factors	were	found	 to	 be	 tetrachlorodibenzodioxin	 (TCDD,	 8	 targets),	 cyclosporine	 (5	 targets)	 and	resveratrol	 (5	 targets).	 Among	 these	 drugs,	 resveratrol	 shows	 a	 considerably	 more	favorable	 effect,	 i.e.	 lower	 area	 under	 the	 enrichment	 curve	 (see	 Figure	 4.3),	 and	additionally	 reverts	 59.4%	 of	 the	 pathologic	 gene	 expression	 program	 upon	 in	 silico	simulation	its	reported	effects.	Experimental	evidence	in	human	macrophages	supports	this	prediction,	since	resveratrol	has	been	shown	to	act	as	an	antiatherogenic	agent,	i.e.	it	 counters	 the	 formation	 of	 fatty	 deposits	 in	 the	 arteries	 (Reiss	 et	 al.,	 2012).	 Even	though	 TCDD	 shows	 a	 less	 favorable	 enrichment	 pattern,	 it	 has	 been	 found	 to	 act	immunosuppressive	 to	 SLE	 mice	 and	 significantly	 decreased	 the	 symptoms	 (Li	 and	McMurray,	 2009).	 Interestingly,	 cyclosporine	 has	 significant	 effect	 on	 the	 disease	pathology	of	SLE,	which	has	been	proven	in	clinical	trials	(Caccavo	et	al.,	1997),	but	does	not	turn	out	to	be	the	most	effective	drug	according	to	the	analysis.		
4.2 Prediction of Chromatin Accessibility in Gene-Regulatory Regions from 
Transcriptomics Data 	 Cellular	phenotypes	are	shaped	by	the	complex	interplay	of	transcriptional	and	epigenetic	 regulatory	 interactions.	 The	 dynamic	 epigenetic	 landscape	 allows	 for	establishing	distinct	 transcriptional	 regulatory	 interactions	 through	 the	modulation	of	chromatin	 accessibility	 and	 activity.	 Therefore,	 it	 is	 of	 utmost	 importance	 to	 pinpoint	the	accessible	gene-regulatory	genomic	regions	that	give	rise	to	a	particular	phenotype.	Several	 experimental	 procedures,	 such	 as	 DNase	 I	 hypersensitive	 site	 sequencing	(DNase-seq),	 formaldehyde-assisted	 isolation	 of	 regulatory	 elements	 (FAIRE-seq)	 and	the	assay	for	transposase-accessible	chromatin	using	sequencing	(ATAC-seq),	have	been	
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developed	for	profiling	the	accessibility	landscapes	in	different	cell	types	(Buenrostro	et	
al.,	2013;	Song	et	al.,	2011).	However,	current	downstream	computational	tools	for	the	identification	of	enriched	genomic	sites,	i.e.	peak	callers,	fail	to	provide	reliable	results.	Based	 on	 a	 previous	 study,	 the	 overlap	 of	 the	 four	 most	 widely	 used	 peak	 calling	algorithms	(Hotspot,	F-Seq,	ZINBA	and	MACS)	applied	 to	the	same	dataset	amounts	 to	only	11%	of	all	 identified	regions	(Koohy	et	al.,	2014).	In	addition,	the	configuration	of	peak	 calling	 parameters	 has	 significant	 effects	 on	 the	 identification	 of	 these	 regions	whereby	a	dataset-dependent	optimal	setting	is	usually	unknown	(Koohy	et	al.,	2014).	Especially	 the	 control	 of	 the	 false	 discovery	 rate	 is	 fundamental	 for	 balancing	 false	negative	and	false	positive	peaks.	Here,	more	stringent	cutoffs	may	result	in	increased	false	negatives	while	less	stringent	cutoffs	render	an	elevated	number	of	false	positive	peaks.		 Besides	 the	 limitations	 of	 the	 current	 computational	 pipeline,	 the	 absence	 of	experimental	 chromatin	 conformation	 assays	 hinders	 the	 systematic	 study	 of	 gene	regulation	 and	 its	 modulation	 by	 the	 accessibility	 landscape.	 For	 example,	 the	pronounced	 effect	 of	 pioneer	 factors	 on	 the	 formation	 of	 stable,	 compound-induced	phenotypes	 cannot	 be	 described	 without	 additional	 information	 about	 epigenetic	changes	 (see	 section	 4.1.2).	 Hence,	 a	 machine-learning	 approach	 was	 developed	 that	predicts	 gene-level	 accessibility	 from	 transcriptomics	 data	 in	 the	 absence	 of	experimental	data	and	can	assist	in	the	identification	of	optimal	peak	calling	parameters	if	chromatin	accessibility	assays	are	available.			
4.2.1 Machine-Learning Model Construction and Cross-Validation 	 The	methodology	 for	 predicting	 chromatin	 accessibility	 is	 based	 on	 a	 stacked	classification	 tree	 model,	 specially	 designed	 for	 utilizing	 transcriptomics	 data	 as	 an	input	(see	Methods	section	3.4.2	for	details).	In	order	to	train	the	model,	a	collection	of	18	distinct	RNA-seq	gene	expression	profiles	and	corresponding	chromatin	accessibility	assays	 (DNase-seq)	 from	 various	 cell	 types	 and	 cell	 lines	 was	 compiled	 and	homogenously	processed.	Chromatin	 accessibility	data	was	aligned	to	human	genome	version	 19	 (hg19)	 and	 subsequently	 screened	 for	 enriched	 genomic	 regions	 using	Hotspot	(John	et	al.,	2011)	with	standard	false	discovery	rate	of	1%.	It	 is	important	to	note	 that	 the	 training	datasets	consists	of	several	cancer	cell	 lines	typically	containing	several	 structural	 variations	 (Moncunill	 et	 al.,	 2014;	 Malhotra	 et	 al.,	 2013).	 Thus,	experimental	 sequencing	 data	 of	 these	 samples	 should	 be	 aligned	 to	 their	 specific	sequenced	 genome	 instead	 of	 the	 reference	 genome	 to	 account	 for	 these	 genetic	
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variations.	 However,	 the	 unavailability	 of	 these	 sequenced	 genomes	 only	 leaves	 the	possibility	of	aligning	it	to	a	reference	genome.	To	facilitate	the	utilization	of	the	model	predictions	 in	 the	 context	 of	 gene	 regulatory	 network	 reconstruction,	 a	 gene-level	accessibility	measure	was	obtained.	A	previous	study	reported	distinct	DNase-seq	peak	locations	depending	on	the	expression	level,	 i.e.	highly	expressed	genes	predominantly	show	 peaks	 around	 their	 transcription	 start	 site	 (TSS)	 while	 medium	 and	 lowly	expressed	genes	 contain	peaks	 in	 their	 gene	bodies	 (He	et	al.,	 2014).	 Consequently,	 a	gene	is	called	accessible	if	its	promoter	or	gene	body	is	overlapping	a	peak	identified	by	Hotspot	and	inaccessible	otherwise.			 After	the	model	was	conceived	and	an	appropriate	training	dataset	was	selected,	its	predictive	power	and	generalizability	to	unseen	samples	was	analyzed	by	means	of	leave-one-out	 cross-validation.	 More	 specifically,	 leave-one-out	 cross-validation	 was	performed	 horizontally	 and	 vertically	 by	 partitioning	 the	 complete	 dataset	 either	 by	sample	or	by	chromosome.	The	model	was	then	trained	with	all	but	one	partition	while	the	remaining	one	was	left	out	for	prediction.	The	correlation	of	the	predictions	of	the	reduced	 model	 with	 those	 of	 the	 full	 model	 then	 quantifies	 the	 generalizability	 to	unseen	data.		 The	horizontal	comparison	of	the	full	model	against	the	cross-validation	model	by	 means	 of	 binary	 gene-level	 accessibility	 and	 assigned	 confidence	 scores	 of	 the	predictions	 reveal	 strong	 individual	 correlations	 of	 at	 least	 0.95	 (Figure	 4.4A).	 On	average,	the	predictions	of	both	models	are	highly	concordant	showing	correlations	of	0.984	and	0.997	for	binary	gene-level	accessibility	assignments	and	their	corresponding	confidence	 scores,	 respectively.	These	 results	 are	 further	 confirmed	by	vertical	 cross-validation	in	which	all	but	one	chromosome	was	used	for	training	while	the	predictions	were	carried	out	on	 the	hold	out	chromosome.	The	obtained	correlations	of	predicted	binary	gene-level	accessibility	(Figure	4.4B)	and	confidence	scores	(Figure	4.4C)	of	the	full	 and	 hold-out	model	 are	 similar	 to	 those	 of	 the	 horizontal	 cross-validation.	While	some	 chromosomes	 exhibit	 greater	 correlation	variations,	 a	minimum	concordance	of	0.947	supports	the	insensibility	of	the	model	towards	the	training	dataset.	Of	note,	the	correlations	 of	 the	 confidence	 scores	 in	 chromosome	 8	 appear	 lower	 than	 all	 others.	However,	 since	 all	 obtained	 correlations	 are	 above	 0.98,	 these	 differences	 are	insignificant.	Owing	 to	 the	 cellular	heterogeneity	 leading	 to	 variations	 across	different	 gene	expression	measurements	of	the	same	cell	type,	the	reproducibility	of	predictions	in	the	presence	 of	 gene	 expression	 replicates	was	 assessed	 (Figure	 4.4D).	 A	 reliable	 second	expression	sample	was	collected	for	17	cell	types	or	cell	lines	in	the	training	dataset.	The	
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available	replicate	of	HMEC	cells	was	of	poor	quality	showing	no	expression	for	most	of	the	 genes	 and	 was	 consequently	 excluded	 from	 further	 analysis.	 All	 other	 replicates	where	highly	consistent	(median	correlation	of	0.97)	with	HeLa-S3	cells	being	a	notable	outlier	(correlation	0.7).	The	hierarchical	classification	tree	model	was	then	trained	with	the	 set	 of	 first	 (second)	 replicates	 to	 predict	 the	 accessibility	 of	 both	 replicates.	Subsequently,	 the	 correlations	 of	 the	 gene-level	 assignments	 and	 confidence	 scores	were	 assessed	 (Figure	 4.4D,	 left	 and	 middle	 boxes).	 In	 the	 optimal	 case,	 similar	correlations	 than	 in	 the	 horizontal	 cross-validation	 analysis	were	 expected.	 However,	even	 though	 the	 obtained	 correlations	 of	 at	 least	 0.85	 (median:	 0.91	 and	 0.88,	respectively)	 indicate	 a	 strong	 concordance	 between	 the	 predictions	 of	 the	 model	trained	with	different	 replicates,	 a	 significant	difference	was	observed.	Given	 that	 the	confidence	scores	do	not	exhibit	median	correlation	differences,	a	plausible	explanation	of	 the	 correlation	 differences	 in	 predicted	 gene-level	 accessibility	 assignments	 is	 that	the	 optimal	 confidence	 score	 thresholds,	 above	 which	 a	 gene	 is	 predicted	 to	 be	accessible,	are	distinct	in	both	cases.	However,	due	to	the	inability	of	identifying	optimal	thresholds	for	unseen	data	and	the	obtained	strong	correlations,	the	standard	threshold,	which	assigns	the	gene	to	the	accessibility	status	having	the	highest	confidence,	is	kept	throughout	the	following	analyses.		 Overall,	 the	 results	 of	 the	 cross-validated	 model	 highlight	 the	 insensitivity	 of	predictions	 to	 the	 training	 dataset	 and	 its	 generalizability	 to	 unseen	 data	 providing	confidence	in	the	accurate	model	design	for	predicting	gene-level	accessibility.	
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Figure	4.4.	Correlation	analysis	of	cross-validated	and	full	model	predictions	
	
		
Analysis	 results	 of	 cross-validation	 assays	 correlating	 predictions	 from	 the	 full	
model	 trained	 with	 18	 samples	 and	 leave-one-out	 models	 are	 represented	 by	
boxplots.	 Whiskers	 extend	 to	 1.5	 times	 the	 interquartile	 range	 and	 outliers	 are	
depicted	 as	 circles.	 (A)	 Pearson	 correlation	 of	 binary	 gene-level	 predictions	 and	
confidence	 scores	 show	 highly	 reproducible	 results	with	 values	 greater	 than	0.95.	
(B)	 Cross-validation	 by	 training	 the	 model	 with	 all	 but	 one	 chromosome	 and	
predicting	the	remaining	one	yields	similar	performance	to	the	sample-based	cross-
validation	having	correlations	greater	 than	0.94	 in	all	cases.	 (C)	Comparison	of	 the	
correlation	 of	 scores	 shows	 an	 almost	 perfect	 relationship	 through	 correlations	
greater	than	0.98.	(D)	Reproducibility	analysis	for	multiple	samples	of	the	same	cell	
lines.	 Training	 with	 the	 first	 (left)	 and	 second	 (right)	 replicates	 while	 predicting	
gene-level	 accessibility	 of	 both	 shows	 high	 correlations	 between	 the	 predicted	
values.	Correlations	of	raw	gene	expression	replicates	are	depicted	 in	 the	blue	box	
plot.	
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4.2.2 Comparison of predicted gene-level chromatin accessibility with traditional 
peak calling algorithms 	 Despite	 the	 previous	 quantitative	 evaluation	 of	 the	 conceived	 model,	 it	 is	inevitable	 to	 assess	 its	 predictive	 power	 with	 respect	 to	 experimental	 evidences	 and	compare	 it	 to	 current	 downstream	 computational	 tools	 for	 processing	 chromatin	accessibility	assays	based	on	a	gold	standard	dataset.	Since	DNase-seq	experiments	that	were	 processed	 with	 traditional	 peak	 calling	 algorithms	 were	 used	 for	 training	 the	model,	 a	 distinct	 validation	 set	was	 compiled.	 First,	 between	 31	 to	 100	 transcription	factor	 binding	 site	 (TFBS)	 ChIP-seq	 experiments	 were	 obtained	 from	 ENCODE	((Dunham	et	al.,	2012),	Table	S2)	 in	six	cell	 lines	(A549,	GM12878,	H1-hESC,	HeLa-S3,	HepG2	and	K562)	 for	 pinpointing	 accessible	 regions.	 Genes	 overlapping	with	 at	 least	one	 TFBS	 are	 defined	 as	 accessible,	 due	 to	 the	 high	 overlap	 of	 TFBS	 and	 DNase	hypersensitive	sites	(Song	et	al.,	2011).	Inaccessible	genes,	on	the	other	hand,	cannot	be	reliably	 determined	 by	 TFBS	 ChIP-seq	 experiments,	 since	 it	 is	 impossible	 to	 decide	whether	 the	absence	of	binding	events	 is	caused	by	 incorrect	downstream	processing,	the	unavailability	of	experimental	data	for	other	TFs	that	could	bind	this	region	or	the	gene’s	 location	 in	 inaccessible	 chromatin.	 Therefore,	 inaccessible	 genes	 were	determined	 based	 on	 ChromHMM	 (Ernst	 and	 Kellis,	 2012),	 a	 computational	 tool	 for	annotating	 genomic	 regions	 based	 on	 histone	 modification	 ChIP-seq	 experiments.	Precompiled	 datasets	 for	 the	 six	 cell	 lines	 were	 obtained	 from	 the	 Roadmap	Epigenomics	 project	 (Roadmap	 Epigenomics	 et	 al.,	 2015)	 including	 annotations	dependent	on	 five	histone	modifications	 (H3K4me1,	H3K4me3,	H3K9me3,	H3K27me3	and	 H3K36me3).	 Heterochromatin	 was	 then	 defined	 as	 regions	 enriched	 in	 either	 a	combination	of	H3K4me3,	H3K36me3	(Chantalat	et	al.,	2011)	and	H3K9me3	indicating	ZNF	genes	and	repeat	regions	targeted	by	heterochromatin	proteins	(Vogel	et	al.,	2006;	Blahnik	et	al.,	2011)	or	H3K9me3	alone.	Genes	that	overlap	at	least	one	genomic	region	enriched	in	one	of	the	two	aforementioned	categories	are	defined	as	inaccessible.		 For	 comparing	 the	 developed	 machine	 learning	 approach	 against	 traditional	peak	calling	methods,	 transcriptomics	and	experimental	DNase-seq	data	was	obtained	for	the	six	cell	 lines	in	the	gold	standard	dataset.	DNase-seq	assays	were	processed	by	MACS	 (Zhang	 et	al.,	 2008),	 F-Seq	 (Alan	 P	 Boyle	 et	al.,	 2008)	 and	Hotspot	 (John	 et	al.,	2011)	with	varying	false	discovery	rates	or	Z-score	cutoffs	to	identify	genes	located	in	accessible	 and	 inaccessible	 regions.	 Identified	 peaks	were	 processed	 as	 described	 for	model	training.	Predictions	were	obtained	by	applying	the	model	to	corresponding	RNA-seq	 datasets	 and	 subsequently	 compared	 to	 the	 assignments	 from	 MACS,	 F-Seq	 and	Hotspot	by	means	of	the	harmonic	mean	of	precision	and	recall,	the	𝐹Q-	score.	Since	the	
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developed	model	utilizes	transcriptomics	data,	 it	 is	of	utmost	importance	to	assess	the	predictive	power	for	different	expression	ranges.	Therefore,	different	lower	expression	cutoffs	 were	 applied	 to	 define	 sets	 of	 genes	 whose	 expression	 is	 greater	 than	 the	threshold	(Figure	4.5).		
Figure	4.5.		Comparison	of	stacked	classification	tree	model	with	peak	calling	methods	
	
Analysis	 of	 the	 complete	 datasets,	 corresponding	 to	 a	 lower	 threshold	 of	 0	FPKM,	suggests	a	strong	predictive	power	of	the	developed	method	but	shows	slightly	reduced	 performance	 compared	 to	 traditional	 peak	 calling	 approaches	 (average	difference	between	0.055	and	0.094).	However,	in	contrast	to	F-Seq,	MACS	and	Hotspot,	the	 performance	 gradually	 increases	 until	𝐹Q-	 scores	 of	 0.999	 are	 reached	 for	 genes	more	 expressed	 than	0.08	FPKM.	This	 trend	 is	 observed	 in	 all	 gold	 standard	datasets	except	HepG2.	 Of	note,	 this	 cutoff	 cannot	 be	 regarded	as	 a	 threshold	 for	 determining	expressed	 genes	 and	 is	 substantially	 lower	 than	 previously	 reported	 values	
Comparison	of	gene-level	accessibility	predictions	(red)	with	processed	experimental	
data	by	F-Seq	(blue),	MACS	(orange)	and	Hotspot	(green)	in	six	gold	standard	datasets	
by	means	 of	 F-scores.	 Performance	 is	 measured	 for	 different	 expression	 thresholds	
including	 only	 genes	 expressed	 above	 the	 cutoff.	 Dots	 represent	 mean	 values	 and	
corresponding	confidence	intervals	are	shown	for	different	replicates	and	parameter	
settings	(FDR	or	z-score).	Predictions	on	the	full	dataset	have	on	average	0.075	lower	
scores.	 Performance	 is	 gradually	 increasing	 for	 higher	 cutoffs	 with	 similar	
performance	achieved	when	excluding	non-expressed	genes	(0	FPKM).	
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(Haltaufderhyde	 and	Oancea,	2014;	Rau	et	al.,	 2013;	Trakhtenberg	et	al.,	 2016).	Thus,	the	visible	robust	performance	 is	not	due	 to	 the	 trivial	assertion	 that	expressed	genes	should	be,	generally,	located	in	accessible	chromatin	domains.	Importantly,	remind	that	the	𝐹Q-score	 is	 defined	 as	 the	 harmonic	mean	 of	 precision	 and	 recall	 i.e.	 the	 ratios	 of	truly	accessible	predictions	over	all	genes	predicted	to	be	accessible	and	all	accessible	genes,	 respectively.	 Therefore,	 it	 is	 independent	 of	 the	 amount	 of	 accessible	 and	inaccessible	chromatin	regions.	This	implies	that	the	𝐹Q-scores	of	embryonic	stem	cells	(H1-hESC),	which	 contain	more	 accessible	 chromatin	 regions	 than	differentiated	 cells,	do	not	differ	significantly	from	the	other	cell	lines.	Even	 though	 the	 developed	 machine	 learning	 approach	 yields	 comparable	performance	 to	 any	peak	 calling	methodology,	which	 relies	 on	 experimental	 data,	 the	utilization	of	gene	expression	as	a	predictor	of	chromatin	accessibility	might	introduce	unexpected	 biases	 in	 the	 predictions.	 In	 particular,	 three	 potential	 sources	 can	 be	distinguished:	
• GC	 content	of	 genes.	 The	 GC	 content	 of	 genes	 is	 negatively	 correlated	with	 their	 methylation	 level	 (Meissner	 et	 al.,	 2008),	 which	 in	 turn	influences	 gene	 expression.	 In	 particular,	 high	 methylation	 levels	 are	indicative	 of	 low	 or	 no	 expression	 even	 though	 the	 gene	 is	 located	 in	accessible	chromatin.	
• Gene	 expression.	 The	 hierarchical	 classification	 tree	 model	 uses	 gene	expression	 as	 a	 predictor	 while	 peak	 calling	 algorithms	 neglect	transcription.	
• Gene	 type.	 Genes	 of	 different	 types	 differ	 in	 their	 expression,	 e.g.	transcripts	 of	 protein-coding	 genes	 are	 typically	 more	 abundant	 than	those	 of	 non-coding	 genes	 (Djebali	 et	 al.,	 2012).	 Especially	 non-coding	genes	are	largely	lowly	expressed	(Iyer	et	al.,	2015)	(<	1	FPKM)	and,	as	such,	might	be	more	often	misclassified.	The	 analysis	 of	 the	 proportion	 of	 misclassified	 genes	 for	 each	 potential	 bias	source	 revealed	 gene	 expression	 as	 the	 only	 significant	 difference	 (Figure	 4.6).	 More	specifically,	 the	maximum	difference	 in	 the	proportion	of	misclassified	genes	between	predictions	and	peak	calling	methods	amounts	to	only	3%	per	chromosome	and	7%	per	gene	type.	Differences	in	genes	by	their	GC	content	are	below	1%	and	as	such	negligible.	However,	 as	 already	 suggested	 by	 the	 evaluation	of	 predictions	 on	 the	 gold	 standard	dataset,	gene	expression	 is	a	significant	source	of	bias.	94%	of	misclassified	genes	are	expressed	 below	 0.1	 FPKM,	 which	 is	 significantly	 higher	 in	 comparison	 to	 F-Seq	(58.4%),	MACS	 (61.4%)	and	Hotspot	 (67.3%),	 respectively.	A	possible	 explanation	 for	
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this	result	is	the	deterministic	behavior	of	the	model.	When	using	only	gene	expression	or	its	derivatives	as	predictors	for	accessibility,	the	same	expression	value	is	classified	as	 either	 accessible	or	 inaccessible.	 Especially	non-expressed	genes	 (0	FPKM)	 show	a	high	 misclassification	 rate	 because	 of	 the	 indistinguishability	 of	 accessible	 and	inaccessible	 chromatin	 regions.	 Finally,	 the	 discrimination	 of	 genes	 by	 chromosomal	location	 was	 not	 expected	 to	 yield	 significant	 biases	 in	 the	 prediction	 of	 gene-level	accessible	 and	 was	 analyzed	 as	 a	 negative	 control.	 The	 results	 of	 this	 assessment	confirmed	the	unbiased	predictions.	
Figure	4.6.	Assessment	of	potential	sources	of	bias	in	the	prediction	of	gene-level	accessibility	
	
	 At	last,	further	investigation	was	conducted	with	respect	to	the	number	of	genes	predicted	to	be	accessible	but	declared	to	be	inaccessible	by	downstream	processing	of	DNase-seq	assays.	Interestingly,	between	47%	and	67%	(median:	62%)	of	these	genes	in	 the	 six	 gold	 standard	 cell	 lines	 were	 bound	 by	 a	 transcription	 factor	 and	 were	therefore	accessible	(Figure	4.7).	Since	the	gold	standard	dataset	consists	of	only	31	to	100	 transcription	 factor	 binding	 site	 ChIP-seq	 experiments,	 these	 numbers	 are	supposedly	increasing	with	more	available	datasets.	Overall,	the	developed	methodology	 is	able	 to	accurately	classify	genes	located	in	 accessible	 and	 inaccessible	 chromatin	 regions	 based	 on	 transcriptomics	data	when	experimental	DNase-seq	data	is	unavailable.	Additionally,	the	accordingly	derived	gene-
Potentially	 influencing	 factors	 of	 the	 predictions	 (red	 bars)	 were	 assessed	 and	
compared	against	assignments	of	F-Seq	(blue	bars),	MACS	(orange	bars)	and	Hotspot	
(green	bars).	Neither	 the	 chromosomal	 location	nor	 gene	 type	nor	 the	GC	content	 of	
misclassified	 genes	 distinguishes	 predictions	 from	 observations.	 However,	 by	
predicting	 accessibility	 based	 on	 gene	 expression	 (bottom	 right	 histogram),	 we	
significantly	reduce	the	number	of	misclassified	genes	in	regions	expressed	above	0.1	
FPKM	 (6%	 compared	 to	 41.6%,	 38.6%	 and	 37.2%).	 Due	 to	 the	 deterministic	
prediction,	 non-expressed	 genes	 are	 overrepresented	 in	 the	 range	 of	 0	 to	 0.1	 FPKM	
(first	bar,	38%	out	of	94%).	
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level	 accessibility	 is	 readily	 usable	 for	 integration	 into	 the	 gene	 regulatory	 network	framework	 and	 provides	 a	 reliable	 proxy	 for	 identifying	 genes	 that	 are	 actively	regulated.	 Experimental	 DNase-seq	 data	 is,	 however,	 still	 favorable	 if	 peak	 calling	parameters	 could	 be	 optimized	 to	 render	 less	 false	 negatives	 assignments,	 due	 to	 its	pronounced	ability	of	distinguishing	the	chromatin	accessibility	of	non-expressed	genes.	
Figure	4.7.	Validated	predicted	accessible	regions	not	detected	by	peak	callers	
	
4.2.3 Optimizing peak calling parameters with model predictions 	 Obtaining	 functional	 insights	from	chromatin	accessibility	assay	peak	 locations	and	reliable	gene-level	assignments	of	non-expressed	genes	are	major	obstacles,	which	cannot	 be	 overcome	 by	 the	 sole	 use	 of	 gene	 expression.	 Instead,	 other	 experimental	assays	 could	 be	 used	 to	 improve	 the	 predictions	 or	 the	 parameters	 for	 downstream	computational	tools	could	be	optimized.	In	the	following,	the	latter	approach	will	be		
Percentage	 of	 validated	 accessible	 genes	 that	 are	 predicted	 by	 the	 model	 and	 not	
detected	by	peak	calling	methods.	Validation	was	performed	on	the	basis	of	the	TFBS	
ChIP-seq	experiments	in	the	gold	standard	datasets	from	ENCODE.	Bars	represent	the	
percentage	 of	 genes	 bound	 by	 transcription	 factors	 with	 respect	 to	 all	 predicted	
accessible	genes	that	are	not	detected	by	peak	callers.	Between	49%	(A549)	and	69%	
of	predictions	could	be	validated	(median	62%,	dashed	line).		
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Table	4.5.	False	Discovery	Rate	thresholds	for	peak	calling	methods	
Peak	Caller	 Thresholds	
F-Seq	(version	1.84)	 0.5,	1,	2,	3,	4,	5,	6,	7	
MACS	(version	2.1.0.20140616)	 0.01,	0.05,	0.075,	0.1,	0.15,	0.2	
Hotspot	(version	5.1)	 0.01,	0.05,	0.075,	0.1,	0.15,	0.2	
	addressed.	 In	 particular,	 the	 conducted	analysis	 focuses	 on	 the	 optimization	 of	the	 false	 discovery	 rate,	 an	 important	parameter	 in	 all	 peak	 calling	methodologies	 (Koohy	 et	 al.,	 2014),	through	 the	 employment	 of	 predicted	gene-level	accessibility..	The	 validation	 results	 in	 the	 six	gold	 standard	 datasets	 highlighted	 the	accuracy	 of	 the	 machine-learning	 model	predictions	 for	 genes	 expressed	 above	0.01	 FPKM.	 Thus,	 peak	 calling	parameterizations	resulting	in	the	highest	resemblance	 of	 recovered	 accessible	genes	with	 respect	 to	 genes	predicted	 to	be	 accessible	 should	 render	 the	 most	reliable	 results.	 More	 specifically,	 this	translates	 to	 the	 recall	 of	 peak	 caller	derived	 accessibility	 assignments	 with	respect	 to	 model	 predictions.	 This	assertion	 was	 tested	 for	 F-Seq,	 Hotspot	and	 MACS	 with	 varying	 false	 discovery	rate	(Z-score)	parameters	(Table	4.5)	and	evaluated	 against	 the	𝐹Q-	 score	 in	 the	 six	
Figure	4.8.	Dependence	between	Recall-measure	
and	F-score	
For	MACS	and	Hotspot,	thresholds	correspond	to	false	discovery	rate	(FDR)	and	in	case	
of	F-Seq	to	z-score	thresholds.	Z-score	thresholds	are	negatively	correlated	with	FDR.	
Thus,	 small	 values	 correspond	 to	 high	 FDR	 thresholds	 and	 large	 values	 to	 low	 FDR	
thresholds.	
Regression	 analysis	 provides	 evidence	
for	 the	 strong	 linear	 relationship	 of	 F-
scores	 on	 the	 gold	 standard	 datasets	
and	the	proposed	recall	measure	(adj.	R	
squared	 of	 0.92,	 0.84	 and	 0.79).	 Dots	
represent	 distinct	 parameterization,	
cell	line,	and	replicate	settings.	
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gold	 standard	 cell	 lines	 for	 each	parameterization.	Of	note,	 the	 called	peaks	 are	 again	transformed	to	gene-level	accessibility,	as	described	earlier	in	this	section.	The	results	of	the	analysis	reveal	a	strongly	positive,	linear	relationship	between	the	𝐹Q-	scores	and	the	proposed	recall	measure.	Adjusted	coefficients	of	determination	of	0.92,	0.84	and	0.79	for	F-Seq,	MACS	and	Hotspot,	respectively,	indicate	that	the	recall	measure	explains	the	vast	 majority	 of	 variation	 in	 the	𝐹Q -	 scores	 (Figure	 4.8).	 However,	 for	 practically	determining	the	best	parameterizations,	the	rankings	based	on	the	recall	measure	and	𝐹Q-	score	have	to	agree.	Therefore,	rankings	were	obtained	for	the	individual	measures	and	pairwise	compared.	This	intuitively	corresponds	to	the	orthogonal	projection	of	the	dots	in	Figure	4.8	onto	the	regression	line.	As	expected	from	the	visual	representation	in	Figure	 4.8,	 the	 rankings	 agree	 for	 all	 peak	 calling	 methodologies,	 which	 provides	support	for	the	suitability	of	the	proposed	recall	measure	for	parameter	optimization.		 Overall,	 if	 experimental	 data	 is	 available,	 the	 developed	 methodology	 can	 be	used	 for	 optimizing	 parameters	 of	 downstream	 computational	 tools	 leading	 to	 more	accurate	assignments	of	non-expressed	genes.	
4.3 Integrating Epigenetics, Transcriptomics and Prior Knowledge Networks 
for Predicting Candidate Instructive Factors in Adipocyte to Osteoblast 
Conversion 	 The	methodology	for	predicting	gene-level	accessibility	can	be	readily	integrated	into	 the	 framework	 for	reconstructing	 condition-specific	 gene	 regulatory	networks.	 In	the	attractor	state,	inaccessible	genes	cannot	regulate	other	genes,	due	to	the	absence	of	expression,	and	cannot	be	regulated	by	other	genes.	Therefore,	these	genes	do	not	play	an	 active	 role	 in	 the	 stabilization	 of	 the	 attractor	 and	 should	 be	 excluded	 from	 the	during	network	reconstruction	in	a	condition	dependent	manner.	More	specifically,	the	attractor	 of	 the	 condition-specific	 networks	 should	 only	 be	 explained	 by	 accessible	genes	that	can	be	actively	regulated	while	inaccessible	genes	need	to	be	removed	from	the	networks.		 In	 order	 to	 highlight	 the	 utility	 of	 the	 proposed	 condition-specific	 differential	network	analysis,	gene-level	accessibility	 is	 integrated	 into	 the	existing	 framework	 for	predicting	multitarget	combinations	inducing	the	cellular	conversion	of	adipocytes	into	osteoblasts.	 An	 integrative	 analysis	 approach	 is	 presented	 that	 involves	 the	reconstruction	 of	 condition-specific	 networks	 as	 well	 as	 the	 identification	 of	 genes	targeting	osteoblast-specific	super-enhancers	(Figure	4.9).		
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Figure	4.9.	Workflow	for	predicting	instructive	factors	of	adipocyte	to	osteoblast	conversion	
	
 
4.3.1 Differential Network Reconstruction and Identification of Candidate 
Instructive Factors 	 Transcriptome	profiling	of	mouse	 ST2	multipotent	bone	marrow	stromal	 cells	(MSCs)	differentiated	into	adipocytes	and	osteoblasts	was	performed	after	15	days	by	RNA	sequencing	(differentiation	was	conducted	following	the	protocol	in	(Gerard	et	al.,	2017))	 and	 differentially	 expressed	 genes	 were	 detected	 (log2	 FC	 >=	 1).	 A	 prior	
The	workflow	for	predicting	instructive	factors	for	adipocyte	to	osteoblast	conversion	
consists	of	two	parts.	First,	cell	type	specific	networks	were	reconstructed	and	optimal	
combinations	 of	 genes	 were	 identified	 by	 differential	 network	 analysis	 (red).	 Then,	
super	 enhancers	 unique	 to	 osteoblasts	 were	 obtained	 and	 the	 transcription	 factors	
with	 predicted	 binding	 sites	 in	 them	 were	 identified	 by	 position	 weight	 matrices	
(green).	The	pareto	optimal	 solutions	of	 both	assessments	 constitute	 the	 final	 set	 of	
predictions.	
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knowledge	 network	 of	 direct	 gene	 regulatory	 interactions	 between	 differentially	expressed	genes	was	extracted	from	MetaCoreTM	and	subset	to	interactions	contributing	to	 transcriptional	 regulation.	 In	 total,	 147	 regulatory	 interactions	 among	 55	transcription	 factors	 were	 retrieved	 from	 which	 cell	 type	 specific	 networks	 were	reconstructed.	Due	 to	 the	 absence	 of	 experimental	 chromatin	 accessibility	 data	 for	 the	differentiated	cells,	the	methodology	for	predicting	gene-level	accessibility	was	applied	to	 the	 transcriptomics	profiles.	The	 stacked	 classification	 tree	model	was	 validated	 in	the	previous	section	using	solely	human	data.	Therefore,	in	order	to	apply	the	method	to	expression	 data	 from	 mouse	 cells,	 a	 training	 dataset	 was	 compiled	 from	 ENCODE	(Dunham	et	al.,	 2012)	 consisting	of	14	homogeneously	processed	 transcriptomics	and	DNase-seq	samples	of	various	cell	lines,	cell	types	and	tissues.	All	transcription	factors	more	 expressed	 than	1	 FPKM	 or	 those	 predicted	 to	 be	 accessible	were	 defined	 to	 be	accessible.	With	it,	inaccessible	genes	in	adipocytes	and	osteoblasts	were	removed	from	the	corresponding	networks	during	network	reconstruction.	Following	this	rationale,	cell	type	specific	networks	were	obtained	for	both	cell	types	 and	 candidate	 instructive	 factors	 for	 inducing	 the	 transition	 from	adipocytes	 to	osteoblasts	were	derived	from	elementary	feedback	loops	in	the	common	network	parts	and	transcription	factors	under	differential	regulation.	Due	to	the	dense	transcriptional	regulation	 in	 the	 two	 networks,	 38	 transcription	 factors	 are	 selected	 as	 candidate	factors.		
4.3.2 Prediction of Instructive Factors for Adipocyte to Osteoblast conversion The	 identified	 candidate	 instructive	 factors	 were	 combined	 into	 multitarget	combinations	of	up	 to	three	 transcription	 factors	and	used	 for	 in	silico	perturbation	of	the	adipocyte	network.	In	addition,	active	super-enhancers	were	identified	in	adipocytes	and	osteoblasts	as	dense	 regions	of	active	 enhancers	marked	by	H3K27ac.	Due	 to	 the	pronounced	effect	of	super-enhancers	on	cell	identity	(Hnisz	et	al.,	2013),	the	330	genes	that	overlap	256	osteoblast	specific	super-enhancers	are	presumed	to	play	an	important	role	 in	 the	 cellular	 conversion.	 Therefore,	 potential	 regulators	 for	 each	 osteoblast	specific	super-enhancer	were	identified	by	transcription	factor	binding	site	predictions	with	MOODS	(Korhonen	et	al.,	2009)	using	position	weight	matrices	 from	HOCOMOCO	(Kulakovskiy	et	al.,	2016).		
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Figure	4.10.	Predicted	pareto-optimal	combinations	for	inducing	adipocyte	to	osteoblast	conversion	
	
Pareto-optimal	multitarget	combinations	were	derived	based	on	the	predicted	number	of	 targeted	 osteoblast	 specific	 super-enhancers	 and	 the	 in	 silico	 induction	 of	 the	osteoblast	phenotype	upon	perturbation	(Figure	4.10).	 In	particular,	pareto-optimality	describes	 a	 combination	 in	which	 one	 ranking	 criterion	 cannot	 be	 improved	without	lowering	 the	 other	 criterion.	 Markedly,	 all	 but	 one	 of	 the	 seven	 pareto-optimal	combinations	 contain	myocyte	 enhancer	 factor	 2c	 (MEF2C)	 highlighting	 its	 predicted	pronounced	 effect	 in	 the	 induction	 of	 osteoblasts.	 A	 previous	 study	 provides	 further	support	 to	 this	 finding	 showing	 that	 MEF2C	 deficiency	 impedes	 osteoblast	differentiation,	 extracellular	 matrix	 mineralization	 and	 osteoblast	 specific	 gene	expression	 (Stephens	 et	 al.,	 2011).	 Due	 to	 the	 pronounced	 effect	 of	 the	 multitarget	combination	 of	 interferon	 regulatory	 factor	 1	 (IRF1),	 MEF2C	 and	 runt-related	transcription	 factor	 3	 (RUNX3)	 on	 the	 network	 attractor	 upon	 in	 silico	 perturbation	(81%	reversion	of	the	core	adipocyte	network)	while	potentially	regulating	76%	of	the	osteoblast	 specific	 super-enhancers,	 it	 was	 selected	 as	 a	 suitable	 candidate	 for	 the	induction	 of	 osteoblasts.	 More	 specifically,	 perturbation	 of	 the	 network	 with	 this	
Combinations	 of	 candidate	 instructive	 factors	 were	 scored	 based	 on	 their	 ability	 to	
induce	 the	osteoblast	phenotype	upon	 in	silico	perturbation	and	predicted	 targeting	of	
osteoblast-specific	 super-enhancers.	 Annotated	 red	 dots	 are	 the	 pareto-optimal	
combinations.	 Darker	 dots	 represent	multiple	 combinations	 having	 the	 same	 score	 in	
both	 assessments.	 A	 normalized	 perturbation	 score	 of	 100	 corresponds	 to	 81%	
induction	of	the	core	adipocyte	network.	
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combination	 involves	 the	 down-regulation	 of	 IRF1	 together	with	 the	 up-regulation	 of	both	 MEF2C	 and	 RUNX3.	 From	 a	 practical	 point	 of	 view,	 micro	 RNAs	 can	 efficiently	modulate	 down-regulation	 of	 IRF1	 through	 post-transcriptional	 regulation.	 Especially	miR-23a	and	miR-24-2,	which	 are	both	 contained	 in	 the	micro	RNA	 cluster	mirn-23a,	are	 predicted	 targets	 of	 IRF1,	 according	 to	miRDB	 (Wong	 and	Wang,	 2015).	 Further	support	to	this	prediction	is	provided	by	a	previous	study	that	identified	IRF1	as	a	direct	target	of	miR-23a	resulting	in	significantly	decreased	expression	(Liu	et	al.,	2013).	The	potential	efficacy	of	the	identified	multitarget	combination	is	supported	by	previous	studies.	RUNX3-deficient	mice	show	a	decreased	number	of	active	osteoblasts	and	 bone	 formation	 deficiencies,	 which	 provides	 evidence	 that	 RUNX3	 is	 an	 integral	component	 in	 proper	 osteogenesis	 (Bauer	 et	 al.,	 2015).	 On	 the	 other	 hand,	 miR-23a,	together	 with	 miR-23b,	 is	 a	 vital	 regulator	 of	 osteoblast	 and	 adipocyte	 cell	 fate	determination	(Guo	et	al.,	2016).	In	particular,	it	has	been	shown	that	overexpression	of	these	micro	RNAs	promotes	osteoblast	differentiation	in	mesenchymal	stem	cells	while	their	 down-regulation	 promotes	 adipocyte	 differentiation.	 This	 observation	 is	confirmed	 by	 the	 transcriptomics	 data	 from	MSC-derived	 adipocytes	 and	 osteoblasts	used	in	this	analysis,	since	miR-23a/b	are	undetectable	in	adipocytes	while	being	clearly	expressed	in	osteoblasts	(143	and	85	FPKM,	respectively).		
4.3.3 Experimental Validation of Predicted Instructive Factors 	 Despite	 the	 support	 provided	 to	 the	 predictions	 by	 previous	 studies	 of	 the	individual	 factors,	 it	 is	 necessary	 to	 validate	 the	 predicted	 multitarget	 combination	experimentally.	 Mouse	 ST2	 MSCs	 from	 Whitlock-Witte	 BC8	 long-term	 bone	 marrow	culture	will	 be	 cultured	 and	differentiated	 into	 adipocytes	 as	 described	 in	 a	 previous	study	 (Gerard	 et	 al.,	 2017).	 More	 specifically,	 a	 differentiation	 medium	 consisting	 of	growth	 medium,	 5	 μg\mL	 insulin	 (Sigma-Aldrich,	 I9278),	 0.5	 mM	isobutylmethylxanthine	 (IBMX)	 (Sigma-Aldrich,	 I5879)	 and	 0.25	 μM	 dexamethasone	(DEXA)	(Sigma-Aldrich,	D4902)	will	be	added	for	two	days.	After	48	hours,	the	medium	will	be	exchanged	with	another	differentiation	medium	consisting	of	growth	medium,	5	μg/mL	 insulin	(Sigma-Aldrich,	 I9278)	and	500	nM	rosiglitazone	(RGZ)	(Sigma-Aldrich,	R2408).	The	medium	will	be	replaced	every	two	days	until	15	days	of	differentiation.	Lentiviral	 vectors,	 designed	 as	 LV-EF1A-mirn23a-CMV-MEF2C-T2A-RUNX3-T2A-eGFP,	 were	 produced.	 EF1A	 and	 CMV	 are	 constitutive	 promoters	 in	mammalian	cells	 showing	 high	 expression	 in	many	 cell	 types	 (Qin	 et	 al.,	 2010).	 These	 sequences	serve	as	gene	promoters	to	allow	the	active	transcription	of	mirn-23a,	MEF2C,	RUNX3	and	GFP.	For	expressing	multiple	genes	with	the	same	promoter,	T2A	sequences	were	
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added	 as	 separators.	 With	 it,	 polypeptide	 cleavage	 is	 mediated	 by	 skipping	 the	formation	 of	 peptide	 bonds	 and,	 thus,	 allowing	 the	 individual	 translation	 of	 MEF2C,	RUNX3	and	GFP	(Liu	et	al.,	 2017).	 In	 this	setting,	 lentiviral	 vectors	are	utilized	due	 to	their	ability	to	transduce	non-dividing	cells,	like	the	adipocytes	used	for	the	predictions	of	the	multitarget	combination.	Vectors	will	 be	 transduced	 to	 the	 differentiated	 adipocytes	deprived	 from	 the	differentiation	 medium	 and	 compared	 to	 cells	 also	 deprived	 from	 the	 differentiation	medium	but	transduced	with	a	control	virus	containing	a	GFP	reporter	only.	Successful	transduction	will	 be	 validated	by	 the	 expression	of	 the	GFP	 reporter	 contained	 in	 the	vectors	 allowing	 for	 a	 visual	 assessment	 of	 the	 transduction	 efficiency	 and	 for	fluorescence	activated	cell	sorting	(FACS),	if	needed.		 Validation	of	the	successful	conversion	will	be	organized	in	two	parts.	First,	cells	before	 and	 after	 virus	 transduction	 will	 be	 stained	 with	 Oil	 Red	 O	 and	 alkaline	phosphatase	 to	 measure	 the	 decrease	 of	 lipid	 droplets	 and	 the	 increase	 of	 alkaline	phosphatase,	 which	 is	 expressed	 in	 mineralized	 tissues	 (Golub	 and	 Boesze-Battaglia,	2007),	respectively.	Second,	qPCR	of	different	osteoblast	marker	genes,	such	as	RUNX2	and	SP7,	will	be	performed.	These	experiments	will	be	conducted	during	the	course	of	two	 weeks	 post-transduction	 for	 observing	 the	 transient	 changes	 in	 marker	 gene	expression	as	well	as	alkaline	phosphatase	activity	and	lipid	droplet	abundance.	
4.4 Reference-based Discretization of Gene Expression Data 	 Although	the	utility	of	the	developed	methodology	for	reconstructing	condition	specific	gene	regulatory	networks	has	been	highlighted	by	applications	to	the	prediction	of	 candidate	 instructive	 factors	 and	 drugs	 that	 are	 implicated	 in	 reversing	 disease	phenotypes,	 a	 significant	 disadvantage	 was	 identified.	 So	 far,	 all	 presented	 analyses	involved	 the	 comparison	 of	 only	 two	 cellular	 phenotypes	 by	 differential	 expression	analysis.	 However,	 this	 creates	 an	 isolated	 view	 on	 the	 two	 conditions	 under	 study	(Hudson	et	al.,	2012)	while	detecting	significant	differences,	but	lacks	the	possibility	of	comparing	multiple	 cell	 types	 or	 conditions.	 For	 example,	when	 considering	 the	 gene	expression	patterns	of	three	cell	types	A,	B	and	C,	the	discretized	gene	expression	of	A	is	dependent	on	the	comparison	to	either	B	or	C.	Therefore,	the	reconstructed	network	is	dependent	on	B	or	C,	as	well,	and	does	not	allow	for	the	reconstruction	of	more	than	two	condition	specific	networks	with	mutually	consistent	phenotypes.		 Unlike	differential	expression	analysis,	other	methods	have	been	developed	for	providing	discretized	values	 consistent	with	multiple	 conditions.	These	pseudo-global	approaches	rely	on	the	combined	analysis	of	multiple	time	points,	cell	types	or		
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Table	4.6.	Methods	for	comparison	against	RefBool	
	conditions.	However,	all	of	 these	methods	have	certain	 limitations	such	as	 the	 lack	of	statistical	 support	 or	 the	 sensitivity	 to	 changes	 in	 the	 analyzed	 datasets.	 In	 order	 to	overcome	the	distinct	 limitations	of	differential	expression	analysis	and	pseudo-global	approaches,	 RefBool	 was	 developed.	 Based	 on	 a	 background	 distribution	 of	 gene	expression	 profiles,	 it	 classifies	 expression	 values	 into	 active	 and	 inactive	 states	 and	provides	 the	 statistical	 significance	 for	 each	 classification.	 This	 chapter	 details	 the	validation	 of	 RefBool	 against	 10	 other	 discretizaton	 approaches	 on	 the	 basis	 of	 a	qualitative	 and	 quantitative	 analysis	 (see	 Table	 4.6	 for	 an	 overview	 of	 the	 different	methods).	 A	 dataset	 of	 675	 RNA-seq	 samples	 of	 cancer	 cell	 lines	 served	 as	 the	background	 distribution	 ((Klijn	 et	 al.,	 2014),	 Table	 S3).	 Time-series	 RNA-seq	measurements	 of	 12	 equally-spaced	 timepoints	 from	 neuroepithelial	 differentiation	experiments	were	selected	as	a	validation	dataset,	which	is	comprised	of	17088	genes	for	which	RefBool	contains	a	background	distribution	((Qiao	et	al.,	2015),	Table	S3).	This	dataset	 reflects	 the	 induced	 differentiation	 of	 human	 embryonic	 stem	 cells	 and	undergoes	distinct	stages	that	can	be	subsumed	 in	 three	categories,	embryonic	bodies	(EBs),	 embryonic	 bodies	 attached	 to	 the	 cultureware	 (attached	 EBs)	 and	 neuronal	sphere	(NS).	
Method	 Discretization	 Statistical	significance	 Reference	
BiKmeans	 Ternary	 No	 (Li	et	al.,	2010)	
BascA	 Binary	 Per	gene	 (Müssel	et	al.,	2016)	
BascB	 Binary	 Per	gene	 (Müssel	et	al.,	2016)	
kMeans	(Basc	toolkit)	 Ternary	 Per	gene	 (Müssel	et	al.,	2016)	
TascA	 Ternary	 Per	gene	 (Müssel	et	al.,	2016)	
EFD	 Binary	 No	 (Catlett,	1991;	Dougherty	
et	al.,	1995;	Kerber,	1992)	
EWD	 Binary	 No	 (Catlett,	1991;	Dougherty	
et	al.,	1995;	Kerber,	1992)	
Gallo	et	al.	 Binary	 No	 (Gallo	et	al.,	2011)	
kMeans	 Ternary	 No	 (Macqueen,	1967)	
MeanPlusEstDev	 Ternary	 No	 (Madeira	and	Oliveira,	2005)	
Current	methods	for	discretizing	transcriptomics	data.	These	approaches	either	binarize	
expression	 values	 or	 include	 a	 third	 state	 corresponding	 to	 intermediate	 expression	
(ternary	 discretization).	 Only	 the	 most	 recent	 developments	 of	 the	 Basc-Toolkit	
(including	BascA,	BascB,	kMeans	(basc)	and	TascA)	assign	statistical	significance	scores	to	
the	obtained	discretizations.	
	92	
4.4.1 Qualitative analysis of discretized neuroepithelial differentiation 
measurements 	 Despite	 the	 sole	 separation	of	 continuous	 gene	 expression	measurements	 into	active	 and	 inactive	 states,	 discretization	 methods	 should	 still	 preserve	 descriptive	characteristics	of	the	dataset.	One	important	characteristic	of	time	series	measurements	is	the	order	of	samples	that	plays	an	important	role	to	determine	causal	changes	in	the	regulation	 of	 genes.	 In	 the	 differentiation	 experiment	 of	 embryonic	 stem	 cells	 into	neuroepithelial	 cells,	 distinct	 stages	 of	 the	 development	 become	 evident	 when	clustering	 the	 samples	 hierarchically	 so	 that	 time-points	with	 similar	 transcriptomics	profile	are	close	to	each	other	(Figure	4.11).		
Figure	4.11.	Hierarchical	clustering	of	raw	expression	
	After	 discretization	 of	 the	 whole	 dataset	 with	 RefBool	 and	 all	 other	 methods,	hierarchical	 clustering	was	 performed	 using	 the	 same	 criterion	 as	 for	 the	 continuous	expression	 data	 (Figure	 4.12).	 Evidently,	RefBool	 is	 the	 only	 approach	 that	 is	 able	 to	resemble	the	clustering	of	the	continuous	data	and	correctly	groups	the	different	stages	during	the	differentiation.	The	most	common	clustering	error	is	the	relation	of	the	early	neuronal	sphere	stage	(day	18)	to	early	attached	embryonic	bodies	(days	8	and	10)	by	TascA,	BascB,	kMeans	(basc),	kMeans,	MeanPlusEstDev,	EWD,	GalloEtAl	and	BiKmeans.	Less	 common	 errors	 constitute	 the	 incorrect	 distinction	 of	 embryonic	 bodies	 from	embryonic	 stem	 cells	 by	 BascB	 and	 EFD	 or	 the	 relation	 of	 early	 attached	 embryonic	bodies	(days	8	and	10)	to	neuronal	sphere	cells	(days	18,	20	and	22)	by	BascA	and	EFD.		 RefBool’s	superior	descriptive	ability	is	further	supported	by	the	analysis	of	the	correlation	 differences	 between	 discretized	 and	 continuous	 expression	 in	 successive	
Hierarchical	 clustering	 of	 gene	
expression	 data	 resembles	 distinct	
developmental	 stages	 in	 the	
differentiation	 of	 human	 embryonic	
stem	 cells	 into	 neuroepithelial	 cells.	
(hESC:	 human	 embryonic	 stem	 cells;	
EB:	 embryonic	 bodies;	 attached	 EB:	
embryonic	bodies	attached	to	feeder-
free	 medium;	 NS:	 neural	 sphere	
corresponding	 to	 neuroepithelial	
cells)	
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samples.	 Of	 note,	 spearman	 correlation	 was	 employed	 for	 this	 assessment	 due	 to	 its	applicability	 to	 ordinal	numbers.	 On	 average,	 the	 correlation	differences	 between	 the	continuous	 and	 discretized	 data	 by	 RefBool	 amounts	 to	 only	 0.17	 whereas	 the	differences	of	all	other	methods	amount	to	at	least	0.38	(Figure	4.13).	The	significantly	increased	 concordance	 between	 successive	 timepoints	 thus	 provides	 a	 plausible	explanation	of	the	higher	clustering	resemblance.		
Figure	4.12.	Hierarchical	clustering	of	discretized	data	
	
Hierarchical	 clustering	 of	 discretized	 gene	 expression	 data	 provided	 by	 different	
methods	shows	that	only	RefBool	is	able	to	accurately	recapitulate	the	ordering	of	the	
raw	data.	Most	other	methods	wrongly	assign	the	early	neuronal	sphere	stage	(day	18)	
to	 the	early	attached	embryoid	body	state	 (days	8	and	10).	 (hESC:	human	embryonic	
stem	cells;	EB:	embryonic	bodies;	attached	EB:	embryonic	bodies	attached	to	 feeder-
free	medium;	NS:	neural	sphere	corresponding	to	neuroepithelial	cells)		
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Figure	4.13.	Correlation	differences	between	continuous	and	discretized	values	of	successive	time	
points	
	
	Due	 to	 the	 fact	 that	 RefBool	 was	 developed	 for	 discretizing	 gene	 expression	measurements,	 it	 is	 crucial	 to	 assess	 its	 ability	 to	 accurately	 identify	 active	 genes	 in	different	conditions	or	cell	types.	In	this	regard,	the	study	of	known	marker	genes	of	the	different	stages	in	the	neuroepithelial	differentiation	dataset	is	of	particular	importance.	The	 considered	 genes	 in	 this	 assessment	 are	 inner	 cell	 mass	markers	 (FGF4,	 ZFP42,	TDGF1,	 POU5F1	 and	 NANOG)	 that	 should	 be	 active	 during	 the	 first	 six	 days	 of	 the	differentiation	as	well	as	neuroectodermal	(PAX6,	ZIC1,	SOX1,	SOX3,	ZNF521	and	CDH2)	and	forebrain	markers	(FOXG1,	EMX1	and	OTX2)	that	should	become	activated	at	later	stages	of	the	differentiation.	The	TascA	method	was	selected	for	this	comparison,	since	it	is	the	most	recent	advancement	in	the	field	of	gene	expression	discretization.	
Correlation	differences	of	discretized	and	raw	data	of	adjacent	time	points	show	that	
RefBool	 most	 accurately	 resembles	 the	 trends	 in	 gene	 expression	 data.	 All	 other	
methods	 have	 similar	 error	 trends.	 This	 indicates	 a	 more	 plausible	 temporal	
ordering	of	successive	time	points.	
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Figure	4.14.	Comparison	of	RefBool	and	TascA	on	known	marker	genes	
Similar	 to	 the	 results	 of	 the	 cluster	 resemblance	 analysis,	 RefBool	 and	 TascA	 show	significant	 differences	 in	 the	 discretization	 of	 marker	 genes	 (Figure	 4.14).	 First	 and	foremost,	TascA	is	only	able	to	obtain	significant	discretizations	for	four	of	the	fourteen	genes	(false	discovery	rate	cutoff:	0.05)	while	RefBool	classifies	most	of	the	expression	values	in	different	conditions	to	be	either	active	or	inactive	(false	discovery	rate	cutoff:	0.05).	 The	 inner	 cell	 mass	 markers	 NANOG,	 POU5F1,	 TDGF1,	 ZFP42	 and	 FGF4	 are	constitutively	 active	 throughout	 the	 first	 six	 days	 of	 the	 differentiation	 and	 are	subsequently	 gradually	 down-regulated.	 On	 the	 other	 hand,	 the	 activity	 of	 OTX2	throughout	the	whole	differentiation	process	is	seemingly	unexpected	owing	to	its	role	as	a	 forebrain	marker.	However,	 an	 extensive	 study	of	 the	 role	of	OTX2	 in	 embryonic	stem	cell	determination	validated	its	expression	and	necessity	in	ESC	maintenance	and	embryoid	 body	 formation	 (Acampora	 et	 al.,	 2013).	 Similarly,	 SOX3	 and	 CDH2	 were	found	 to	 play	 a	 fundamental	 role	 in	 maintaining	 pluripotency	 (Pieters	 and	 van	 Roy,	2014;	 Abdelalim	 et	al.,	 2014)	 and	are	 therefore	 likely	 to	 be	 correctly	 classified	 in	 the	embryonic	 stem	 cell	 state.	 Strikingly,	 the	 early	 activation	 of	 ZNF521	 identified	 by	
Comparison	of	discretized	marker	genes	obtained	by	RefBool	and	TascA	(red:	inactive;	
violet:	 intermediate	 expression;	 blue:	 active,	 grey:	 insignificant).	 TascA	 only	 obtains	
significant	 discretization	 for	 EMX1,	 CDH2,	 PAX6	 and	 NANOG	 while	 determining	 all	
other	 genes	 insignificant	 (grey).	 In	 contrast,	 discretizations	 from	RefBool	 indicate	 a	
patterning	consistent	with	the	marker	genes.	
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RefBool	 was	 shown	 to	 be	 essential	 and	 sufficient	 for	 neural	 differentiation	 in	 mice	(Pieters	 and	 van	 Roy,	 2014).	 The	 remaining	 forebrain	 and	 neuroectodermal	 marker	genes	were	found	to	be	active	after	six	days	of	differentiation	and	were,	thus,	correctly	classified.		 TascA,	in	contrast,	provides	significant	discretizations	for	only	four	genes.	Recall	that	 TascA	 assesses	 the	 significance	 of	 the	 discretization	 per	 gene	 while	 RefBool	performs	 more	 fine-grained	 significance	 analysis	 per	 expression	 value.	 Most	importantly,	TascA	does	not	classify	PAX6	and	EMX1	as	constitutively	active	at	the	later	stages	 of	 differentiation	 but	 identifies	 a	 rather	 dispersed	 pattern.	 Similarly,	 the	functional	 importance	 of	 CDH2	 in	 embryonic	 stem	 cells	 is	 not	 captured,	 as	 it	 is	 not	classified	 to	 be	 active.	 The	 expression	 of	 NANOG	 seems	 to	 be	 the	 only	 reasonably	discretized	 pattern	 being	 active	 in	 embryonic	 stem	 cells	 and	 embryoid	 bodies	 and	inactive	(down-regulated)	during	the	formation	of	neuroepithelial	cells.		 Overall,	 RefBool	 shows	 clear	 advantage	 in	 the	 qualitative	 description	 of	phenotypes	with	respect	to	the	accurate	recapitulation	of	developmental	processes	and	the	 discretization	 of	 known	 marker	 genes.	 Especially	 the	 dynamic	 expression	 of	important	 genes	 for	maintenance	 of	 embryonic	 stem	 cells	 is	 accurately	 captured	 and	overall	 highlights	 the	 descriptive	 power	 of	 the	 approach	 even	 when	 applying	 strict	significance	thresholds.		
4.4.2 Quantitative Assessment of Discretization with RefBool 	 Apart	from	the	increased	descriptive	ability	of	RefBool,	it	is	important	to	analyze	and	compare	the	discretized	gene	expression	profiles	quantitatively	against	the	results	of	other	methods.	There	exist	two	different	categories	for	validating	cluster	consistency,	external	 and	 internal	 clustering	 indices.	 External	 clustering	 indices	 rely	 on	 additional	information	 that	 validates	 the	 correct	 clustering	 while	 internal	 indices	 quantify	 the	clustering	consistency	based	on	 features	derived	 from	the	original	dataset.	Due	 to	 the	absence	 of	 a	 ground	 truth	 for	 determining	 whether	 genes	 are	 active	 or	 inactive,	 the	following	analysis	quantifies	consistency	based	on	internal	indices.	More	specifically,	the	internal	 clustering	 indices	 utilized	 in	 this	 assessment	 are	 Ksq_DetW	 (Marriott,	 1971),	Ray-Turi	(Ray	and	Turi,	1999),	SD	(Halkidi	et	al.,	2001),	Trace_W	(Edwards	and	Cavalli-Sforza,	 1965),	 Trace_WiB	 (Friedman	 and	 Rubin,	 1967),	 Wemmert	 Gancarski	(WEMMERT	et	al.,	2000)	and	Xie-Beni	(Xie	and	Beni,	1991),	which	are	implemented	in	the	 clusterCrit	 R-package	 (Desgraupes,	 2013).	 All	 of	 these	 metrics	 assess	 either	 the	within-cluster	scattering,	the	between-cluster	separation	or	a	weighted	combination	of	
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both.	 An	 overview	 of	 how	 the	 different	 indices	 can	 be	 compared,	 i.e.	 whether	 the	minimum	or	maximum	value	constitutes	the	best	clustering,	can	be	found	in	Table	4.7.		
Table	4.7.	Rules	for	determining	best	clustering	
Index	 Rule	for	best	clustering	
Ksq_DetW	 Max	
Ray-Turi	 Min	
SD	 Min	
Trace_W	 Max	
Trace_WiB	 Max	
Wemmert	Gancarski	 Max	
Xie-Beni	 Min	
	 All	clustering	indices	were	calculated	on	a	per	gene	basis	for	the	discretizations	obtained	by	RefBool	 and	 the	other	 approaches	previously	presented	 in	 the	qualitative	comparison.	In	particular,	the	clustering	indices	are	calculated	for	each	gene	separately	on	 the	 basis	 of	 the	 neuroepithelial	 RNA-seq	 dataset.	RefBool	 is	 then	 said	 to	 perform	better	 (worse)	 in	 clustering	 a	 gene	 if	more	 clustering	 indices	 are	better	 (worse)	with	respect	to	the	rules	in	Table	4.7.	Importantly,	some	indices	might	not	be	able	to	assess	the	 quality	 due	 to	 the	 composition	 of	 the	 expression	 values	 for	 each	 gene	 and	 are	therefore	excluded	from	the	comparison.	In	case	of	ties	in	the	number	of	superior	and	inferior	clustering	indices,	a	third	category	indicating	the	equality	of	the	clustering	will	be	described.	The	results	of	this	assessment	are	summarized	in	Figure	4.15.	It	is	evident	that	RefBool	outperforms	all	other	methods	and	classifies	at	least	27.7%	of	genes	more	consistently	 than	 other	 methods	 (mean:	 40.4%).	 On	 the	 other	 hand,	 on	 average,	 the	discretization	of	only	44	genes	(0.26%)	is	worse	when	compared	to	existing	approaches.	Of	 note,	 the	 performance	 against	 TascA,	 the	 most	 recently	 introduced	 method	 for	discretizing	gene	expression	data,	is	highly	elevated	and	results	in	60.4%	higher	cluster	consistency.	In	 order	 to	 support	 the	 increased	 accuracy	 of	 RefBool	 and	 to	 investigate	 the	generalizability	 of	 the	 approach	 to	 other	 experimental	 transcriptional	 profiling	techniques,	the	same	quantitative	assessment	was	performed	for	microarray	expression	
Each	 cluster	 consistency	 index	used	 for	 validating	 the	discretized	datasets	 is	 assigned	a	
rule	 for	comparing	different	values.	 ‘Min’	means	 that	 the	minimum	value	 is	 the	superior	
while	‘Max’	shows	that	the	maximum	consistency	value	is	regarded	as	the	best	score.	
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data.	A	 compiled	dataset	 of	 27887	microarray	 samples	 ((Torrente	et	al.,	 2016),	Table	S3),	which	 comprises	 47000	probesets,	 served	as	 the	 basis	 of	 the	 previously	detailed	analysis.	 The	 first	 ten	 samples	 of	 this	 set	 were	 used	 for	 discretization	 and	 cluster	consistency	 assessments	while	 the	 remaining	 samples	built	 the	 reference	distribution	for	 RefBool.	 Evidently,	 the	 obtained	 results	 substantiate	 the	 improvements	 of	 the	developed	reference-based	discretization	(Figure	4.16).	However,	even	though	RefBool	performs	 similarly	 against	 TascA,	 having	 60.8%	 more	 consistent	 clusterings,	 the	improvements	 against	 other	 methods	 decreased	 compared	 to	 RNA-seq	 data.	 Better	discretizations	are	obtained	in	at	least	16.8%	of	probesets	(mean:	31.6%)	compared	to	only	0.01%	less	consistent	clusterings	totaling	5	out	of	47000	probesets.		
Figure	4.15.	Quantitative	comparison	of	RefBool	against	other	methods	in	clustering	RNA-seq	data	
	
Quantitative	comparison	of	RefBool	against	other	state-of-the-art	methods	on	the	basis	
of	 internal	 clustering	 indices.	 The	 assessment	was	 conducted	 on	 17088	genes	 in	 12	
RNA-seq	measurements	 of	 a	 neuroepithelial	 differentiation	 study.	 Evidently,	RefBool	
provides	 the	most	 consistent	 clustering	with,	 on	 average,	 40.4%	 better	 (green)	 and	
0.26%	 worse	 (red)	 discretizations	 per	 gene.	 All	 other	 genes	 resulted	 in	 an	 equal	
number	of	superior	and	inferior	consistency	scores	(blue).		
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Figure	4.16.	Clustering	consistency	assessment	on	microarray	data.	
	
	 Overall,	the	developed	reference-based	discretization	approach	provides	better	qualitative	and	quantitative	results	 than	other	currently	used	state-of-the-art	methods	for	classifying	genes	as	active	or	inactive	based	on	transcriptomics	data.	Especially	the	predominantly	correct	classification	of	biologically	relevant	marker	genes	in	the	context	of	 neuroepithelial	 differentiation	 supports	 the	 application	 in	 the	 context	 of	 gene	regulatory	network	inference.		
4.4 Chapter Summary  	 This	 chapter	 described	 the	 results	 of	 the	 proposed	 Boolean	 condition-specific	gene	 regulatory	 network	 inference	 method,	 including	 a	 strategy	 for	 identifying	candidate	 instructive	 factors	 for	 cellular	 conversions	 and	 the	 selection	 of	 multitarget	combinations	 thereof.	 The	 strategy	 was	 applied	 to	 disease-control	 case	 studies	 of	Systemic	Lupus	and	Rheumatoid	Arthritis	where	potential	therapeutic	compounds	were	selected	based	on	 their	reported	effects	 in	multitarget	combinations.	Validation	of	 the	reconstructed	networks	with	transcription	factor	binding	site	ChIP-seq	data	revealed	an	elevated	condition	specificity	in	comparison	to	other	state-of-the-art	methodologies	by	retaining	most	of	the	experimentally	determined	regulatory	interactions.	
Quantitative	 comparison	 of	 RefBool	 against	 other	 state-of-the-art	 methods	 on	 the	
basis	 of	 internal	 clustering	 indices	 for	 47000	 microarray	 probesets	 in	 27887	
samples.	Evidently,	RefBool	provides	the	most	consistent	clustering	with,	on	average,	
31.6%	better	(green)	and	0.01%	worse	(red)	discretizations	per	gene.	The	remaining	
genes	 showed	 no	 differences	 in	 the	 number	 of	 superior	 and	 inferior	 clustering	
indices	(blue).			
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To	 overcome	 the	 widespread	 absence	 of	 condition	 specific	 epigenetic	information,	 a	 machine-learning	 approach	 for	 predicting	 gene-level	 chromatin	accessibility	 from	 transcriptomics	 data	 was	 developed	 that	 can	 be	 readily	 integrated	into	 the	Boolean	gene	regulatory	network	 framework.	A	 thorough	comparison	against	traditional	computational	downstream	analysis	tools	for	chromatin	accessibility	assays	supports	 the	 reliability	 of	 the	 predictions.	 In	 addition,	 the	 predicted	 gene-level	accessibility	 can	 be	 utilized	 for	 obtaining	 more	 reliable	 peak	 calling	 parameters	 by	increasing	the	number	of	correctly	identified	accessible	chromatin	regions.	With	 it,	a	multitarget	combination	of	candidate	 instructive	 factors	 for	 inducing	the	cellular	conversion	of	adipocytes	 into	osteoblasts	was	derived	 from	an	 integrative	network	 reconstruction	 and	 analysis	 approach	 involving	 transcriptomics,	 epigenetics	and	prior	knowledge	networks.	Finally,	RefBool	was	developed,	a	reference-based	method	for	discretizing	gene	expression	 data	 that	 does	 not	 require	 multiple	 replicates	 of	 the	 same	 condition	 and	provides	 statistical	 confidence	 to	 each	 discretized	 expression	 value.	 In	 contrast	 to	differential	 expression	 analysis,	 RefBool	 provides	 an	 absolute	 discretization	independent	 of	 the	 condition	 it	 is	 compared	 to,	 thus	 allowing	 for	 the	 comparison	 of	multiple	 cell	 types	 or	 conditions.	 Moreover,	 quatitative	 and	 qualitative	 analyses	highlight	the	increased	performance	in	comparison	to	current	methodologies,	which	is	underlined	 by	 an	 accurate	 resemblance	 of	 marker	 gene	 expression	 in	 induced	neuroepithelial	differentiation.		 In	the	Discussion	chapter	these	methods	and	their	results	are	considered	in	the	context	 of	 the	 challenges	 in	 gene	 regulatory	 network	 inference	 that	 complicate	 the	identification	 of	 instructive	 factors	 for	 cellular	 conversions.	 Also,	 the	 particular	advantages	 and	disadvantages	of	 the	different	methodologies	 are	outlined,	 and	 future	directions	 are	 pinpointed	 to	 provide	 more	 realistic	 gene	 regulatory	 networks	 and	ultimately	more	efficient	combinations	of	instructive	factors.		 	
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CHAPTER 5 Discussion 	 Cellular	 reprogramming	 is	 perhaps	 the	 most	 promising	 strategy	 towards	patient-specific	 therapeutic	 interventions	 for	 treating	 disease	 pathologies.	 After	 the	groundbreaking	 finding	 that	 the	 cellular	 conversion	 of	 somatic	 cells	 into	 pluripotent	stem	 cells	 can	 be	 induced	 by	 ectopic	 expression	 of	 only	 four	 transcription	 factors	(Yamanaka	factors),	great	efforts	have	been	devoted	to	understand	the	underlying	gene	regulatory	 network	 (Li	 and	 Belmonte,	 2017).	 As	 a	 result,	 a	 complex	 circuitry	 of	intertwined	 transcriptional	 and	 epigenetic	 regulation	was	 identified	 that	 orchestrates	the	 activation	 of	 the	 pluripotency	 program	 of	 cells.	 In	 particular,	 two	 of	 the	 four	identified	transcription	factors,	i.e.	SOX2	and	OCT4,	are	mutually	regulating	themselves	(Kashyap	 et	 al.,	 2009)	 for	 keeping	 up	 their	 expression	 in	 an	 equilibrium	 state	 while	initiating	 the	rearrangement	of	 the	global	chromatin	conformation	(Soufi	et	al.,	2012).	Cooperation	of	 transcription	 factors	eventually	elicit	 the	activation	of	genes	necessary	and	sufficient	for	establishing	and	maintaining	pluripotency	(Soufi	et	al.,	2015).		 Besides	the	instructive	factors	for	inducing	pluripotency,	other	combinations	of	genes	have	been	identified	and	implicated	in	the	direct	cellular	conversion	of	cell	types	belonging	 to	 distinct	 lineages	 (Ieda	 et	 al.,	 2010;	 Szabo	 et	 al.,	 2010;	 Son	 et	 al.,	 2011).	However,	 due	 to	 the	 limited	 understanding	 of	 the	 underlying	 the	 gene	 regulatory	network	 and	the	dynamic	 formation	of	 accessible	and	 inaccessible	 chromatin	 regions,	which	eventually	enable	or	inhibit	transcription,	current	screening	strategies	for	novel	combinations	of	instructive	factors	are	time	consuming	and	expensive.	In	particular,	the	most	 commonly	 followed	 strategy	 is	 a	 combinatorial	 approach	 with	 which	 the	Yamanaka	factors	were	identified	(Takahashi	and	Yamanaka,	2016).	Starting	with	a	list	of	 candidate	 transcription	 factors	or	microRNAs	that	 are	assumed	 to	 regulate	 the	 cell	fate	or	are	involved	in	differentiation,	the	list	is	gradually	decreased	until	a	minimal	set	of	factors	is	identified	that	induce	the	desired	transition.		 The	development	of	computational	tools	constitutes	a	promising	alternative	 to	the	above-mentioned	approach	and	enables	the	a	priori	in	silico	evaluation	of	candidate	instructive	 factors.	 With	 such	 computational	 approaches,	 both	 screening	 times	 and	experimental	 costs	 could	be	 significantly	 reduced	by	preselecting	 the	most	 reassuring	combinations.	 Due	 to	 the	 availability	 of	 high	 throughput	 sequencing	 technologies	 for	quantifying	 RNA	 abundance	 and	 the	 resulting	 ability	 of	 integrating	 transcriptional	information	 from	 large	amounts	of	diverse	cell	types,	 this	area	of	 research	has	gained	increasing	attention.		 Of	 these	 developed	 methods	 for	 identifying	 instructive	 factors	 of	 cellular	conversions,	 network	 based	 approaches	 are	 of	 special	 interest,	 since	 they	 offer	 the	
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possibility	 of	 understanding	 the	 regulatory	 mechanisms	 leading	 to	 stabilization	 and	destabilization	 of	 cellular	 phenotypes.	 However,	 current	 methodologies	 suffer	 from	certain	important	limitations.	First,	the	input	to	those	methods	is	mostly	static	and,	thus,	cannot	be	 customized	 towards	new,	unseen	experimental	 data	(Rackham	et	al.,	 2016)	or,	second,	demand	substantial	amounts	of	data	for	tailoring	it	to	the	desired	cell	types	(Cahan	et	al.,	2014).	At	last,	network	models	represent	different	cell	types	or	conditions	within	 the	 same	 topology	 (Crespo	 et	 al.,	 2013;	 Cahan	 et	 al.,	 2014)	 even	 though	experimental	 evidence	 verified	 the	 existence	 of	 differential	 regulatory	 interactions	(Song	et	al.,	2011).	Although	it	is	difficult	to	assess	the	correspondence	of	reconstructed	gene	 regulatory	 networks	 with	 the	 real	 regulatory	 circuitry,	 these	 methods	 might	misrepresent	the	regulatory	interactions	of	at	least	one	phenotype.		 The	differential	network	analysis	approach	presented	in	this	thesis	is	justified	by	the	large-scale	profiling	of	epigenetic	data,	such	as	chromatin	accessibility	and	covalent	histone	 modifications,	 that	 revealed	 the	 structural	 differences	 of	 active	 regulatory	elements	in	diverse	cell	types	(Ernst	and	Kellis,	2012;	Song	et	al.,	2011).	It	is,	therefore,	rational	 to	 attempt	 the	 integration	 of	 an	 epigenetic	 layer	 into	 the	 gene	 regulatory	network	 for	 explaining	 the	 differential	 regulatory	 mechanisms	 modulating	 distinct	phenotypes.	With	current	technology	of	epigenetic	and	transcriptional	profiling	as	well	as	transcription	factor	target	identification,	the	reconstruction	of	cell	type	or	condition	specific	 networks	 became	 feasible.	 An	 accurate	 inference	 of	 the	 gene	 regulatory	networks	seems	eventually	necessary	for	enhancing	the	understanding	of	the	complex	transcriptional	 landscape	 to	 identify	 important	 genes	 whose	 deregulation	 induces	 a	desired	cellular	conversion.		
5.1 Cell-type specific network reconstruction and differential network 
analysis 	 	The	differential	network	analysis	and	reconstruction	approach	proposed	in	this	thesis	 accounted	 for	 the	 differences	 of	 cellular	 gene	 regulatory	 network	 topologies	between	 different	 cell	 types	 and	 addressed	 two	 distinct	 aspects.	 First,	 the	reconstruction	of	cell	type	specific	networks	considers	the	regulatory	differences	in	the	network	 topology	 that	 might	 be	 responsible	 for	 stabilizing	 the	 cellular	 phenotype.	Second,	 the	premise	 for	 the	 approach	 is	 the	 general	applicability	 to	diverse	 cell	 types	and	 cellular	 conditions.	 Thus,	 it	 only	 requires	 a	 single	 transcriptional	 readout	 for	 the	initial	 and	 final	 cell	 type	 as	 well	 as	 a	 prior	 knowledge	 network	 obtained	 from	proprietary	 or	 public	 databases.	 Modeling	 gene	 regulation	 within	 the	 Boolean	
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framework	enabled	 the	 joint	 realization	of	 these	 goals.	While	Boolean	networks	are	 a	rather	 coarse	 approximation	 of	 the	 regulatory	 behavior,	 their	 utility	 in	 describing	cellular	phenotypes	and	transitions	upon	perturbation	has	been	highlighted	previously	(Albert	and	Othmer,	2003).	Besides	 the	 topological	 insights	obtained	 from	differential	 network	 analysis,	 it	enabled	the	 identification	of	candidate	 instructive	 factors	 for	 inducing	desired	cellular	conversions.	 In	 the	 context	 of	 chemically	 induced	 alterations	 of	 the	 gene	 regulatory	networks,	important	genes	have	been	pinpointed	whose	perturbation	is	prone	to	induce	the	 phenotype	 after	 treatment.	 In	 the	 context	 of	 drug	 prioritization,	 the	 phenotypic	changes	 induced	 by	 Cobalt	 chloride	 include	 the	 down-regulation	 of	 two	 reported	pioneer	 factors,	 ASCL1,	 SOX2	 (Vierbuchen	 et	 al.,	 2010;	 Soufi	 et	 al.,	 2012).	 As	 a	consequence,	 large-scale	epigenetic	changes	can	be	expected	that	in	turn	influence	the	transcriptional	 regulation	 of	 other	 genes	 in	 the	 network.	 Even	 without	 including	epigenetic	 information	 in	 this	 analysis,	 the	 developed	 differential	 network	 analysis	methodology	was	able	to	pinpoint	these	genes	as	candidates	for	inducing	the	observed	changes.	 The	 accuracy	 in	 recognizing	 important	 stability	 determinants	 is	 further	underlined	by	 the	proposed	prioritization	scheme	 for	selecting	compounds	 inducing	a	desired	cellular	transition.	In	all	examples	of	induced	changes	with	known	compounds,	the	drug	target	enrichment	in	in	silico	perturbations	was	shown	to	be	predictive	of	the	correct	compound.	The	sensitivity	of	this	analysis	has	been	underlined	by	the	ability	to	correctly	predict	the	used	compounds	while	showing	comparable	enrichment	results	for	drugs	inducing	similar	phenotypes,	i.e.	the	drugs	are	predicted	to	have	similar	functions.	It	 further	 provides	 support	 for	 the	 qualitative	 ability	 of	 the	 network	 to	 prioritize	combinations	of	candidate	instructive	factors	that	are	able	to	induce	a	desired	cellular	transition.	 In	 particular,	 the	 enrichment	 of	 drug	 effects	 in	 simulated	 multitarget	combinations	 solely	 relies	 on	 the	 simulated	 effects	 of	 perturbations	 to	 the	 network	attractor.	 Therefore,	 a	 correct	 drug	 prioritization	 requires	 the	 network	 to	 identify	essential	regulators	and	reflect	their	importance	in	the	network	dynamics.	After	validating	the	differential	network	analysis	pipeline	for	prioritizing	drugs	according	 to	 their	 expected	 efficacy	 based	 on	 known	 drug	 effects,	 its	 application	 to	Rheumatoid	 Arthritis	 and	 Systemic	 Lupus	 Erythematodes,	 two	 autoimmune	 diseases,	provided	 continued	 support	 for	 the	 sensitivity	 of	 the	 approach.	 In	both	 cases,	 current	state-of-the-art	 therapeutics	 were	 predicted	 alongside	 potentially	 novel	 candidates.	However,	 since	 the	method	 is	 only	 based	 on	 previously	 reported	phenotypic	 changes	induced	 by	 the	 enriched	 drugs,	 their	 efficacy	 cannot	 be	 concluded.	 Other	 important	aspect	 such	 as	 toxicity,	 concentration	 and	 susceptibility	 of	 the	 cells	 for	 uptake	 are	
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disregarded.	 Therefore,	 this	 approach	 solely	 enables	 the	 prioritization	 of	 promising	drugs	 for	 further	 screening.	 Nevertheless,	 the	 results	 of	 the	 analysis	 suggest	 that	 the	developed	 analysis	 approach	 constitutes	 a	 helpful	 tool	 for	 reducing	 the	 number	 of	screened	drugs	significantly.	The	particular	advantages	and	limitations	of	the	developed	differential	network	reconstruction	 methodology,	 which	 constitutes	 the	 basis	 of	 the	 drug	 prioritization	strategy,	are	discussed	in	the	remainder	of	this	section.		
5.1.1 Advantages of this approach 		 The	 presented	 approach	 offers	 several	 advantages	 in	 the	 identification	 of	combinations	 of	 instructive	 factors	 for	 inducing	 cellular	 transitions.	 First,	 by	 using	available	 biological	 knowledge	 about	 gene	 regulatory	 interactions	 in	 form	 of	 prior	knowledge	 networks,	 an	 appropriate	 search	 space	 for	 the	 network	 reconstruction	process	 can	 be	 defined.	 The	 wealth	 of	 manually	 curated,	 functional	 regulatory	interactions	that	have	been	obtained	in	the	past	through	a	combination	of	DNA	binding	experiments	 (ChIP-seq)	 and	 gene	 knockouts	 have,	 thus	 far,	 not	 been	 systematically	exploited	in	the	reconstruction	of	gene	regulatory	networks.	However,	it	constitutes	an	indispensable	resource	 in	 the	search	 for	accurate	network	models,	particularly	due	 to	the	 infeasibility	 of	 large	 scale	de	novo	 network.	 For	 instance,	 the	 approximately	1700	known	 or	 predicted	 transcription	 factors	 (Zhang	 et	 al.,	 2015)	 alone	 could,	 in	 theory,	establish	 2,890,000	 regulatory	 interactions	 among	 themselves,	 which	 would	 require	vast	amounts	of	heterogeneous	datasets	to	stratify	for	actual	and	unreal	interactions.	By	using	public	 or	proprietary	databases,	 like	MetaCoreTM,	 that	 already	 contain	manually	curated	 and	 experimentally	 validated	 information	 about	 gene	 regulatory	 interactions	observed	in	diverse	cell	or	tissue	types,	the	search	space	can	be	significantly	reduced	to	a	 few	 thousand	 interactions.	 Furthermore,	 networks	 reconstructed	 from	 prior	knowledge	 databases,	 using	 the	 proposed	 differential	 network	 reconstruction	methodology,	retain	most	of	the	cell	type	specific	experimentally	validated	interactions,	which	provides	support	to	the	chosen	strategy.	However,	it	is	of	note	that	the	utilization	of	DNA	binding	experiments	for	validation	can	only	support	the	existence	of	interactions	rather	than	their	absence.	There	is	a	wealth	of	reasons	why	downstream	computational	tools	 do	 not	 detect	 certain	 interactions.	 On	 one	 hand,	 the	 antibody	 used	 for	 the	experimental	 assay	 should	 show	 high	 sensitivity	 against	 the	 target	 protein	while	 not	being	 cross-reactive	with	 other	 related	 protein	 family	members	 (Kidder	 et	al.,	 2011).	However,	this	cannot	be	guaranteed	for	all	proteins.	On	the	other	hand,	computational	
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methods	 for	 detecting	 regions	 significantly	 enriched	 in	 reads	 require	 the	 setting	 of	various	 parameters,	 such	 as	 the	 false	 discovery	 rate	 (FDR).	 Generally,	 lower	 false	discovery	rates	render	less	but	more	certain	interactions	while	higher	thresholds	result	in	more	false	positives	(Thomas	et	al.,	2017).	Since	an	optimal	parameter	setting	is	not	a	priori	 known,	 the	 datasets	 used	 for	 validating	 the	 condition	 specificity	 of	 the	reconstructed	 networks	were	 processed	with	 low	 false	 discovery	 rates	 for	 increasing	the	certainty	in	the	observed	interactions.		 Secondly,	 the	 differential	 network	 analysis	 greatly	 helps	 in	 pinpointing	important	 network	 structures,	 such	 as	 regulatory	 feedback	 loops	 and	 genes	 under	differential	 regulation,	 for	 reducing	 the	 search	 space	 of	 candidate	 instructive	 factors.	Previous	 approaches	 mainly	 relied	 on	 the	 identification	 of	 positive	 feedback	 loops	(Crespo	 et	 al.,	 2013)	 or	 hub	 genes	 (Cahan	 et	 al.,	 2014)	 in	 the	 network	 structure.	However,	the	combination	of	positive	and	negative	feedback	loops	in	Boolean	networks	could	lead	to	network	stabilization	(Remy	and	Ruet,	2008),	since	they	are	embedded	in	a	 greater	 network	 structure	 controlling	 them.	 Furthermore,	 negative	 feedback	 loops	have	 also	 been	 reported	 in	 real	 biological	 networks	 and	 occur,	 for	 example,	 in	 the	transcriptional	 control	 of	 P53	 (Brown	 et	 al.,	 2009).	 Therefore,	 the	 perturbation	 of	negative	 feedback	 loops	 in	 the	 reconstructed	 networks	 has	 to	 be	 considered	 for	identifying	 candidate	 instructive	 factors.	 On	 the	 other	 hand,	 the	 proposed	 context	specific	gene	regulatory	network	reconstruction	allows	for	the	selection	of	genes	under	differential	 regulation,	 i.e.	 genes	 whose	 set	 of	 regulators	 differ	 in	 the	 two	 networks.	These	genes	 constitute	 important	perturbation	 targets,	as	 their	discretized	expression	cannot	be	explained	with	one	network	topology.	Support	for	this	assertion	is	provided	by	 the	 selected	 candidate	 instructive	 factors	 for	 reverting	 the	 disease	 phenotypes	 of	Systemic	 Lupus	 Erythematodes	 and	 Rheumatoid	 Arthritis.	 In	 particular,	 STAT1,	 a	marker	 gene	 for	 onset	 and	 activity	 of	 Systemic	 Lupus	 (Liang	 et	 al.,	 2014),	 as	 well	 as	TCF7L2	 and	 CDKN1A,	 which	 are	 associated	 to	 the	 Rheumatoid	 Arthritis	 (Mota	 et	 al.,	2012;	Perlman	et	al.,	2003),	have	been	identified	as	differentially	regulated.		 Lastly,	 the	 proposed	 network	 reconstruction	 approach	 is	 able	 to	 readily	integrate	gene-level	accessibility	for	removing	genes	in	inaccessible	chromatin	domains,	which	cannot	be	regulated	and	cannot	regulate	other	genes.	Thus,	the	context	specificity	of	 the	 networks	 is	 expected	 to	 increase.	 In	 contrast,	 other	 methodologies	 modeling	multiple	phenotypes	within	a	single	network	topology	do	not	allow	for	the	integration	of	cell	 type	 specific	 information,	 since	 it	 requires	 distinct	 alterations	 to	 the	 network	topology.		
	106	
5.1.2 Limitations 	 Despite	 the	advantages	of	 the	developed	methodology,	network	reconstruction	within	a	Boolean	framework	has	certain	limitations.	For	instance,	it	requires	the	choice	of	logic	rules	determining	when	a	gene	is	expressed	given	the	state	of	its	regulators.	In	living	systems,	these	logic	rules	are	gene-specific	and	are	determined	by	several	aspects.	For	example,	binding	sites	of	different	regulators	that	are	sufficiently	close	to	each	other	are	likely	to	be	mutually	exclusive,	i.e.	only	one	regulator	can	bind.	However,	in	contrast	to	 this	 complexity,	 the	 reconstructed	networks	 in	 this	 thesis	 simplified	 this	notion	by	using	 a	 majority	 rule,	 which	 determines	 the	 gene’s	 state	 based	 on	 whether	 most	regulators	are	active	or	inactive.	Even	though	cellular	gene	regulatory	networks	possess	a	robust,	redundant	design	(Macneil	and	Walhout,	2011),	which	supports	the	choice	of	a	majority	 rule,	 and	 all	 regulatory	 interactions	 in	 the	 prior	 knowledge	 networks	 have	been	 experimentally	 validated,	 the	 choice	 of	 the	 same	 logic	 rule	 for	 each	 gene	constitutes	a	simplification.	However,	this	issue	is	not	unique	to	Boolean	modeling	but	pertains	to	all	 logic	modeling	frameworks	such	as	ordinary	differential	equations.	This	leaves	 it	 an	 important	 direction	 for	 future	 research.	 However,	 due	 to	 the	 conferred	robustness	and	redundancy	of	the	majority	rule,	it	constitutes	a	reasonable	assumption	for	reconstructing	gene	regulatory	networks.		 Another	 important	 aspect	 constitutes	 the	 utilization	 of	 available	 biological	knowledge	 for	 reconstructing	 gene	 regulatory	 networks.	 On	 one	 hand,	 this	 approach	limits	 the	 search	 space	 to	 a	 tractable	 amount	 of	 potential	 interactions,	 as	 described	earlier	 in	 this	 chapter,	 which	 is	 an	 important	 advantage	 over	methods	 without	 prior	knowledge.	 On	 the	 other	 hand,	 however,	 the	 impossibility	 of	 de	 novo	 interaction	identification	creates	a	significant	dependence	of	the	networks	on	the	knowledge	base.	Therefore,	 the	 utilization	 of	 a	 reliable	 database	 is	 essential	 for	 accurate	 network	reconstruction.	Previous	approaches	relying	on	prior	knowledge	networks	of	regulatory	interactions	use	ChIP-seq	derived	 interactions	whose	mode	of	 action	 is	 undetermined	(CellNet	 (Cahan	 et	 al.,	 2014))	 or	 text-mining	 based	 approaches	 such	 as	 the	 ResNet	mammalian	database	(Crespo	et	al.,	2013).	In	contrast,	MetaCoreTM,	which	has	been	used	throughout	 this	 thesis,	 contains	manually	 curated	 interactions	 whose	mode	 of	 action	was	 predominantly	 experimentally	 validated	 and	 as	 such	 constitutes	 a	 valuable	 and	accurate	resource	of	prior	knowledge	networks.		 Finally,	the	proposed	approach	for	integrating	epigenetics	information	currently	only	involves	the	static	removal	of	genes	in	inaccessible	chromatin	domains.	However,	such	 a	network	 cannot	 explain	 the	dynamic	 changes	 that	must	be	 induced	during	 the	desired	cellular	transitions.	Nonetheless,	the	epigenetic	information	provides	additional	
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support	 for	 the	 selection	 of	 stability	 determinants	 and	 differentially	 regulated	 genes	during	network	analysis	and,	ultimately,	the	deduction	of	candidate	instructive	factors.		
5.2 Prediction of gene-level chromatin accessibility 	 The	accessibility	landscape	of	cells	plays	an	important	role	in	the	transcriptional	regulation	of	genes,	since	active	regulatory	elements,	such	as	enhancers	and	promoters,	were	 identified	 to	be	 located	 in	accessible	 chromatin	domains	 (A	P	Boyle	et	al.,	 2008;	Song	 et	 al.,	 2011;	 Thurman	 et	 al.,	 2012).	 In	 order	 to	 identify	 these	 active	 regulatory	elements,	several	experimental	assays	have	been	utilized,	e.g.	DNase-seq,	FAIRE-seq	and	ATAC-seq	(Song	et	al.,	2011;	Buenrostro	et	al.,	2013),	and	required	the	development	of	downstream	 computational	 tools,	 i.e.	 peak	 callers,	 for	 detecting	 genomic	 regions	significantly	enriched	in	aligned	reads.		However,	a	previous	study	comparing	the	most	widely	used	peak	calling	methodologies,	Hotspot	(John	et	al.,	2011),	MACS	(Zhang	et	al.,	2008),	F-Seq	(Alan	P	Boyle	et	al.,	2008)	and	ZINBA	(Rashid	et	al.,	2011),	found	that	the	overlap	of	detected	peaks	 amounts	 to	only	11%	(Koohy	et	al.,	 2014).	 In	 addition,	 the	reliability	 of	 these	 methodologies	 is	 heavily	 dependent	 on	 the	 particular	 parameter	settings,	which	are	usually	not	known	a	priori	(Koohy	et	al.,	2014).	In	contrast	to	these	methodological	 issues,	 the	 availability	 of	 chromatin	 accessibility	 assays	 is	 still	 limited	for	specialized	cell	types	or	conditions.	In	order	 to	 address	 these	 limitations,	 a	machine-learning	 framework	has	been	developed	 that	 predicts	 chromatin	 accessibility	 based	 on	 transcriptomics	 data.	Importantly,	instead	of	predicting	the	actual	enriched	genomic	regions,	the	method	aims	at	 identifying	 the	 gene-level	 accessibility,	 i.e.	 whether	 a	 gene	 is	 located	 in	 accessible	chromatin	 domains,	 for	 readily	 integrating	 the	 information	 in	 the	 proposed	 Boolean	network	 model.	 Since	 machine-learning	 approaches	 rely	 on	 the	 identification	 of	patterns	in	known	datasets,	the	use	of	computationally	processed	accessible	chromatin	assays	was	unavoidable,	 despite	 their	 known	 limitations.	The	 choice	 for	 experimental	DNase-seq	datasets	that	were	processed	with	current	downstream	computational	tools	relied	on	two	considerations.	First,	DNase-seq	data	shows	a	higher	signal-to-noise	ratio	compared	to	FAIRE-seq	(Tsompana	and	Buck,	2014),	which	makes	the	identification	of	peaks	 more	 reliable.	 Second,	 Hotspot	 shows	 the	 least	 sensitivity	 to	 its	 parameter	settings	 (Koohy	 et	 al.,	 2014)	 and	 was,	 thus,	 chosen	 for	 the	 identification	 of	 DNase	hypersensitive	sites.	Based	on	cell	type	specific	gold	standard	datasets	including	transcription	factor	binding	site	ChIP-seq	 and	heterochromatin	 regions	defined	by	 a	 combination	of	 three	
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histone	modifications,	H3K4me3,	H3K9me3	and	H3K36me3,	 the	conceived	 framework	was	evaluated.	Importantly,	the	definition	of	heterochromatin	regions	in	these	datasets	does	 not	 include	 polycomb	 repressed	 sites,	 defined	 by	 H3K27ac,	 which	 are	 usually	considered	 to	 be	 epigenetically	 silenced.	 An	 integrative	 analysis	 of	 111	 human	epigenomes	 revealed	 that	 polycomb	 repressed	 regions	 are	 moderately	 enriched	 in	DNase-seq	 reads	 and,	 thus,	 might	 contain	 DNase	 hypersensitives	 sites	 reflecting	accessible	 chromatin	 (Roadmap	 Epigenomics	 et	 al.,	 2015).	 Therefore,	 polycomb	repressed	regions	are	not	considered	for	the	composition	of	the	gold	standard	datasets.	This	implies	that	polycomb	repressed	sites	are	prone	to	misclassifications,	due	to	the	co-occurrence	of	DNase	hypersensitive	sites	and	epigenetic	silencing	in	certain	cases.	The	 particular	 advantages	 and	 limitations	 of	 the	 developed	 machine-learning	framework	will	be	discussed	in	the	following.	
5.2.1 Advantages of the chromatin accessibility prediction 	 The	 evident	 advantage	 of	 the	 proposed	 machine-learning	 framework	 is	 its	ability	 to	 provide	 gene-level	 accessibility	 assignments	 of	 genes	 in	 the	 absence	 of	experimental	 chromatin	 accessibility	 assays.	 Validation	 against	 F-Seq,	 MACS	 and	Hotspot	 in	 six	 gold	 standard	 datasets	 suggested	 a	 comparable	 accuracy	 of	 the	predictions	 without	 predictive	 biases	 to	 gene	 types	 or	 the	 GC	 content	 of	 genes.	Especially	 genes	more	 expressed	 than	 0.08	 FPKM	were	 significantly	more	 accurately	classified	 by	 the	 developed	 methodology.	 This	 expression	 level	 is	 significantly	 lower	than	typical	thresholds	for	defining	expressed	genes	(Haltaufderhyde	and	Oancea,	2014;	Rau	et	al.,	2013;	Trakhtenberg	et	al.,	2016)	such	that	the	increased	accuracy	cannot	be	explained	by	the	trivial	assignment	of	expressed	genes	to	accessible	chromatin	domains.		 Furthermore,	 the	 method	 is	 able	 to	 identify	 the	 optimal	 set	 of	 peak	 calling	parameters	in	the	presence	of	experimental	data.	Importantly,	the	optimization	of	peak	calling	 parameters	 does	 not	 require	 prior	 knowledge	 about	 certain	 accessible	 or	inaccessible	genomic	regions,	but	solely	relies	on	the	comparison	to	the	predictions.	Of	note,	the	applicability	of	the	proposed	recall	measure	together	with	the	results	in	the	six	gold	standard	examples	suggests	 that	peak	callers	 typically	 impose	 too	stringent	 false	discovery	rates,	which	is	in	accordance	with	previous	results,	suggesting	that	acceptable	true	positive	rates	require	less	stringent	false	discovery	rates	(Koohy	et	al.,	2014).		 Besides	the	prediction	of	accessible	chromatin	from	transcriptomics	data	alone,	the	 design	 of	 the	 stacked	 classification	 tree	 model	 enables	 the	 integration	 of	 other	predictors.	In	particular,	the	integration	of	chromatin	conformation	capture	data	from,	for	example,	Hi-C	experiments	(Lieberman-Aiden	et	al.,	2009)	could	further	increase	the	
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predictive	 power	 of	 the	 methodology	 by	 providing	 information	 about	 spatial	organization	of	chromatin.	In	 the	 context	 of	 Boolean	 network	 reconstruction,	 the	 prediction	 of	 whether	genes	 are	 located	 in	 accessible	 or	 inaccessible	 chromatin	 domains	 allows	 for	 a	more	precise	 identification	 of	 the	 regulatory	 interactions	 during	 network	 reconstruction.	More	specifically,	it	enables	the	distinction	of	genes	that	are	transcriptionally	repressed	from	those	 that	are	epigenetically	repressed	and	 is	expected	 to	 increase	 the	condition	specificity	of	the	reconstructed	networks.		
5.2.2 Limitations 	 The	 analysis	 of	 the	 predictive	 accuracy	 revealed	 that	 the	 performance	 of	 the	developed	machine-learning	approach	is	reduced	when	considering	all	genes	contained	in	the	gold	standard	datasets.	More	specifically,	non-expressed	genes	(0	FPKM)	cannot	be	 reliably	determined.	 Since	 only	 transcriptomics	 data	 is	 utilized	 for	 the	 predictions	and	 due	 to	 the	 deterministic	 behavior	 of	 the	 stacked	 classification	 tree	model,	 all	 of	these	 genes	 are	 classified	 as	 being	 inaccessible.	 In	 particular,	 deterministic	 machine-learning	 approaches	 relate	 the	 same	 input	 gene	 expression	with	 the	 same	 chromatin	accessibility	 assignment	 such	 that	 this	 limitation	 can	only	be	overcome	by	 integrating	additional	predictors	such	as	chromatin	conformation	capture	experiments.	As	already	mentioned	 in	 the	 last	 section,	 the	 design	 of	 the	 proposed	 methodology	 enables	 the	integration	 of	 additional	 experimental	 data	 as	 a	 predictor	 for	 chromatin	 accessibility,	which	could	address	this	issue.	 	However,	 its	use	for	predicting	gene-level	accessibility	of	the	differentially	expressed	transcription	factors	in	adipocytes	and	osteoblasts	is	not	impeded.	In	particular,	the	only	differentially	expressed	transcription	factor	showing	no	expression	 is	 TCF21,	 which	 has	 no	 reported	 interaction	with	 any	 other	 differentially	expressed	TF	and	is,	thus,	not	included	in	the	prior	knowledge	network.		 Finally,	 it	 is	 worth	 noting	 that	 the	 developed	 methodology	 cannot	 be	 readily	extended	 to	 predict	 active	 regulatory	 regions,	 as	 defined	 by	 peak	 callers,	 from	transcriptomics	 data.	 Gene	 expression	 measurements	 from,	 for	 example,	 RNA-seq	experiments	 do	 not	 provide	 the	 sufficient	 resolution	 for	 pinpointing	 regions	significantly	enriched	in	aligned	reads	from	chromatin	accessibility	assays.	However,	the	proposed	 approach	 is	 able	 to	 assist	 in	 a	 more	 reliable	 definition	 of	 the	 accessible	chromatin	 landscape	 by	 optimizing	 the	 parameters	 of	 current	 peak	 calling	methodologies.	 Nevertheless,	 this	 limitation	 does	 not	 relate	 to	 the	 primary	 aim	 of	predicting	gene-level	accessibility	for	integration	into	the	Boolean	network	formalism.	
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5.3 Reference-based discretization of transcriptomics data Computational	 processing	 of	 experimentally	 derived	 gene	 expression	 data	 is	vital	 for	 drawing	 conclusions	 about	 transcriptional	 differences	 among	 cells	 or	conditions.	 Numerous	 biological	 insights	 have	 been	 obtained	 from	 the	wealth	 of	 data	that	has	been	generated	from	microarray	and	RNA-seq	experiments.	Most	notably,	the	derivation	 of	 cell	 type	 and	 condition	 specific	 gene	 signatures	 allowed	 for	 the	identification	 of	 enriched	 pathways	 and	 biological	 process	 (Palmer	 et	 al.,	 2006;	Ashburner	 et	 al.,	 2000;	 Ko	 et	 al.,	 2013).	 Great	 efforts	 have	 been	 devoted	 to	 the	development	 of	 more	 accurate	 methodologies	 for	 carrying	 out	 enrichment	 analysis	relying	on	previously	defined	gene	 signatures	(Subramanian	et	al.,	 2005;	Huang	et	al.,	2009;	 Eden	 et	 al.,	 2009)	while	 the	 necessity	 for	 the	 concurrent	 development	 of	 tools	producing	these	signatures	has	been	largely	disregarded.	Like	the	development	of	gene	signatures,	discretization	of	gene	expression	data	is	vital	for	the	logic	modeling	of	gene	regulation	with	Boolean	networks.		To	date,	the	most	widely	used	methods	for	discretizing	gene	expression	data	are	based	on	differential	expression	analysis.	Generally	speaking,	 these	approaches	aim	at	identifying	significantly	different	genes	in	two	conditions	based	on	location	shifts	in	the	expression	distributions	and,	thus,	create	an	isolated	view	of	the	two	conditions	under	study	 (Hudson	 et	 al.,	 2012).	 However,	 the	 presence	 of	 more	 than	 two	 conditions	requires	 their	pairwise	comparison	and	cannot	be	studied	as	whole.	This	 is	caused	by	the	 lack	 of	 transitivity	 of	 differential	 expression	 analysis	 and	 can	 be	 illustrated	 by	 a	simple	 scenario.	Given	 three	 conditions	A,	B	 and	C,	 if	 a	 gene	 is	 down-regulated	when	comparing	A	 to	B	and	up-regulated	 in	 the	comparison	of	B	 to	C,	no	conclusion	can	be	drawn	about	its	status	in	the	comparison	of	A	to	C.		Several	approaches	have	been	developed	and	applied	to	allow	for	the	consistent	discretization	of	multiple	gene	expression	profiles	(Catlett,	1991;	Dougherty	et	al.,	1995;	Gallo	et	al.,	2011;	Madeira	and	Oliveira,	2005;	Müssel	et	al.,	2016).	However,	all	of	these	methods	 possess	 important	 limitations.	 First,	 most	 of	 the	 approaches	 derive	 a	 single	gene	 expression	 threshold	 and	 classify	 genes	 to	 be	 active	 or	 inactive	 depending	 on	whether	their	expression	is	greater	or	lower	than	the	threshold,	respectively,	regardless	of	the	statistical	support	(Macqueen,	1967;	Catlett,	1991;	Gallo	et	al.,	2011;	Madeira	and	Oliveira,	 2005).	 More	 recent	 advances	 included	 the	 assessment	 of	 the	 statistical	significance	on	the	separation	of	active	and	inactive	genes	(Müssel	et	al.,	2016),	but	are	limited	 in	 their	 application.	 In	 particular,	 the	 combined	 analysis	 of	 gene	 expression	
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datasets	 from	 different	 cell	 types	 or	 unequally	 spaced	 time-series	 datasets	 results	 in	unquantifiable	 biases	 of	 the	 results.	 Generally,	 all	 developed	 approaches	 share	 the	limitation	of	being	sensitive	to	changes	in	the	datasets	used	for	discretization,	since	they	do	not	take	into	account	the	distinct	expression	distributions	of	genes	across	different	cell	types.	The	developed	methodology,	RefBool,	addresses	these	issues	and	makes	actively	use	 of	 already	 available	 transcriptomics	 data	 for	 providing	 a	 reference-based	discretization	of	gene	 expression	values.	 Its	 particular	advantages	and	 limitations	will	be	discussed	in	the	following.		
5.3.1 Advantages of RefBool 	 RefBool’s	 main	 contribution	 is	 the	 integration	 of	 biological	 knowledge	 in	 the	discretization	 of	 gene	 expression	 data	 and	 considers	 the	 distinct	 expression	characteristics	 of	 individual	 genes	(Djebali	et	al.,	 2012).	Through	 the	 compilation	of	 a	homogenously	processed	set	of	transcriptomics	samples	in	distinct	cell	types,	each	gene	is	associated	 to	an	 individual	distribution	 that	eventually	enables	 the	discretization	of	expression	values	without	requiring	gene	expression	replicates.	In	addition,	rather	than	assigning	 no	 or	 per	 gene	 significance	 of	 the	 discretized	 values,	RefBool	 computes	 the	significance	of	 the	discretized	expression	values	 individually	based	on	 the	distribution	provided	 in	 the	 reference	 library.	 This	 way,	 it	 is	 possible	 to	 dissect	 which	 samples	include	significantly	active	and	inactive	genes	and	which	result	in	insignificant	results.		 Another	advantage	of	the	approach	is	that	the	discretized	expression	values	are	more	 reliable	 compared	 to	 currently	 employed	methodologies	 both	 qualitatively	 and	quantitatively.	The	discretization	of	marker	genes	clearly	showed	the	accurate	detection	of	active	genes	important	for	distinct	stages	of	neuroepithelial	differentiation.	They	have	been	largely	confirmed	by	previously	published	studies	that	particularly	illustrated	their	necessity	 for	 maintaining	 cellular	 identity.	 In	 addition,	 the	 comparison	 to	 current	methods	highlighted	the	improved	performance	with	respect	to	cluster	consistency.	On	average,	the	discretization	of	more	than	30%	of	genes	is	more	consistent	compared	to	any	other	method.		 In	the	context	of	Boolean	network	modeling,	it	allows	the	reconstruction	of	cell	type	or	condition	specific	networks	 that	 is	not	dependent	on	 the	comparison	 to	other	conditions.	 Due	 to	 the	 requirement	 of	 a	 single	 transcriptomics	 sample	 without	replicates,	cellular	heterogeneity	measured	by	single-cell	RNA-seq	could	be	effectively	addressed.	 Cellular	 differences	 in	 the	 transcriptional	 and	 epigenetic	 regulation	 have	
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been	 previously	 implicated	 in	 the	 response	 to	 drugs	 for	 therapeutic	 intervention,	making	 several	 subpopulations	 responsive	 while	 others	 are	 in	 a	 drug-tolerant	 state	(Altschuler	and	Wu,	2010).	Therefore,	the	identification	of	instructive	factors	for	cellular	conversions	as	well	as	the	response	to	cellular	perturbations	is	likely	dependent	on	the	individual	 configuration	 of	 each	 cell.	 Thus,	 modeling	 these	 differences	 could	 provide	important	insights	to	predict	more	efficient	instructive	factors	for	cellular	conversions.		
5.3.2 Limitations 	 Despite	 the	 demonstrated	 improvements	 in	discretizing	 gene	 expression	 data,	the	 utilization	 of	 available	 transcriptomics	 datasets	 as	 a	 reference	 has	 limitations.	 In	particular,	 the	 reference	 dataset	 must	 resemble	 the	 global	 expression	 distribution	closely	 for	 obtaining	 reliable	 results.	 However,	 these	 real	 distributions	 are	 unknown,	which	 hinders	 an	 assessment	 of	 how	 suitable	 the	 selected	 reference	 is.	 Due	 to	 the	impossibility	of	quantifying	those	differences,	it	is	important	to	include	as	many	samples	as	possible	coming	from	diverse	cell	and	tissue	types	and	covering	the	whole	organism.	Nonetheless,	a	weaker	condition	for	 the	reference	 samples	 is	their	 indistinguishability	upon	random	selection	to	identify	a	minimal	number	of	gene	expression	profiles,	which	has	 the	 same	 distribution	 as	 the	 complete	 reference.	 Following	 this	 approach,	 a	minimum	of	550	samples	was	identified	to	be	sufficient	as	a	reference	set.	The	675	RNA-seq	 samples	 used	 throughout	 the	 qualitative	 and	quantitative	 comparison	with	 other	methodologies	is	thus	expected	to	yield	comparable	results	as	if	the	global	distribution	would	be	known.		 Another	important	aspect	to	consider	is	the	experimental	data	that	was	used	for	estimating	the	background	distribution	and	comparing	RefBool	against	other	methods.	In	particular,	all	datasets	were	obtained	 from	bulk	RNA-seq	experiments	 in	which	 the	RNA	 of	 multiple,	 potentially	 heterogeneous	 cells	 was	 sequenced.	 Therefore,	 the	quantified	 expression	 values	 correspond	 to	 the	 average	 expression	 of	 all	 cells,	which	hampers	 the	 interpretation	 of	 discretized	 gene	 expression	 values.	 This	 especially	concerns	 later	 stages	 in	 the	 comparison	 of	 RefBool	 to	 other	 methods	 based	 on	 a	neuroepithelial	differentiation	dataset	including	the	formation	of	embryoid	bodies	(EBs)	and	neural	tube-like	rosettes.	Embryoid	bodies,	for	example,	are	composed	of	multiple	cells	 that	 concurrently	 differentiate	 or	 remain	 undifferentiated	 and	 are,	 thus,	 a	heterogeneous	 population.	 A	 previous	 report	 exemplified	 this	 heterogeneity	 by	examining	 the	 expression	 of	 OCT4	 and	 identified	 significant	 differences	 in	 individual	cells	within	the	same	EB	and	between	different	EBs	(Wilson	et	al.,	2014).	Therefore,	the	marker	genes	of	EB	and	neural	tube-like	rosettes,	which	were	proposed	in	literature	and	
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have	 been	 used	 for	 comparing	 RefBool	 with	 other	 methods,	 are	 not	 necessarily	expressed	 in	 all	 individual	 cells.	 However,	 due	 to	 their	 high	 average	 expression,	 an	accurate	 discretization	 approach	 should	 classify	 these	 genes	 to	 be	 active	 on	 the	population	 level.	 Of	 note,	 RefBool	 can	 be	 readily	 applied	 to	 single	 cell	 sequencing	datasets,	given	that	the	background	samples	cover	the	different	gene	expression	ranges,	to	directly	address	the	heterogeneity	of	cellular	populations.	
5.4 Future Work/Outlook 	 Due	 to	 the	 aforementioned	 limitations	 of	 the	 network	 reconstruction	 process	and	 the	 increasing	 knowledge	 about	 transcriptional	 and	 epigenetic	 mechanisms,	subsequent	 research	 could	 focus	 on	 two	main	 lines.	 First,	 incorporating	 gene-specific	logic	rules	considering	the	cooperative	effects	of	genes	on	the	activation	and	repression	of	 genes.	 Second,	 by	 integrating	 the	dynamic	 regulation	of	accessible	and	 inaccessible	chromatin	 domains	 into	 the	 transcriptional	 regulatory	 network,	 the	 prediction	 of	instructive	factors	might	be	significantly	refined.	In	addition,	the	use	of	proteomics	data	for	 defining	 the	 activity	 genes	 could	 be	 beneficial	 to	 overcome	 the	 use	 of	 gene	expression	data	as	a	proxy	for	protein	abundance.		
Logic Rules 	 Elucidating	the	cooperative	behavior	of	genes	in	the	activation	or	repression	of	transcription	 remains	 a	major	 objective.	 In	 this	 context,	 cell	 type	 specific	 enhancers,	identified	by	acetylation	of	 lysine	27	on	histone	3,	 have	been	 shown	 to	be	an	 integral	part	of	the	regulatory	landscape	for	expressing	lineage-determining	TFs	(Lara-Astiaso	et	
al.,	 2014;	 Monticelli	 and	 Natoli,	 2017).	 Especially	 in	 the	 context	 of	 Boolean	 gene	regulatory	networks,	 the	 integration	 of	 enhancers	 is	 vital	 for	 the	 formulation	 of	 logic	rules.	Since	general	transcription	factors	and	RNA	polymerase	II	are	recruited	to	active	enhancers	where	the	pre-initiation	complex	is	formed	and	transferred	to	the	promoter,	they	are	seemingly	necessary	for	transcription	at	high	levels	(Koch	et	al.,	2011).	For	this	reason,	 a	 gene	 should	 only	 be	 active	 in	 the	 Boolean	 framework	 if	 at	 least	 one	 of	 its	enhancers	 is	 bound	 by	 a	 transcription	 factor.	 However,	 practically,	 the	 availability	 of	enhancer	 specific	 interactions	 in	biological	 knowledge	bases	needs	 to	be	 analyzed	 for	assessing	 the	 feasibility	 of	 distinguishing	 the	 genomic	 binding	 locations	 in	 reported	interactions.		
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Data Integration 	 Understanding	 the	 interplay	 of	 epigenetic	 and	 transcriptional	 changes	 plays	 a	vital	 role	 in	 enhancing	 the	 identification	of	more	 efficient	 combinations	of	 instructive	factors	both	in	vitro	and	in	vivo.	Especially	epigenetic	alterations	are	gaining	increasing	attention	in	the	treatment	of	disease	pathologies	due	to	their	pronounced	effects	on	the	phenotypes	 (Heerboth	 et	 al.,	 2014).	 For	 instance,	 cardiovascular	 diseases,	 such	 as	atherosclerosis,	 are	 attributed	 to	 epigenetic	 dysregulations	 of	 key	 genes.	 There,	estrogen	 receptors	 ESR1	 and	 ESR2,	 which	 are	 usually	 expressed,	 are	 stably	 silenced	through	 hypermethylation	 in	 vascular	 smooth	 muscle	 cells	 leading	 to	 the	 loss	 of	atheroprotective	 estrogen	 effects	 (Heerboth	 et	 al.,	 2014).	 However,	 epigenetic	restructuring	 does	 not	 only	 occur	 in	 the	 context	 of	 disease	 development	 and	progression,	but	also	during	normal	development	and	cellular	conversions,	in	general.	A	notable	 example	 constitutes	 the	 addition	 of	 vitamin	 C	 in	 the	 induction	 of	 pluripotent	stem	cells	promoting	histone	demethylation	and	thereby	increasing	the	efficiency	of	the	conversion	(Esteban	et	al.,	2010;	Eid	and	Abdel-Rehim,	2016).	Thus,	 the	 integration	of	different	regulatory	layers	into	the	framework	for	network	reconstruction	promises	the	identification	of	more	efficient	instructive	factors.		 As	 a	 first	 step,	 gene-level	 chromatin	 accessibility	 information,	 as	predicted	 by	the	presented	machine	learning	approach,	can	be	overlaid	to	exclude	inaccessible	genes,	as	has	been	done	 in	 the	prediction	of	 instructive	 factors	 for	 inducing	 the	 transition	of	adipocytes	 into	 osteoblasts.	 Without	 additional	 information,	 this	 approach	 cannot	explain	how	genes	dynamic	formation	of	accessible	or	inaccessible	chromatin	domains.	However,	 a	 directed	mechanism	 has	 been	 reported	 for	 inducing	 accessible	 chromatin	through	 the	 binding	 of	 pioneer	 transcription	 factors	 to	 unprogrammed	 chromatin	domains,	 i.e.	 in	 which	 histones	 are	 not	 marked	 by	 activating	 or	 repressing	 covalent	modifications	(Iwafuchi-Doi	and	Zaret,	2016).	Even	though	the	molecular	mechanisms	of	 pioneer	 factors	 are	 not	 yet	 understood,	 it	 can	 be	 hypothesized	 that	 a	 reported	interaction	 in	 prior	 knowledge	 networks	 first	 triggers	 chromatin	 decompression,	provided	 that	 the	 target	 gene	 is	 located	 in	 inaccessible	 domains,	 and	 subsequently	regulates	its	target	transcriptionally.	Thus,	including	this	information	leads	to	a	dynamic	rewiring	 of	 the	 gene	 regulatory	 network	 in	 which	 a	 pioneer	 factor	 makes	 a	 gene	accessible	and	allows	for	additional	regulation	of	non-pioneer	TFs.		 Based	on	these	considerations,	a	prototype	was	conceived	that	reconstructs	cell	type	 specific	 networks	 containing	 only	 interactions	 originating	 from	 active	 genes.	Nonetheless,	 inactive	genes	are	still	 included	in	the	networks	as	terminal	nodes	whose	expression	 is	 explained	 by	 transcriptional	 repression	 while	 inaccessible	 genes	 are	
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omitted.	 This	 conceived	model	 is	 otherwise	 based	 on	 the	 same	 considerations	 as	 the	method	presented	 in	this	thesis,	but	overcomes	 the	necessity	 for	representing	distinct	phenotypes	 as	 attractors	 of	 the	 same	 network.	 Due	 to	 the	 absence	 of	 interactions	originating	 from	repressed	genes,	 the	network	 is	 inherently	stable	upon	perturbation.	Therefore,	dynamics	can	be	introduced	through	topological	changes	induced	by	copying	interactions	 from	 the	 final	 to	 the	 initial	 network	 whenever	 a	 gene	 becomes	 active.	Interactions	 to	 inaccessible	 genes	 are	 only	 included	 in	 case	 a	 pioneer	 factor	 was	activated	that	is	a	reported	activator	or	repressor	of	these	genes	and	assuming	its	target	becomes	readily	accessible	for	other	factors,	as	well.	On	the	other	hand,	the	formation	of	inaccessible	genes	could	be	induced	probabilistically	in	each	simulation	step,	since	the	temporal	ordering	of	the	events	is	not	known	a	priori.	With	it,	each	perturbation	needs	to	be	 simulated	multiple	 times	 to	obtain	a	distribution	of	 in	silico	 induced	phenotypic	changes	on	the	network.		 The	 primary	 drawback	 of	 this	 approach	 is	 in	 the	 computational	 resources	needed	 for	 scoring	 the	perturbations.	A	hypothetical	 scenario	 could	 contain	networks	with	 1000	 genes	 and	 the	 simultaneous	 perturbation	 of	 up	 to	 three	 genes.	 Without	preselecting	candidate	instructive	factors,	more	than	166	million	combinations	need	to	be	 simulated	 and,	 due	 to	 the	 probabilistic	 closing	of	 genes,	 repeated	 several	 times.	 If	each	 simulation	 takes	 one	 second	 and	 each	 combination	 is	 repeated	 100	 times,	 the	analysis	 would	 require	 more	 than	 520	 years	 on	 a	 single	 computing	 core.	 This	hypothetical	 example	 underpins	 the	 need	 for	 other	 pre-selection	 schemes	 taking	 into	account	 the	dynamic	 topology	of	 the	networks.	Therefore,	 the	proposed	methodology	remains	 a	 prototype	 needing	 further	 research	 to	 obtain	 insights	 into	 its	 predictive	abilities.		
Proteomics 	 Many	transcriptional	regulatory	processes	require	the	abundance	of	genes	in	the	form	of	proteins	that	bind	to	DNA.	For	that,	the	messenger	RNA	molecules	are	translated	into	 proteins	 by	 ribosomes	 through	 the	 recruitment	 of	 complementary	 tRNA	 codons	carrying	 amino	 acids.	 Like	 transcription,	 the	 translation	 of	 mRNA	 to	 proteins	 is	regulated	through	various	processes,	such	as	microRNA	binding	or	phosphorylation	and	inactivation	 of	 the	 translational	 initiation	 factor	 eIF-2	 (Sonenberg	 and	 Hinnebusch,	2009).	 Due	 to	 this	 additional	 layer	 of	 regulation,	 there	 is	 no	 trivial	 correspondence	between	protein	and	mRNA	abundance,	which	probably	impedes	the	appropriate	use	of	gene	 expression	 as	 a	 proxy	 for	 protein	 abundance	 (Maier	 et	 al.,	 2009).	 Correlation	
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analysis	of	mRNA	and	protein	abundance	in	mouse	xenograft	models	of	ovarian	cancer	highlights	 this	 issue	 and	 found	 no	 significant	 correlations	 between	 the	 two	measures	(Koussounadis	 et	 al.,	 2015).	 The	 same	 study,	 however,	 also	 identified	 significantly	elevated	correlations	for	differentially	expressed	genes,	which	supports	the	decision	of	a	Boolean	modeling	 framework	 based	 on	 differential	 expression	 analysis.	 Nevertheless,	evaluating	the	correspondence	with	respect	to	discretization	by	RefBool	is	important	to	verify	the	suitability	of	absolute	discretization,	as	well.	In	case	no	significant	correlation	can	 be	 detected,	 the	 use	 of	 proteomics	 data	 that	 can	 be	 translated	 to	 network	 states	could	overcome	this	impediment.		
5.5 Conclusion 	 The	 advent	of	 cellular	 conversions	 through	 the	 ectopic	 expression	of	 cell	 type	specific	 transcription	 factors	 constituted	 an	 important	 step	 towards	 regenerative	medicine.	Continued	efforts	in	elucidating	the	transcriptional	and	epigenetic	landscapes	have	 led	 to	 the	 identification	 of	 numerous	 target	 gene	 combinations	 that	 are	 able	 to	induce	the	conversion	towards	a	desired	cell	type.	Predominantly,	these	approaches	rely	on	cell	type	specific	expert	knowledge	and	the	sequential	interpretation	of	experimental	evidences.	 Here,	 computational	 approaches	 that	 systematically	 analyze	 and	 integrate	diverse	sources	of	available	biological	information	are	beneficial	to	the	establishment	of	instructive	factors	inducing	novel	cellular	transitions.	Knowing	the	regulatory	networks	and	their	differences	in	the	modulation	of	distinct	gene	expression	programs	will	enable	the	selection	of	crucial	cell	fate	regulators,	the	simulation	of	cellular	responses	to	gene	perturbations,	 and	 ultimately	 an	 increase	 in	 efficiency	 and	 fidelity	 of	 cellular	conversions.		 Both	 the	 absence	 of	 experimental	 data	 and	 adequate	 computational	 tools	 for	processing	 them	as	well	as	the	simplifications	of	existing	models	hindered	the	orderly	identification	of	instructive	factors.	The	goal	of	this	thesis	was	to	address	some	of	these	issues.	The	contributions	made	in	this	thesis	are	that:	
• Condition	specific	Boolean	gene	regulatory	networks	can	be	reconstructed	from	 transcriptomics	data	 and	prior	 knowledge	networks	 that	 account	 for	 the	distinct	 transcriptional	 and	 epigenetic	 landscapes	 of	 cells.	 The	 developed	methodology	largely	captures	validated	interactions,	which	have	been	identified	by	 transcription	 factor	 specific	 ChIP-seq	 experiments.	 This	 provides	 a	topological	 validation	 of	 the	 networks,	 which	 has	 direct	 consequences	 on	 the	dynamic	 behavior	 of	 the	 model.	 The	 elevated	 condition	 specificity	 of	
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reconstructed	networks	is	further	supported	by	the	comparison	to	other,	similar	methods	 showing	 decreased	 recoveries	 of	 discretized	 phenotypes	 and	experimentally	validated	interactions.	
• Using	 a	 knowledgebase	 of	 biological	 information	 makes	 network	
reconstruction	 tractable	 with	 minimal	 data	 requirements.	 Large	 data	requirements	 hindered	 the	 development	 of	 a	 general	 tool	 for	 inferring	instructive	 factors	 of	 cellular	 conversions.	 Most	 current	 tools	 either	 require	substantial	amounts	of	experimental	input	data,	which	is	largely	unavailable,	or	do	 not	 allow	 for	 the	 specification	 of	 condition	 specific	 data	 other	 than	 gene	expression.	 The	 presented	 methodology	 for	 condition	 specific	 network	reconstruction	 provides	 a	 framework	 that	 only	 requires	 a	 discretized	 gene	expression	 profile	 and	 prior	 knowledge	 networks	 as	 a	 minimal	 requirement	while	 additional,	 condition	 specific	 epigenetic	 information	 can	 be	 readily	integrated.	
• Candidate	 instructive	 factors	 can	 be	 defined	 by	 differential	 network	
analysis.	 In	 the	 search	 for	 combinations	 of	 instructive	 factors	 having	 the	potential	to	induce	a	desired	cellular	transition	upon	perturbation,	it	is	essential	to	 prioritize	 and	 select	 a	 tractable	 number	 of	 candidate	 genes.	 Topological	comparison	 of	 two	 networks	 by	means	 of	 common	 regulatory	 feedback	 loops	and	differentially	regulated	genes	identifies	important	cellular	regulators.	With	it,	 important	 genes	 implicated	 in	 maintenance	 and	 progression	 of	 Systemic	Lupus	Erythematosus	and	Rheumatoid	Arthritis	as	well	as	in	shaping	the	cellular	identity	of	osteoblasts	could	be	identified.	
• Drugs	can	be	prioritized	by	 in	silico	perturbation	of	candidate	 instructive	
factors.	 The	 simulated	 effects	 of	 multitarget	 combination	 perturbations	establish	 a	 condition	 for	 prioritizing	 drugs	 that	 are	 able	 to	 induce	 desired	phenotypes.	 Applying	 the	 proposed	 strategy	 might	 substantially	 reduce	 the	amount	of	compounds	that	need	to	be	screened	for	identifying	new	therapeutic	interventions	by	repurposing	known	drugs.	However,	the	efficacy	of	prioritized	drugs	dependence	 on	many	 other	 factors	 such	 as	 their	 toxicity	 or	 affinity	 and	specificity	to	molecular	targets.	
• Transcriptional	 comparison	 of	 multiple	 cell	 types	 can	 be	 enhanced	 by	taking	 into	 account	 the	 distinct	 expression	 distribution	 of	 individual	 genes.	Typically,	 transcriptional	 profiles	 are	 processed	 by	 means	 of	 differential	expression	 analysis	 to	 obtain	 insights	 into	 significant	 differences	 in	 mRNA	abundance.	 This	 approach,	 however,	 creates	 an	 isolated	 view	 of	 the	 two	
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conditions	under	study	and	does	not	allow	for	 the	comparison	of	multiple	cell	types	 or	 conditions.	 RefBool	 integrates	 available	 transcriptomics	 data	 for	providing	 accurate	 assignments	 of	 whether	 genes	 are	 active	 or	 inactive	 in	 a	particular	 condition.	 With	 it,	 the	 comparison	 of	 multiple	 cell	 types	 becomes	feasible	 and	 can	 be	 applied	 to	 all	 analysis	 involving	 the	discretization	 of	 gene	expression	data	 such	 as	 gene	 set	 and	overrepresentation	 enrichment	 analysis.	Together	 with	 the	 developed	 methodology	 for	 gene	 regulatory	 network	reconstruction,	 it	 enables	 the	 consistent	 comparison	 of	 multiple	 condition	specific	networks.	
• Transcriptomics	data	is	 indicative	of	gene-level	accessibility	and	is	equally	predictive	as	experimental	chromatin	accessibility	data	processed	with	current	downstream	 computational	 tools.	 The	 developed	machine-learning	 framework	for	predicting	gene-level	accessibility	enables	the	distinction	of	transcriptionally	and	 epigenetically	 silenced	 genes	 for	 better	 understanding	 the	 cellular	 gene	regulatory	network	in	the	absence	of	experimental	data.	In	addition,	parameter	settings	of	 current	peak	 calling	methods	 can	be	optimized	 for	 improving	 their	ability	to	detect	active	regulatory	regions	throughout	the	genome.	 	As	such,	the	developed	 methodology	 is	 able	 to	 overcome	 the	 main	 limitation	 of	 current	downstream	 computational	 tools	 and	provides	 predictions	 that	 can	 be	 readily	integrated	into	the	condition	specific	gene	regulatory	network	reconstruction.		This	thesis	provided	an	innovative	framework	for	reconstructing	condition	specific	gene	regulatory	networks	 that	 approaches	 current	 impediments	 through	 the	 integration	 of	available	 prior	 knowledge	 networks,	 statistical	 and	 machine	 learning	 methodologies	and	the	acknowledgment	of	the	cellular	differences	in	transcriptional	regulation,	which	are	modulated	by	 the	 chromatin	 accessibility	 landscape.	The	 assumption	 that	distinct	networks	 underlie	 phenotypic	 stabilization	 and	 its	 implementation	 in	 the	 current	approach	 is	 an	 integral	 component	 for	 future	 integration	 of	 additional	 layers	 of	condition	specific	information,	such	as	histone	modifications	and	chromatin	remodeling	by	 pioneer	 factors.	 Finally,	 the	 proposed	 framework	 is	 able	 to	 identify	 candidate	instructive	 factors	 and	 prioritize	 their	 combination	 in	 inducing	 desired	 cellular	transitions,	 which	 will	 be	 useful	 in	 assisting	 the	 establishment	 of	 new	 therapeutic	approaches	in	regenerative	medicine.		 	
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Appendix 	
Supplementary Tables 	
Table	S1.	Gene	expression	datasets	for	network	inference	validation	
Cell	line	 GEO	accessions	
GM12878	 GSM993481,	GSM993482,	GSM993483	
H1-hESC	 GSM993497,	GSM993498,	GSM993499,	GSM993500	
HepG2	 GSM993552,	GSM993554,	GSM993556,	GSM993557	
K562	 GSM993518,	GSM993519,	GSM993520			
Table	S2.	ENCODE	filenames	of	transcription	factor	ChIP-seq	data	for	defining	accessible	chromatin	
regions	
A549	 GM12878	 H1-hESC	 HeLa-S3	 HepG2	 K562	
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Table		S3.	Utilized	datasets	for	reference-based	discretization	of	gene	expression	data	
Dataset	 Reference	 Accession	
Cancer	cell	line	background	
distribution	
(Klijn	et	al.,	2014)	 E-MTAB-2706	(Array	Express)	
Neuroepithelial	differentiation	 (Qiao	et	al.,	2015)	 GSE68396	(GEO)	
Microarray	background	
distribution	
(Torrente	et	al.,	2016)	 E-MTAB-3732	(Array	Express)		
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